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Abstract

The nucleosome remodeling factor (NURF) is an evolutionary conserved ATPdependent chromatin remodeling factor. It was first isolated from Drosophila as a
complex with enzymatic activity that once recruited to nucleosome, it slides the
nucleosome to provide accessibility for transcription factors. Since then, numerous
works from animal models and cell lines show the role of NURF as a regulator of gene
expression. NURF interacts with H3K4me3 and sequence specific transcription factors
that recruit the complex to promoter regions. Whether this is the only mechanism by
which NURF regulates gene expression is not known. However, other ATP-dependent
chromatin remodeling complexes are known to regulate gene expression independent
from transcription initiation. In order to explore the role of NURF in regulating gene
expression, we utilized two genome wide approaches to map NURF binding and NURF
dependent changes in chromatin structure using ChIP-Seq and FAIRE-Seq,
respectively. From these analyses, we discovered that NURF broadly localizes in the
genome with preferences to gene bodies and 3’ends of genes. Also, we found that
NURF maintains open chromatin regions at upstream, intron and downstream of genes.
These novel findings shed light on new roles for NURF complex within genes, in
addition to its classical role at promoter regions. Furthermore, we discovered the
function of a previously uncharacterized domain in the NURF specific subunit BPTF. We
show that the N-terminal the plant homeodomain (PHD) of BPTF directly interacts with
THOC4, a protein associated with RNA-pol 2. Also, we show using ChIP analyses that
this interaction recruits BPTF to gene bodies. Next, we investigated functional
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consequences for NURF recruitment to gene bodies using Cyclin D1 (Ccnd1) gene as a
model. These analyses revealed that NURF is required for normal mRNA processing
and loss of NURF induces intron retention, which results in unstable transcripts. Finally,
we show that the defect in mRNA processing is not specific to the Ccnd1 gene, as we
observe similar defects in four other BPTF dependent genes. Together, our work
uncovered new role of mammalian NURF complex in regulating gene expression
through mRNA processing.
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CHAPTER ONE
Introduction

Overview
In multicellular organisms, all cells share the same genetic material. However
diverse cell types exist which are functionally and phenotypically distinct. This is
achieved by modulating the genome to allow cell type specific gene expression. A key
to this process is regulating the chromatin structure. Mechanisms that regulate the
chromatin structure include histone modifications, histone variants and Adenosinetriphosphate (ATP)-dependent chromatin remodeling complexes (Rando and Chang
2009). In oppose to alterations in DNA sequences, alterations in chromatin structure
can be reversible. Extensive research on histone modifications clarifies their role in
normal tissues and their impact on diseases and tumorigenesis (Brookes and Shi 2014).
Eventually, this led to the development of successful therapeutic drugs, such as the
histone deacetylase inhibitors suberoylanilide hydroxamic acid (SAHA) to treat certain
type of human cancers (Esteller 2007). This highlights the importance of exploring roles
of other chromatin regulators in cell biology and the impact they have on pathological
states. Important regulators of chromatin structures that also impact gene expression
are the ATP-dependent chromatin remodeling complexes (Clapier and Cairns 2009).
These complexes have enzymatic activity that allows remodeling chromatin structure,
and they are involved in regulating gene expression, DNA repair and DNA replication.
The Nucleosome Remodeling Factor (NURF) is one of the ATP-dependent
chromatin remodeling complexes. NURF is essential for embryonic development and
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cell differentiation, but not survival of normal cells (Landry , Sharov , et al. 2008)
(Landry, et al. 2011). Recently, a number of reports showed the requirement of the
NURF specific subunit BPTF in cancer cell growth, and correlation between BPTF
expression and the poor prognosis in cancer patients (Dar, et al. 2015) (Xiao, Liu and
Lu, et al. 2015) (Xiao, Liu and Fang, et al. 2015). In addition, down regulation of NURF
catalytic subunit has adverse effects on cancer cell growth but not normal cells (Ye, et
al. 2012). This suggests that further characterization of NURF is required to understand
its role in normal cells as well as cancer cells. Works from Drosophila and mouse model
as well as human cell lines suggest that NURF functions as a regulator of gene
expression (Alkhatib and Landry 2011). However, mechanisms by which NURF
regulates gene expression in vivo are largely unknown. To date, NURF localizes to
promoter regions through specific recognition to H3K4me3, H4K16ac and interaction
with sequence specific transcription activators or repressors. However, in Drosophila
the recognition of H3K4me3 by NURF is not required to regulate a majority of NURF
dependent genes. In addition, role of chromatin remodeling complexes in gene
expression is not limited to transcription initiation. Genome wide approaches uncovered
new insights into roles of chromatin-associated proteins. In this work we proposed three
aims to better understand how NURF complex function as a regulator of gene
expression:
Aim1: Identifying NURF Localization Genome Wide in Mouse Genome

Aim2: Identifying NURF Dependent Changes in Chromatin Structure Using
FAIRE-Seq
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Aim3: Characterize a Mechanism of NURF Recruitment to Chromatin and
Role in Regulation of Gene Expression

1.1 Chromatin structure
In eukaryotes, the genetic information is stored in the deoxyribonucleic acid
(DNA). The human genome contains ~3 billion nucleotides, which as a linear DNA is
approximately 2 meters length. In order to fit the DNA into the ~10 micrometer (µm)
nucleus, the nuclear DNA is packaged with RNA and proteins to form chromatin.
However, this structure prevents the accessibility of DNA binding proteins (DBPs) to the
underling DNA sequences, which is required to read, replicate or maintain the integrity
of the genetic information. To overcome this problem, the cells utilize mechanisms that
modulate the chromatin structure and to promote the accessibility of DBPs. Thus, the
chromatin functions is an efficient tool to package the genomic material in the nucleus
and an important regulator of DNA dependent processes such as gene expression,
DNA replication and DNA damage repair (Clapier and Cairns 2009).
Fundamental component of the chromatin are histone proteins. The core histone
proteins are highly conserved, which reflects the conservation of chromatin structure in
eukaryotes. The basic subunit of this structure is a nucleosome in which 146 base pair
(bp) of double stranded DNA is wrapped around eight histone proteins (2 dimer each of
H2A/H2B and H3/H4) (Luger, et al. 1997). Series of nucleosomes form the beads on
string, 11 nanometer (nm) nucleosome fiber. Addition of linker histones and internucleosomal interactions within the fiber fold the chromatin into more condensed, 30 nm
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structure. Further folding of the chromatin into even higher ordered structures exists in
the nucleus (Li and Reingberg 2011).
Based on degree, chromatin is organized into domains with less condensed and
active regions (euchromatin) or more condensed and repressed regions
(heterochromatin) each contains specific set of chromatin modifications and associated
proteins (discussed below). Heterochromatin further can be divided into constitutive and
facultative heterochromatin. Constitutive heterochromatin are usually gene poor regions
and contain high content of repetitive elements which occupy telomeric, centromeric
and pericentromeric regions. Therefore, Constitutive heterochromatins are similar in
different cell types. Facultative heterochromatin regions contain genes that are
developmentally regulated genes or genes that are inactive at specific cell stage or
expressed from one allele depends on parent of origin (imprinting). Thus, facultative
heterochromatin is different between cells types (Trojer and Reinberg 2007).
Maintaining the integrity of these domains can be mediated through insulator
elements at the boundaries of these domains. CCCTC-binding factor (CTCF) is a
protein that binds to these elements and involve in long distance interactions that
regulate the chromatin topology within the nucleus (Ghirlando, et al. 2012). In addition,
the cohesin complex, which is a multi-subunit complex that associates with CTCF, is
also involved in chromatin looping that mediate close localization of two regulatory
elements that are far from each other in term of genetic distance such as enhancer to
promoter regions (Dekker 2008)
The chromatin structure is highly dynamic, and global change in chromatin
structure occurs during cell differentiation. In embryonic stem cells (ESC) the chromatin
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is less condensed and more accessible comparing to differentiated cells. For example,
deposition of linker histone and heterochromatin protein 1 (HP1) is more dynamic in
ESC, and they become more stabilized upon differentiation. Also, an increase in
incorporation of repressive histone marks is associated with differentiation which lead to
more heterochromatin formation in differentiated cells (Saladi and Serna 2010).

1.2 Factors Influence Chromatin Structure
1.2.1 Histone Modifications
Histone modifications are post-translational modifications (PTMs) on histone
proteins mainly at the amino terminal (N-terminal) and to less extent in the carboxy
terminal (C-terminal) and core residues. The N- terminal tails of H2A, H2B, H3 and H4
are extended outside the nucleosome core structure and contain 19 to 40 amino acids
rich with basic residues (Lysine (K) and Arginine (R)). Histone tails can directly influence
chromatin folding through interactions with other histone proteins. For example, basic
residues between amino acid 16-20 of H4 tail interact with an acidic region at H2A core
protein of the neighboring nucleosome and promote internucleosome interaction (Luger,
et al. 1997) (Zhou, et al. 2007). Another example is the role of the N-terminal tail of the
H2A in regulating the linker histone H1 incorporation into nucleosome (Jason, et al.
2005).
Major PTMs that can modify histone proteins are methylation, acetylation,
phosphorylation and ubiquitination (Figure 1.1). The main role of PTMs on histone tails
is to serve as a signal or a platform for chromatin modifying proteins and transcription

	
  

5	
  

	
  
factors (TFs) that contain specific domains that recognize these PTMs. For example,
methylation can be recognized by chromodomain, plant homeodomain (PHD) and
PWWP domain, and acetylation is mainly recognized by bromodomain (Zeng and Zhou
2002), but, recently, tandem PHD finger also found to bind to acetylated histone (Zeng,
Zhang, et al. 2010).

Figure 1.1

Figure 1.1: A diagram showing common PTMs on canonical histone
tails
Amino acids sequences for canonical histone tails N-terminal, left and Cterminal, right from the core protein (center, bold). Each residue colored
based on the PTM and numbered based on the distance from the core
protein. Adopted and modified from (Lodish, et al. 2008).

Acetylation occurs on lysine (K) residues. One proposed function of acetylation is
to modulate high order chromatin structure as it neutralizes the basic charge of the

	
  

6	
  

	
  
lysine. As mentioned above the basic residue in the H4 tail from one nucleosome can
interact with the H2A in the adjacent nucleosome (Luger, et al. 1997), and acetylation
neutralizes the charge of these residues and abolishes the interaction. An in vitro study
using recombinant nucleosome showed that acetylation of lysine 16 on histone 4
(H4K16ac) affects nucleosome folding compared to unmodified H4K16 (ShogrenKnaak, et al. 2006). Additionally, histone acetylation can facilitate displacement of
H2A/H2B dimer from nucleosomes by histone chaperones, which provide more open
structure (Ito, Ikehara, et al. 2000). In addition, studies in Drosophila showed that
acetylation at H4K16 and H4K12 interfere with nucleosome spacing factors in mediating
chromatin compaction (Corona, et al. 2002). In yeast, acetylation at K56 at the core of
H3 reduces DNA-binding to the nucleosome and promotes nucleosome disassembly
(Williams, Truong and Tyler 2008). These findings suggest that acetylation opens
chromatin structure and promotes accessible chromatin confirmation. Indeed, genome
wide localization of different acetylated lysine residues showed association with active
regions. In mouse embryonic stem cells (mESCs), H4K16ac showed enrichment at
transcription start sites (TSSs) of active genes (Taylor, et al. 2013). Genome wide study
investigating enhancer elements in mESCs and adult tissues showed that acetylation of
lysine 27 on histone 3 (H3K27ac) is enriched at active enhancers versus poised
enhancers (Creyghtona, et al. 2010). In addition, investigation of acetylation of lysine 9
on histone 3 (H3K9ac) and lysine 4 on histone 3 (H3K4ac) localization revealed
enrichment over bivalent promoters mESCs (Karmodiya, et al. 2012). The acetylated
lysine can also facilitate open chromatin structure through recruitment of bromodomain
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containing ATP-dependent chromatin remodeling complexes (Clapier and Cairns 2009)
(discussed below).
Methylation occurs mainly on lysine residues and to less extent on arginine
residues (Kouzarides 2007). Methylation on lysine is a well-characterized modification
and it mediates its effect through recruitment of chromatin binding factors. Depending
on the modified lysine reside, methylation can be associated with euchromatin,
constitutive or facultative heterochromatin. Euchromatin marks include mono-,di and tri
methylation on lysine 4, di and tri-methylation on lysine 36 and tri-methylation on lysine
79 on histone 3, (H3K4me1/2/3), (H3K36me2/3) and (H3K79me3), respectively
(Kouzarides 2007). H3K4me3 marks active promoters and recruits important factors
that modulate open chromatin confirmation. For example, it can recruit ATP-dependent
chromatin remodeling complexes such NURF (Wysocka, et al. 2006) and the
chromodomain helicase DNA binding1 (CHD1) (Sims, et al. 2005) to promoter regions
to facilitate gene expression. Genome wide localization of H3K4me3 showed
localization at TSSs and high correlation with gene expression (Barski, et al. 2007).
H3K4me1 localizes within genes and at distal enhancer regions, which are marked by
presence of p300 histone acetyl transferase, DNase hypersensitivity sites (DHSs), and
conservation among species (Heintzman, et al. 2007). H3K36me2/3 exist as a broad
domain within open reading frame of active genes (Barski, et al. 2007). Within active
transcripts H3K36me3 is more enriched at exons than introns (Spies, et al. 2009)
(Kolasinska-Zwierz, et al. 2009) suggesting a role in messenger RNA (mRNA)
processing through altering elongation rate (Sims and Reinberg 2009). Indeed, many
studies document the role of H3K36me3 in recruiting factors important for alternative
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splicing (discussed in section 1.5.2). Studies in yeast showed the role of H3K36me3 in
maintaining the integrity of nucleosomes during transcription elongation, and reducing
H3K36me3 levels results associated with initiation of incryptic transcription within genes
(Smolle, et al. 2012). H3K36me3 is recognized by the histone deacetylase Rpd3S
complex that mediate deacetylation of the nucleosomes behind the RNA-polymerase II
(RNA-pol 2) to condense the chromatin and prevent cryptic transcript (Li, et al. 2009).
However, in Drosophila Bell, et al. showed that H3K36me2 recruits histone acetyl
transferase (HAT) to mediate H4K16ac and decondense chromatin while H3K36me3
recruits the histone deacetylase (HDAC) Rpd3S to condense the chromatin (Bell, et al.
2007). Although, the human homolog of Rpd3S complex has been recently isolated, it
only promotes deacetylation around TSSs suggesting that this mechanism is not
conserved in mammals (Jelinic , Pellegrino and David 2011). Also, H3K36me3 can
recruit ATP-dependent chromatin remodeling complexes (discussed in section 1.5.1)
(Maltby, et al. 2012) (Smolle, et al. 2012).
Tri-methylation of lysine 9 on histone 3 (H3K9me3) is usually associated with
constitutive heterochromatin and condensed chromatin structure. This effect is mainly
mediated by recruiting the heterochromatin protein 1 (HP1) through its chromodomain.
Subsequently, HP1 recruits factors such HAT and DNA-methyl transferase (DNMT) to
create and maintain a repressed environment. For example, binding of HP1 to
H3K9me3 can recruit H3K9 methyltransferase that methylate adjacent H3K9 which then
serve as a binding site for a new HP1 protein. This mechanism likely involves in the
spreading of the heterochromatin regions (Campos and Reinberg 2009). In ESC,
H3K27me3 (repressive mark) and H3K4me3 (active mark) overlap over promoter
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regions of genes that are regulated during differentiation. Upon differentiation to specific
cell lineage, genes required for the determined fate exhibit the H3K4me3 and actively
expressed while genes that are not required for the fate exhibit H3K27me3 and
remained repressed (Rando and Chang 2009).
Role of ubiquitination is dependent on the modified residue. Monoubiquitination
of H2A functions as a recruiter of polycomb repressive complex 2 (PRC2) complex that
mediate H3K27me3, which is recognized by polycomb repressive complex 1 (PRC1)
repressor complex (Kalb, et al. 2014). Monoubiquitnation of H2AK119 (H2AK119ub1)
has a repressive effect as it prevents dissociation of linker histone H1 and prevents
recruitment of the H2A/H2B histone chaperone facilitates chromatin transcription
(FACT) which is important for RNA-pol 2 elongation (Zhou, et al. 2008). While
H2AK119ub1 acts as a repressor, ubiquitination of human H2BK120 (H2BK123 in
yeast) is associated with active gene expression. Its role in gene expression occurs by
facilitates FACT recruitment (Pavri, et al. 2006).
	
  
1.2.2 Histone Variants
Histone variants are non-canonical histones that are deposited into nucleosomes
in replication independent manner. Due to sequence differences, incorporation of
histone variants alters the nucleosomal properties. Two important histone variants are
the H2A variant H2A.Z and the H3 variant H3.3 (Venkatesh and Workman 2015).
H2A.Z is a highly conserved protein and its incorporation into nucleosomes is
mediated by the ATP-dependent chromatin remodeling complex Snf2-related CBP
activator protein (SRCAP) in human (SWR1 in yeast). Due to sequence differences,
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H2A.Z containing nucleosomes are less stable compared to H2A containing
nucleosomes (Campos and Reinberg 2009). In addition H2A.Z increases association of
chromatin remodelers to nucleosomes as opposed to H2A (Goldman, Garlick and
Kingston 2010). Genome wide studies showed that H2A.Z is enriched in promoters,
enhancer regions and CTCF binding sites (Hu, et al. 2013)(Fu, et al. 2008). In mESC,
loss of H2A.Z is associated with increased nucleosome occupancy at enhancer regions,
which indicates its role in regulating accessibility to DNA (Hu, et al. 2013). In human, the
H2A.Z level at promoters is correlated with gene expression (Barski, et al. 2007).
H3.3 is a replication independent histone 3 variant that only differ from the
canonical H3 at 5 amino acids. H3.3 is found in TSS, gene bodies and distal regulatory
elements. The histone chaperone DAXX in human mediates incorporation of this variant
into nucleosomes (Drané, et al. 2010). Incorporation of H3.3 into nucleosomes
decreases nucleosome stability (Jin and Felsenfeld 2007) and prevents incorporation of
linker histone (Braunschweig, et al. 2009). KD of H3.3 is associated with increased
localization of H1 linker histone at TSS and cis-regulatory elements, suggesting that
H3.3 maintains open chromatin conformation at these regions. Genome wide studies in
mESCs shows that high turnover rate of H3.3 at nucleosomes free regions (NFRs) at
the TSS and enhancers. The H3.3 turnover rate is directly associated with gene activity
(Ha, Kraushaar and Zhao 2014).

1.2.3 ATP-dependent chromatin remodeling complexes
The nucleosome structure can mask or disrupt binding sites for sequence
specific TFs or DBPs. As the double stranded DNA (dsDNA) is wrapped around the
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histone octamer, there are 14 DNA-histone contacts in a nucleosome that need to be
disrupted in order to mobilize the nucleosomes. Major regulators of chromatin structure
that utilize ATP as energy source are the ATP-dependent chromatin remodeling
complexes. These complexes are involved in regulation of gene expression, DNA
damage response and DNA replications (Bartholomew 2014).
Generally, these are multi-subunit complexes; although some function as
monomer. In each complex, accessory subunits are assembled with an ATPase
subunit, which is required for the enzymatic activity (Clapier and Cairns 2009). These
complexes belong to the sucrose non-fermenting 2 (Snf2) family of ATP-dependent
helicases (Flaus, et al. 2006 ). Based on the sequence homology of the ATPase domain
and additional domains within the ATPase subunit this family can be further divided into
subfamilies. The major four subfamilies are Switching defective 2/sucrose nonfermenting 2 (SWI/SNF), Imitation switch (ISWI), Chromodomain, helicase and DNA
binding (CHD) and Inositol requiring 80 (INO80) (Bartholomew 2014).
The ATPase subunits from all the subfamilies share the highly conserved
ATPase domain which has the ATP binding domain DEXDc adjacent to a helicase
domain HELICc that are required for the remodeling activity. However, each subfamily
has characteristic features within the ATPase subunit. These include bromodomain in
the SWI/SNF complexes, three conserved domains in the C-terminal region for the ISWI
complexes (discussed in section 1.4.1) and tandem chromodomains for the CHD
complexes. An extended insertion within the ATPase domain is characteristic for the
INO80 complexes (Clapier and Cairns 2009).
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Chromatin remodeling activity consists of sliding a nucleosome, ejecting histone
octamer, loop or unwrap the DNA from the nucleosome or exchanging histone variants.
Sliding can lead to either expose or mask a DNA motif that can be recognized by a DBP
such as a TF. Ejecting nucleosome is required when a stretch of DNA free of
nucleosome is necessary such as in DNA repair or DNA replication. Histone variant
exchange is required to mark regions in the genome with regulatory (Bartholomew
2014) (Figure 1.2).
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Figure 1.2
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Figure 1.2: Outcomes of ATP-dependent chromatin remodeling complexes
DNA (Black line) is wrapped around the histone octamer (Gray cylinder) to form nucleosomes. A
DNA sequence (Red line) that can be recognized by a DBP (While oval) is inaccessible (Top).
Recruiting a chromatin remodeling complex lead to either slide, eject, unwrap or loop the DNA
or exchange histone variant (Bottom) which make the DNA element accessible to the DBP.
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Recruiting remodelers to chromatin can be through recognition of histone
modifications or interacting with DBPs. These interactions can be through domains in
the catalytic subunits such as the case of the SWI/SNF bromodomain (recognizes
acetylated histones) and the CHD chromodomain (recognizes histone methylation)
(Clapier and Cairns 2009). In addition, accessory subunits that assemble with the
catalytic subunit can further harbor reader domains that recognize modification over
DNA or histones. As the case for the Bromodomain PHD transcription factor (BPTF)
subunit of NURF that has PHD domain and bromodomain that specifically recognize
H3K4me3 and H4K16ac, respectively (Wysocka, Swigut, et al. 2006) (Ruthenburg, et al.
2011). Another example is the methyl binding domain 3 (MBD3) subunit of nucleosome
remodeling and histone deacetylase (NURD) complex (CHD complex) that recognize
methylated DNA (Marfella and Imbalzano 2007). However, accessory subunits can also
function to enhance the remodeling activity of complexes or provide additional
enzymatic activity. For example, in the ACF complex the accessory subunit Acf1 in
Drosophila greatly enhances the ATPase activity of the ATPase subunit ISWI (Ito,
Bulger, et al. 1997). The histone deacetylase HDAC subunit is a core subunit of NURD
complex and allows NURD complex to have a deacetylase activity along with the
ATPase activity (Denslow and Wade 2007). Although the remodeling activity requires
interaction with nucleosomal DNA by the ATPase domain, these interactions are mostly
sequence non-specific. However, remodelers interact with sequence specific TFs that
can recruit them to chromatin (Becker and Workman 2013).
The need of chromatin remodeling in transcription comes from the fact that
transcription is mediated through a chromatin template. Initiation of transcription
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requires binding of sequence specific transactional co-activators at promoter regions
and assembling of pre-initiation complexes (PIC) at transcription start sites. In addition,
following initiation, the elongating RNA-pol 2 must traverse nucleosomes within the
genes bodies (Campos and Reinberg 2009). Thus, along with other chromatin
modifying factors such as histone chaperones, ATP-dependent chromatin remodeling
complexes are required for normal regulation of transcription (Discussed in section
1.5.1)
In DNA replication, multiple remodelers are associated with replication foci
required for DNA synthesis such as the ISWI containing complexes (Erdel and Rippe
2011). For example, the ATP-utilizing chromatin assembly and remodeling factor 1
(ACF1) (a subunit of ACF complex discussed below) protein is associated with
replicating heterochromatin and ACF1 KD showed delay in late S-phase, a time for
heterochromatin replication (Collins, et al. 2002).

1.2.3.1 SWI/SNF Chromatin Remodeling Complexes
In mammals, the SWI/SNF subfamily are large multi-subunits complexes
composed of 8 to 12 subunits which assemble with one of two ATPase subunits;
Brahma (BRM) or Braham-related gene1 (BRG1) to form Brahma-associated factor
(BAF) or polybromo-BAF (PBAF) complexes, respectively. Each complex assembles
with one ATPase subunit (BRG1 or BRM), common accessory subunits and subunits
specific for BAF complexes and specific for PBAF complexes (Hargreaves and Crabtree
2011). The SWI/SNF complexes are essential for embryonic development,
neurogenesis, erythropoiesis, thymocyte development and heart development. They
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can slide or eject nucleosomes as remodeling mechanisms, and their main function is
regulation of gene expression. They are recruited to chromatin through recognition of
histone modifications and interaction with sequence specific transcription factors. The
bromodomain in the ATPase subunit recognizes the acetylated histone tails. In addition,
BRG1 interacts with TFs such as Erythroid Krüppel Like Factor (ELKF) and GATA-1
and BRM interacts with proteins involved in Notch signaling pathways (Kadam and
Emerson 2003). Additionally, the accessory subunits contain domains that provide
additional contact surfaces to histone modifications (e.g. polybromo domains in
BAF180), proteins (HSA in BRG1 and BRM) and DNA (AT-rich interactive domain 1 a/b
(ARID1a/b)) (Hargreaves and Crabtree 2011).
The effect on gene expression can be through remodeling activity at promoter
regions. For example, SWI/SNF complexes are recruited to promoters of nuclear
receptors targeting genes such as glucocorticoid receptor and vitamin D receptor
(Hsiao, et al. 2003) (Kitagawa , et al. 2003). However, mammalian SWI/SNF can also
function at distal regulatory regions. For example, BRG1 containing complex represses
the CD4 gene in early stages of thymocyte development by facilitating the accessibility
of runt-related transcription factor 1 (RUNX1) co-repressor to CD4 silencer elements
(Jani, et al. 208). Genome wide mapping of BRG1 localization in different mouse
tissues, show that 26% of BRG1 binding sites localize at transcription start sites and
47% localize at distal (intergenic) regions. Comparison of the localization profiles
revealed that the TSS binding sites are shared between different tissues, while the
distal sites are more tissue specific and associated with active and repressed histone
marks (Attanasio, et al. 2014). In mESC only 12% of BRG1 binding sites mapped at
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TSS while the majority of the peaks are at distal regions and associated with H3K4me1
(L. Ho, J. L. Ronan, et al. 2009). In addition, BRG1 containing complexes can mediate
long-range chromatin interaction (chromatin looping) between distal regulatory elements
and promoter regions. It has been shown that at the α globin locus, BRG1 is required for
chromatin interaction between the major regulatory elements (MRE) and α2 promoter
that are separated by ~40kb (Kim, Bresnick and Bultman 2009).
In addition to transcription initiation, SWI/SNF are involved in mRNA alternative
splicing. BRM is localized in coding regions of some of its target genes and helps to
recruit the splicing machinery through direct interaction with the small nuclear
ribonucleic proteins (snRNPs) U-rich 1 (U1) and U6. At these locations it promotes
inclusion of alternatively spliced exons. BRM increases RNA-pol 2 occupancy at
alternatively spliced exons, and BRM knock-down (KD) was associated with defects in
RNA-pol 2 elongation and reduces the exon inclusion. The role of BRM in this context
does not require ATP as BRM with mutated ATP domain showed similar effects
(Batsche, Yaniv and Muchardt 2006). In addition, BRG1 has been reported to localize in
gene body of the heat shock protein 70 (hsp70) gene and plays a role in RNA-pol 2
elongation through hsp70 gene (Corey, et al. 2003).
In addition to their role in gene expression, studies in yeast showed that
SWI/SNF are involved in DNA repair and chromosomal segregation. It has been shown
that yeast SWI/SNF complexes are recruited to double stranded breaks (DSBs) sites
and mediates homologues recombination repair mechanism (Chai, et al. 2005). Also,
they localize to centromeric regions during cell cycle, and required for kinetochore
function during chromosome segregation (Hsu, et al. 2003).
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An interesting feature of SWI/SNF complexes is that they undergo combinatorial
assembly of their subunits to form complexes with cell type specific function. Some of
the subunits (BAF53, BAF45, BAF250) have different isoforms and encodes by different
genes, and incorporation of specific isoform gives a cell type specific complex. This
mechanism accounts for the diverse roles of this family in regulating gene expression at
different cell types (Hargreaves and Crabtree 2011).
In mESC, SWI/SNF assembles into a complex with subunits specific for mESC.
The complex is, essential for normal embryonic stem cells (defined by self renewal and
ability to differentiate into multiple tissues (pluripotency)), and inactivation of its subunits
promotes ESC differentiation (L. Ho, J. Ronan, et al. 2009). ChIP-Seq in mouse ESC
revealed that BRG1 localizes at genes highly expressed in mESC but not in
differentiated cells, and those genes important for mESC phenotype such as Sox2,
Nanog, C-Myc, Oct4 and Klf4 (Ho, et al. 2009). In addition, BRG1 is significantly
localizes over genes targeted by master regulator of mESC such as OCT4, SOX2 and
NANOG. Moreover, BRG1 significantly overlaps with genes targeted by STAT3 and
SMAD1 transcription factors which are downstream effectors for the leukemia inhibitory
factors (LIF) and bone morphogenic protein (BMP) signaling pathways which are
important for maintaining the pluripotency state (Ho, et al. 2009). In support to these
findings, overexpression of BRG1 and BAF155 in somatic cells along with OCT4,
SOX2, C-MYC and KLF4 increased the re-programming efficiency and generation of
induced pluripotent stem cells (iPS) (Singhal, et al. 2010).
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1.2.3.2 INO80 Chromatin Remodeling Complexes
In mammals, there are three complexes of the INO80 family; INO80, SRCAP and
TRRAP/Tip60 which assemble with three ATPase subunits INO80, SCRAP and p400
respectively. Similar to SWI/SNF, INO80 complexes are large multi-subunit complexes
with 14 accessory subunits (Clapier and Cairns 2009). The INO80 ATPase differs from
other ATPases because it has a spacer element within the ATPase domain. This
element is important for the binding to other subunits to maintain complex integrity. The
remodeling activity of this family includes sliding nucleosomes, evicting histone octamer
and exchanging histone variant H2A with H2A.Z (Clapier and Cairns 2009). As the other
ATP-dependent remodelers, the INO80 complexes are recruited to promoters and
regulate gene expression. For example, INO80 interacts with yin yang 1 (YY1) and
OCT4 transcription factors as well as WDR5, a subunit of HMT (Cai, et al. 2007) (Wang,
et al. 2014). In addition, the SRCAP complex mediates incorporation of H2A.Z histone
variant, which is associated with diverse cellular mechanisms including gene regulation.
Along with regulation of gene expression, INO80 complexes involve in DNA
damage response. INO80 complexes specifically recognize the phosphorylated H2A.X
(γH2AX), a PTM that are associated with DNA damage sites, and are recruited to the
sites of the DNA damage. INO80 complexes at these sites mediate histone eviction to
expose the DNA for the repair mechanisms (Morrison and Shen 2009).
In mESC, a resent study showed that INO80 is required for ESC self-renewal as
INO80 KD reduces the pluripotency markers and induce differentiation. ChIP-seq
analysis showed that 50% of INO80 peaks are enriched at TSSs and 98% overlap with
DHSs. Also, INO80 is associated with H3K4me3 and H3K27ac peaks but not
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H3K27me3 suggesting enrichment at euchromatin regions. In addition, INO80 colocalizes with stem cell master regulators SOX2, NANOG, OCT4 and KLF4. Gene
expression profiling of INO80 KO mESCs showed down regulation of pluripotency
markers and genes that undergo down regulation following mESC differentiation (Wang,
et al. 2014). In addition, Tip60-p400 is required for normal mESC phenotype and selfrenewal. Depletion of the complex showed defects in genes up regulated during
differentiation, and significant overlap with NANOG dependent genes. ChIP-chip
analysis showed that the complex highly localizes at promoters, and strongly associated
with H3K4me3. This localization is dependent on H3K4me3 level and NANOG.
However, no direct binding between NANOG and Tip60-p400 subunits suggesting the
localization is indirect (Fazzio, Huff and Panning 2008).

1.2.3.3 CHD Chromatin Remodeling Complexes
The CHD subfamily is characterized by an N-terminal chromodomain in the
ATPase subunit. There are 9 different ATPase proteins in this family some of them
function as monomer. (Marfella and Imbalzano 2007). The chromodomain in human
CHD1 specifically interacts with promoter mark H3K4me3. Genome wide localization of
CHD1 and CHD2 in human cell lines showed that they localize to active chromatin
regions and associated with active promoters (Siggens, et al. 2015). Additionally,	
  CHD1
also facilitates recruitment of subunits of spliceosome to transcripts and enhances
splicing efficiency (Sims III, et al. 2007). In yeast, CHD1 interacts with elongation
factors and is important to maintain nucleosome integrity within active transcripts

	
  

21	
  

	
  
(discussed in section 1.5.1) (Smolle, et al. 2012). This role is likely conserved as CHD1
in mammals also interact with the structure- specific recognition protein 1 (SSRP1),
which forms a heterodimer with SPT16 to form FACT, the positive elongation factor
(Kelley , Stokes and Perry 1999).
The CHD3 and CHD4 proteins (also known as Mi-2α and Mi-2β, respectively)
contain double PHD domain in the N-terminal regions, and are the ATPase subunits of
the multi-subunit complex the NURD. In addition to the ATPase activity, NURD has
protein deacetylation activity through the histone deacetylase 1 and 2 (HDAC1 and 2).
The complex contains 7 subunits CHD3 or CHD4, HDAC1/2, MBD2/3), the metastasisassociated gene 1 , 2 or 3 (MTA1, MTA2 or MTA 3), the retinoblastoma associated
protein 46 or 48 (RbAp46 or RbAp48) and GATA2A and B (Lai and Wade 2011).
Domains in the CHD proteins as well as domains in the accessory subunits can recruit
NURD to chromatin through recognition of histone tails, DNA methylation or sequence
specific transcription factors. Combinatorial assembly of some of NURD subunits can
provide specificity in the complex recruitment and function. For example incorporation of
MBD2, but not MBD3, allows NuRD recruitment to methylated DNA (Lai and Wade
2011). The presence of HDAC activity links NuRD to transcription repression.
Consistent with its roles as a repressor KD of CHD4 mediates open chromatin
confirmation and enhances gene expression (Gao, et al. 2009) (Ramirez-Carrozzi, et al.
2006). Genome wide investigation of MBD3 subunits in cancer cell lines showed
localization of MBD3 at promoters and within gene bodies of active genes as well as
distal regulatory elements (Shimbo, et al. 2013). In mESC, MBD3 is required to repress
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genes important for trophectoderm lineage thus it is required to maintain mESC
pluripotency (Zhu, et al. 2009).
Genome wide localization of CHD7 in mESCs showed strong localization at
enhancers marked by H3K4me1, DNase hypersensitive sites and the enhancer binding
protein p300. Also significant overlap with mESC master regulators OCT4, Nanog and
SOX2 was detected. Further investigation reveals that the role of CHD7 is to fine-tune
the mESC specific gene expression (Schnetz, et al. 2010). The CHD7 contains two
copies of Brahma and Kismet domain (BRK) domain, which has been found to interact
with CTCF (Allen, et al. 2007). CHD7 interactions at enhancers suggest that might
mediate chromatin looping through CTCF. CHD8, which also has tandem BRK
domains, interacts with CTCF and it is required for the insulator activity at some of
CTCF sites (Ishihara, Oshimura and Nakao 2006).
In mESC, ChIP-chip analysis showed that CHD1 is associated with H3K4me3
and RNA-pol 2. KD of CHD1 increases chromatin condensation and localization of
heterochromatin marks (H3K9me3 and HP1 proteins using immunofluorescence
staining). In addition, it increases the expression of genes required for neuronal
differentiation, and differentiation to embryoid bodies showed bias toward neuronal
lineage (Gaspar-Maia, et al. 2009). Thus, similar to MBD3, CHD1 is required for mESC
pluripotency.

1.2.3.4 ISWI Chromatin Remodeling Complexes
ISWI subfamily contains multi-complexes assemble with two to four subunits.
There are two ISWI ATPase homolog in human and mouse the sucrose nonfermenting
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2 homolog (SNF2H) and sucrose nonfermenting 2 (SNF2L), one in Drosophila the
imitation switch (ISWI) and two in yeast Imitation switch 1 and 2 (Isw1 and Isw2)
(Clapier and Cairns 2009). These ATPase subunits associate with a variety of
accessory subunits to create a diverse family of remodeling complexes that involves in
regulating gene expression, DNA replication, DNA repair and maintaining chromosome
structure (Erdel and Rippe 2011).
The SNF2H and SNF2L are highly similar with 86% sequence homology and
assemble around seven complexes; the nucleosome remodeling factor (NURF)
(Tsukiyama and Wu 1995) (Barak, Lazzaro and Lane, et al. 2003), the CECR2containing remodeling factor (CERF) (Banting, et al. 2005), the remodeling and spacing
factor (RSF) (LeRoy , Orphanides, et al. 1998), the chromatin-accessibility complex
(CHRAC) (Varga-Weisz, et al. 1997), the ATP-utilizing chromatin assembly and
remodeling factor (ACF) (Ito, Bulger, et al. 1997), the WSTF-ISWI chromatin remodeling
complex (WICH) (Bozhenok, Wade and Varga-Weisz 2002) and the nucleolar
remodeling complex (NoRC) (Strohner, et al. 2001).

CERF is first identified as a SNF2L containing chromatin remodeling complex
from HEK293T cells. (Banting, et al. 2005). However, study in mice showed that it also
forms a complex with SNF2H in testis and embryonic stem cells. It composed of two
subunits cat eye syndrome chromosome region candidate 2 (CECR2) and SNF2L. The
complex requires nucleosomes as a substrate for the ATPase remodeling activity.
CERC2 contains multiple domains localized in the N-terminal region of the protein and
these include the DNA-binding homeobox-containing proteins and the different
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transcription factor and chromatin remodeling factors in which it is found (DDT), AThook and bromodomain (Banting, et al. 2005). All these domains are present in BPTF
subunit of NURF, which suggest that these domains are characteristic of ISWI
containing complexes (Alkhatib and Landry 2011). CECR2 expression is detected in
many adult and fetal tissues. It localizes in the short arm of chromosome 22q11.2, a
region present in multiple copies in patients with cat eye syndrome, which characterized
by multiple congenital defects (Footz, et al. 2001). Gene trap induced mutation of Cecr2
results in perinatal lethality with neuronal tube defects. The main effect on the nerves
system is likely due to the high expression level of Cecr2 in the neuronal cells during
mouse development (Banting, et al. 2005). Investigating the role of CECR2 in mice
using null mutation approaches, showed its role in neurulation, spermatogenesis and
ear development (Banting, et al. 2005) (Dawe, et al. 2011) (Thompson, et al. 2012).
CERF is proposed to function as a regulator of gene expression (Erdel and Rippe 2011)
however, less is known about how CERF complex regulates transcription.

RSF is an SNF2H containing complex, however, it also assemble as SNF2L
containing complex (Banting, et al. 2005). It contains two subunits; RSF-1 protein and
SNF2H or 2L. RSF was first identified as a factor that is required for transcription
initiation by RNA-pol 2 from chromatin template in vitro (LeRoy , Orphanides, et al.
1998). RSF-1 protein has a PHD domain and an acidic stretch at the C-terminal regions
(Loyola, Huang, et al. 2003). Alternative start site generates a transcript that starts 253
amino acids downstream of RSF-1 that is unable to interact with human SNF2H. This
transcript is physically interacts with the viral X protein, a transcriptional activator, and
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activate hepatitis B virus transcription (Shamay , et al. 2002). This suggests an ATPindependent role of RSF-1 protein. Amplification of RSF-1 has been associated with
ovarian cancer, and patients with high Rsf-1 expression have low survival time (Shih, et
al. 2005). Overexpression of Rsf-1 in ovarian cancer cell lines showed resistance to
chemotherapy (Choi, et al. 2009).
In addition, RSF complex functions to assemble regularly spaced nucleosomal
array independent of histone chaperones (Loyola, et al. 2001). In this capacity RSF is
proposed to act as a histone chaperone for H3/H4. This leads to ATP-independent
incorporation of H2A/H2B to form the nucleosome in chromatin. Then, RSF utilizes its
ATP-dependent activity to assemble the nucleosomes in a regularly spaced array. This
role of RSF does not require histone chaperone as required for ACF and CHRAC
complexes (discussed below) (Ito, Bulger, et al. 1997).
Another role of RSF complex is regulation of the centromere structure
(Perpelescu, et al. 2009). RSF mediates deposition of the centromeric specific histone 3
variant centromeric protein A (CENP-A) at the centromeric regions. RSF1 is associated
with CENP-A containing chromatin at centromeric regions, and knockdown of Rsf-1
reduces CENP-A localization and leads to defect in normal mitotic progression
(Perpelescu, et al. 2009).

ACF is a SNF2H containing complex, and contains two subunits the
bromodomain adjacent to zinc finger domain1A (BAZ1) also known as ACF1, and
SNF2H (LeRoy, Loyola, et al. 2000). ACF mediates nucleosome assembly (regularly
space nucleosomal array) in combination with histone chaperones (Ito, et al. 1997). It
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also regulates nucleosomes position to provide accessibility for transcription factors and
promote transcription (Ito, et al. 1997) (LeRoy, Loyola, et al. 2000). The proposed model
for the ACF function is that, following ATP-independent histone deposition ACF utilizes
the ATP to mediate regularly spaced nucleosome assembly of the nucleosomal array. In
mammalian cells, ACF is associated with replicating pericentromeric regions, and
required for replication of heterochromatin (Collins, et al. 2002). Knockdown of Acf1
lead to defect in DNA replication at late S phase, which is the time for heterochromatin
replication. The role of the ACF is proposed to facilitate the DNA replication through the
condensed chromatin, as de-condensation of heterochromatin by chemical agent
rescued the ACF depletion (Collins, et al. 2002). ACF1 protein has multiple domains
including; DDT domain, two PHD fingers, a highly acidic region, bromodomain and two
uncharacterized domains named based on the proteins that has these domains along
with ACF1 as determined by screening sequence databases. These motifs are WSTF/
Acf1/ Cbp146 (WAC) and WSTF/ Acf1/ KIAA0314/ ZK783.4 (WAKZ). Serial deletions of
these domains revealed the importance of the region of the DDT domain in binding to
the ATPase subunit ISWI and the role of the WAC domain in binding to DNA sequence
(Fyodorov and Kadonaga 2002).
Along with its role as a chromatin assembly factor, ACF can also promote
transcription from chromatin template (LeRoy, Loyola, et al. 2000). In T-cells ACF
complex directly regulates the IL-2 and IL-3 gene expression through regulating the
accessibility to promoters and regulatory elements of these genes (Precht, Wurster and
Pazin 2010).
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CHRAC is a SNF2H containing complex. In human, CHRAC is similar to ACF
complex with two addition proteins huCHRAC-15 and huCHRAC-17, which might
function as histone fold proteins based on sequence homology (Poot, et al. 2000).

NoRC is a SNF2H containing complex with two subunits the TTF-I-interacting
protein 5 (TIP5) and SNF2H. TIP5 contains domains exist in ACF1 include;
bromodomain, two PHD domains, WAKZ, and DDT domains, but lack the WAC domain.
In addition, it contains four AT-hooks and a TIP5/ARBP/MBD (TAM) motif, which is
highly similar to MBD domain exit in methyl-CpG binding proteins. The AT-hook and
TAM found to cooperate to synergize TIP5 binding to DNA, and TAM domain can
function as RNA-binding domain (Mayer, et al. 2006). NoRC was first isolated through
screening for factors interact with the TTF-I a termination factor that binds to promoter
of ribosomal RNA (rRNA) genes. Subsequent work showed the role of NoRC in
repressing rRNA gene expression by RNA polymerase I through establishing
heterochromatin architecture, (Zhou, Santoro and Grummt 2002), and regulates the
nucleosome structure at rRNA promoter regions (Li, La ̈ngst and Grummt 2006). NoRC
interacts with histone methyl transferases to promote H3K9 and H4K20 methylation,
histone deacetylase that promotes H3K9 deacetylation and HP1 (Postepska-Igielska, et
al. 2013). Recruiting NoRC to ribosomal DNA (rDNA) is guided by; (i) the interaction
between TIP5 (through TAM domain) and non-coding RNAs that has sequence
homology to rRNA promoters, and (ii) the interaction between TIP5 (through the
bromodomain) and H4K16ac (Zhou and Grummt 2005). In addition, NoRC establishes
heterochromatin architecture at centromeric and telomeric regions, and knockdown of
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TIP5 leads to defects in chromosomal segregation and mitotic abnormalities
(Postepska-Igielska, et al. 2013). Overexpression of TIP5 has been observed in
prostatic cancer, and its expression level can be used as a marker for the disease
recurrence (Gu, et al. 2015).
WICH is a SNF2H containing complex with two subunits the Williams Syndrome
transcription factor (WSTF) and SNF2H. The WSTF gene localizes along with another
15 genes in a chromosomal region that is deleted in patient with Williams Syndrome,
which is an autosomal dominant disorder characterized by craniofacial and heart
defects as well as metal retardation (Barnett and Krebs 2011). WSTF protein is widely
expressed in adult and neonatal tissues, and homozygous KO mice die soon after birth
with significant heart defects. WSTF protein has multiple domains characteristic for
ISWI accessory subunits including WAC, WAKZ, DDT, PHD and bromodomain
(Bozhenok, Wade and Varga-Weisz 2002). Similar to ACF complex, WICH complex
localizes with replicating heterochromatin foci during S phase. This localization is
mediated by direct interaction with the proliferating-cell nuclear antigen (PCNA) (Poot,
Bozhenok, et al. 2004). The role of WICH in this regard is likely to assemble the
chromatin following the replication fork (Poot, Bozhenok, et al. 2004). In contrast to
ACF, WSTF through WICH is also localizes at chromosome in metaphase (condensed
chromosome). This unique feature of WICH complex suggests a role in chromosome
condensation or recruiting factors important to this stage of cell cycle (Bozhenok, Wade
and Varga-Weisz 2002). WICH complex is also involves in regulating DNA damage
response. It has been found that WICH is associated with H2A.X, an important histone
variant associated with early stages of DNA damage response, and it is required for
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DNA damage response. KD of WSTF reduces the γ-H2A.X phosphorylation which likely
due to defect in active ATM recruitment, an important kinases for γ-H2A.X. Additionally,
the WSTF has a kinase activity through the WAC domain that phosphorylates Tyr142 at
H2A.X at the site of DNA damage (Xiao, et al. 2009).

1.3 The Nucleosome Remodeling Factor NURF
NURF complex belongs to the imitation switching (ISWI) family of the ATPdependent chromatin remodeling complexes. It was discovered in 1995 as a factor with
enzymatic activity that disrupts the nucleosome structure and increases the accessibility
of a sequence specific transcription factors in the presence of ATP and promote gene
expression (Figure 1.3) (Tsukiyama and Carl 1995) (Mizuguchi , et al. 1997). Using in
vitro reconstitution systems NURF disrupts nucleosomes at the hsp70 promoter to
expose heat shock factor (HSF) binding sites, which activates transcription (Tsukiyama
and Carl 1995). The role of NURF in regulating the heat shock gene expression (hsp70
and hsp26) and facilitating the recruitment of HSF to their promoters in vivo was
confirmed (Badenhorst, Voas, et al. 2002). These and other studies in Drosophila and
mice (discussed below) show that NURF is a regulator of gene expression (discussed
below) (Badenhorst, Voas, et al. 2002) (Barak, Lazzaro and Cooch, et al. 2004).
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Figure 1.3: Model for NURF as a Chromatin Remodeling Complex
A cartoon represents how the ISWI containing complex NURF remodel the nucleosome to
provide accessibility for DBPs. Left, a DBP (white oval) can’t recognize its DNA binding site
(red line). Middle, recruiting NURF at this site, which can be either by recognition of a histone
modification or interaction with a TF that binds to adjacent region. Once recruited, NURF
hydrolyze ATP to slide the nucleosome. Left, the outcome of NURF function provides the
accessibility for the DBP to its DNA element.

	
  

NURF is highly conserved from Drosophila to human and mammalian NURF has
three conformed subunits; the bromodomain PHD finger transcription factor (BPTF),
SNF2L (the ATPase subunit) and RbAp46/48 (Barak, Lazzaro, et al. 2003). BPTF and
SNF2L are essential for the complex activity, and to date BPTF is unique to NURF
(Barak, Lazzaro, et al. 2003) (Figure 1.4).
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Figure 1.4: Subunits of Mammalian NURF
A cartoon shows the three subunits of mammalian NURF BPTF, SNF2L and RbAp46/48.
Within each subunit functional domains are indicated. For BPTF, Acidic patch, DDT,
PHD, WAC, WACZ, Poly glutamine (Q), C-PHD and Bromodomain. For SNF2L, AtuoN,
ATPase domain, NegC, HAND, SANT and SLIDE. For RbAp46/48 WD repeat domain.

1.3.1 BPTF
BPTF is the largest subunit in the complex with ~320 kDa molecular mass. BPTF
is essential for the complex and acts as a scaffold to maintain the complex integrity
(Xiao, et al. 2001). Isolation of NURF from HEK293T cells, showed that the majority of
endogenous BPTF bound with SNF2L which suggest that BPTF mainly exists in NURF
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complex (Barak, Lazzaro and Lane, et al. 2003). In Drosophila, BPTF homolog exists in
different isoforms with different domain compositions. These isoforms can form
complexes which have different impacts on gene expression (Kwon, Xiao, et al. 2009).
Full-length human BPTF was identified in screening for novel bromodomain containing
proteins (Jones, Hamana and Shimane 2000). However, an early report identified a
truncated transcript of BPTF as a protein reactive to a monoclonal antibody raised
against Alzheimer’s disease brain homogenate named as fetal alz-50-reactive clone 1
(FAC1) (Bowser, Giambrone and Davies 1995). The full length BPTF has similar
transcription start site and almost identical N-terminal region (Jones, Hamana and
Shimane 2000) suggesting an alternatively spliced variant. In adult tissues, BPTF is
ubiquitously expressed in many human tissues with high expression in spleen, thymus
and testis (Jones, Hamana and Shimane 2000). In mouse, BPTF is highly expressed in
embryonic tissues and adult testis, brain and spleen (Landry , et al. 2008).
BPTF has multiple highly conserved domains that mediate its interaction with
subunits of NURF, histone modifications and transcription factors. These include an
acidic rich region, DDT domain, PHD finger, WAC and WAKZ domains in the N-terminal
region and glutamine rich region, PHD and bromodomain in the C-terminal region
(Figure 1.4) (Alkhatib and Landry 2011). Also it has multiple nuclear localization signals
and LXXLL motifs that are recognized by nuclear receptors upon ligand activation
(Jones, Hamana and Shimane 2000).
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DDT domain
The DDT domain (Doerks, Copley and Bork 2001) exists in BPTF, ACF1, TIP5,
CECR2 and WSTF proteins, which are accessory subunits of ISWI containing
complexes. The DDT domain is required for the interaction with the ISWI protein as
deletion of the DDT domain region led to dissociation of the ISWI subunit from Acf1
protein in the ACF complex (Fyodorov and Kadonaga 2002) (Eberharter , et al. 2004).
Deletion analysis of the ISWI homolog in Arabidopasis thaliana showed that the DDT
domain region interacts with SLIDE domain in ISWI, and similar finding observed for the
human SNF2H (Dong, et al. 2013). Similar observation has been reported for the yeast
ISWI homolog. However, in Drosophila an adjacent region to SLIDE domain, is required
for the interaction with ACF1 protein. This interaction is likely essential for NURF
integrity, as the interaction between BPTF and the ATPase subunit is essential for the
complex assembly and function (Xiao, et al. 2001). In addition, a study in yeast showed
that the DDT domain region of Swi1 protein interacts with the DNA in vitro, and it is
required for recruiting the protein to chromatin (Noguchi, et al. 2012). The truncated
version of BPTF in human, FAC1, has been shown to have a DNA binding activity to
specific DNA motif CACAACA. The region responsible of this activity is the first 398
amino acid that has the DDT domain along with the acidic patch and PHD domain (K. L.
Jordan-Sciutto, et al. 1999).

PHD finger
PHD fingers are structural domains in which 4 cysteines, a histidine and 3
cysteines (Cys4HisCys3) are maintained by two Zinc ions (Sanchez and Zhou 2011).
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They are found in nuclear proteins that are associated with chromatin. Many chromatinmodifying proteins contain PHD finger domains such as ATP-dependent chromatin
remodeling complexes (e.g. BPTF in NURF and CHD4 in NuRD), histone deacetylases
(e.g. Inhibitor of Growth Family, Member 2 (ING2), in HDAC), histone
methyltransferases (e.g. Mixed-Lineage Leukemia Protein 1 (MLL1)), histone
demethylases and DNA methyl transferases (DNMT3L) (Musselman and Kutateladze
2011).
PHD fingers mainly interact with histone tails that can be either modified or
unmodified, by PTMs, and their interaction with their ligand is specific. For example, a
class of PHD fingers with particular structure can recognize H3K4me3/2, another class
with slight change in the structure has a strong affinity to unmodified histone 3
(H3K4me0) but not H3K4me3/2. In addition other classes have been found to have
strong affinity to H3K9me3 and H3K14ac (Musselman and Kutateladze 2011).
However, specific interactions with non-histone proteins are reported (Ivanov, et al.
2007) (Miller, et al. 2010).
Mammalian BPTF has two PHD domains one in the N-terminal region (N-PHD)
and one in the C-terminal region (C-PHD) of the protein. Both domains are highly
conserved, and they differ in their amino acid contents around the Cys4HisCys3 residues
(Alkhatib and Landry 2011). The C-PHD is one of the first PHD domains that have been
found which strongly bind to H3K4me3/2 and weakly to H3K4me2 (Wysocka, et al.
2006), and the crystal structure identified specific residues that mediate this interaction
(Li, et al. 2006). Chromatin immunoprecipitation showed that this interaction is required
for BPTF localization at HOXC8 locus, and it has functional consequences on gene
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expression. In frogs, depletion of xBPTF using morphlino injection leads to
morphological changes in developing embryo. This phenotype has been rescued by
introducing wild type human BPTF but not mutant BPTF that is unable to recognize
H3K4me3 (Wysocka, et al. 2006). However, it should be noticed that BPTF has other
domains that have the potential to interact with chromatin. Indeed, point mutation that
abolishes the C-PHD interaction with H3K4me3 partially released (40-50%) BPTF from
the chromatin suggesting other mechanisms recruit BPTF to chromatin (Wysocka, et al.
2006).

Bromodomain
Bromodomain also exists in chromatin-associated proteins such as histone acetyl
transferases (e.g. PCAF and p300), transcription initiation factor TFIID and ATPdependent chromatin remodeling complexes (e.g. BRG1 in BAF and BPTF in NURF). It
mediates recruitment of these proteins to chromatin through specific recognition to the
acetylated lysine residues in histone tails (Sanchez and Zhou 2011). BPTF
bromodomain has a potential to interact with H4K12ac, H4K20ac and H4K1ac in the
peptide level. However, it specifically interacts with H4K16Ace in nucleosomes
(Ruthenburg, et al. 2011). Most of the bromodomain containing proteins have an
adjacent a PHD finger domain, suggesting cooperation in recruitment to chromatin
through recognition to multiple histone modification. In BPTF, the interaction with
H4K16ac by bromodomain requires recognition of the H3K4me3 by the adjacent PHD
domain. Both domains collaborate to enhance BPTF binding to modified nucleosomes.
In vitro pull-down analysis showed that the C-PHD-bromodomain module strongly
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enhances the binding to modified nucleosome over the C-PHD only module. Point
mutation analysis showed that abolishing the C-PHD completely abolishes the
interaction with histones while abolishing the bromodomain only reduced the binding
affinity to level similar to the C-PHD only module (Ruthenburg, et al. 2011). The two
domains are separated by α-helical linker that is important for the combinatorial
interaction between H3K4me3 and H4K16ac with the C-PHD and bromodomain,
respectively. In vivo ChIP showed that mutations in C-PHD, bromodomain or linker
region reduces BPTF localization at HOXA9 locus enriched with H3K4me3 and
H4K16ac modifications in HEK293 cells. This bivalent interaction to nucleosomes by CPHD and bromodomain has functional consequences in vivo. BPTF lacking both
domains was less efficient in rescuing BPTF KD phenotype in frog, comparing to BPTF
with mutant C-PHD and functional bromodomain (Wysocka, et al. 2006).
A splice variant of BPTF homolog in Drosophila (NURF301) creates a truncated
version of the protein without the C-PHD and bromodomain that able to assemble as a
NURF complex (Kwon, Xiao, et al. 2009). This variant is not essential for Drosophila
development and repression of janus kinases / signal transducer and activator of
transcription (JAK/STAT) pathway target genes as the full-length protein , and it is only
required for spermatogenesis. Gene expression analysis revealed that 40% of NURF
dependent genes in Drosophila require recognition of the H3K4me3 and H4K16ac by
the C-terminal domains (Kwon, Xiao, et al. 2009). This suggests that although
recognition of modified histones by BPTF is important for NURF recruiting to the
chromatin, other contact sites such DBPs and sequence transcription factors are
important for BPTF recruitment to chromatin.
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1.3.2 SNF2L
SNF2L is an ISWI protein that is required for the catalytic activity for NURF
complex, and it is essential for the remodeling function. As mentioned earlier, there are
two ISWI homologs in mammals: SNF2L and SNF2H with 86% sequence homology.
The expression pattern of these homologs is different in mice. In adult mice, SNF2L
expression is limited to brain, testis, ovary and uterus tissues, while SNF2H expression
is ubiquitous. During embryonic development, SNF2L expression is low, compared to
high expression of SNF2H. However, two weeks after birth, the expression of SNF2L
increases in brain tissues, which remains high to adult stage, while SNF2H decreases
(Lazzaro and Picketts, Cloning and characterization of the murine Imitation Switch
(ISWI) genes: differential expression patterns suggest distinct developmental roles for
Snf2h and Snf2l 2001). Due to these observations, it has been suggested SNF2L is
required for differentiated cells, while SNF2H is required for progenitor and
undifferentiated cells. Indeed, SNF2H knock out (KO) mice die at day E4.5 (at during
the peri-implantation stage) (Stopka and Skoultchi 2003), while mice with inactive
SNF2L are viable with a normal phenotype in general. However, these mice have larger
brain size comparing to control mice. This phenotype is linked to defects in neuronal
progenitor cells self-renewal and delay differentiation, which leads to increase cell
density. The role of SNF2L in this regard is linked to its role in regulating the expression
of FOXG1, a regulator of neuronal stem cells self-renewal and differentiation, as ChIP
analysis shows binding of SNF2L at Foxg1 promoter region (Yip, et al. 2012).
Furthermore, overexpression of SNF2L induces differentiation in neuroblastoma cell
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lines, which further indicates its role in neuronal cell differentiation (Barak, Lazzaro and
Lane, et al. 2003).
ISWI proteins contain the highly conserved ATPase domain in the N-terminal
region. This domain has two loops the DEXD, the ATP binding domain, and the HELIC
helicase domain, that mediate the translocase activity. The ATP binding domain
interacts with nucleosome ~ 20 bp form the dyad axis where the H4 N-terminal tail
protrude (Dang and Bartholomew 2007). The H4 N-terminal is required for nucleosomal
recognition by ISWI (Clapier, Längst, et al. 2001) and the remodeling activity (Hamiche,
Kang, et al. 2001). The DEXD domain has an acidic patch that has been suggested to
interact with the basic patch in the H4 N-terminal region (Dang and Bartholomew 2007).
Recent work by Mueller-Planits et al. showed that the ATPase domain is sufficient for
the remodeling activity for the ISWI proteins. (Mueller-Planitz , et al. 2013).
In the C-terminal region there are three domains the hand-like domain (HAND),
the Swi3 Ada2 N-Cor TFIIIB domain (SANT) and the SANT-like domain (SLIDE), which
are characteristic for the ISWI proteins (Figure 1.4) (Clapier and Cairns 2009). The
HAND domain is a structural domain unique to ISWI proteins. It interacts with the
nucleosomal DNA at the entry/exit site (Dang and Bartholomew 2007). Adjacent to the
HAND domain is the SANT domain. SANT is similar to the Myb DNA binding domain,
but it lacks conserved residues that mediate the Myb interaction with DNA. It is not
required for the ISWI recognition to the nucleosome or the remodeling activity (Dang
and Bartholomew 2007). However, it has been suggested that SANT domains can
mediate interaction with histone H3 (Boyer, Latek and Peterson 2004). The SLIDE
domain is similar to SANT domain but it has different architecture (Grüne, et al. 2003). It

	
  

39	
  

	
  
has basic residues similar to the Myb DNA binding domain, and it interacts with linker
DNA in sequence independent manner (Dang and Bartholomew 2007). This interaction
proposed to involve in the remodeling activity of the ISWI protein (Hota , et al. 2013). In
addition it can interact with the DDT region in ISWI accessory subunits (Dong, et al.
2013) (Grüne, et al. 2003). Recently, two domains have been identified that have
significant impact on the ATP remodeling activity of the ISWI proteins (Clapier and
Cairns 2012). The N-terminal region has an AutoN domain which has basic residues
highly similar to the H4 N-terminal regions. This domain inhibits the activity of the
ATPase domain when not bound to nucleosomes (Clapier and Cairns 2012). Same
work identified another domain in the C-terminal region adjacent to the HAND domain
named NegC. This domain is required for coupling the ATPase activity to the
transclocase activity in the ATPase domain. These two domains function as auto
inhibitors for the remodeling activity of the ISWI proteins when not bound to chromatin
(Clapier and Cairns 2012).
SNF2L exists in multiple isoforms that can modulate its function. In human
tissues, a splice variant that has inactive ATPase domain due to inclusion of an extra
exon that disrupt the domain sequence, named SNF2L+13. This isoform is ubiquitously
expressed in adult tissues, while the active isoform is expressed in brain tissues (Barak,
Lazzaro and Cooch, et al. 2004). This isoform is able to assemble into a NURF
complex, which suggest a role in regulating NURF activity. Another isoform that also
ubiquitously expressed is a truncated version of SNF2L that lack the C-terminal
domains, which named as SNF2LT (Ye, et al. 2012). However, this isoform likely can’t
assemble a complex since it lacks the SLIDE domain required for interaction with the
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DDT domain in the accessory subunits. Also, an isoform that lacks a nuclear localization
signal due to use of alternative splicing disrupts its nuclear localization signal has been
detected in human tissues (Lazzaro, Matthew, et al. 2008).

1.3.3 RbAp46/48
RbAp46 and RbAp48 (also known as RBBP7 and RBBP4, respectively) are two
homolog proteins with ~ 90% identical amino acid sequences (Qian and Lee 1995).
These proteins are characterized by Tryptophan – Aspartic acid (WD) repeats, in which
each repeat consists of a core amino acid sequence start with Glycine – Histidine (G-H)
dipeptides and end with WD dipeptides, that function as a protein-protein interaction
platform (Figure 1.4) (Xu and Min 2011). Both proteins are ubiquitously expressed with
high expression observed in brain, thymus, lung spleen, kidney, testis and ovary.
Although most tissues show equal expression of both homologs some tissues show
higher expression of one over the other. In testis and thymus RbAp48 is highly
expressed, while in ovary and uterus RbAp46 is highly expressed (Qian and Lee 1995).
RbAp46, RbAp48 and protein 55 (p55) (the Drosophila homolog) are known to function
as histone chaperones which directly interact with H4 tail and H3 tail at different region
within the WD repeats domain (Verreault, Kaufman, et al. 1998) (Song, Garlick and
Kingston 2008) (Nowak , et al. 2011). The H4 epitope recognized by RbAp46 and
RbAp48 is masked when H4 incorporates into chromatin, which suggests that it is not
involve in mediating the proteins to nucleosomal histone (Verreault, Kaufman, et al.
1998). Recent study showed that RbAp48 interact with H3-H4 dimer complex which is
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important to mediate the incorporation of the dimer to newly synthesize chromatin
(Zhang, et al. 2013).
RbAp46 and RbAp48 are found in many complexes associated with chromatin.
These include the ATP-dependent chromatin remodeling complexes NURF and NURD
(Barak, Lazzaro and Lane, et al. 2003) (Tsukiyama and Carl 1995) (Zhang, Ng, et al.
1999), PRC2, a complex involves in heterochromatin formation through H3K27
methylation (Nowak , et al. 2011), the histone deacetylases HDACs (Taunton, Hassig
and Schreiber 1996) (Zhang, Iratni , et al. 1997), and the CREB-binding protein complex
(CBP), a histone acetyl transferase complex ( Zhang, Vo and Goodman 2000). In most
of these complexes (PRC2, HDACs, CBP and NURD) the RbAp46/48 are involved in
tethering the complexes to their chromatin template. In addition, the two proteins can be
a component of different complexes. The RbAp46 but not RbAp48 is a subunit of the
human histone acetyl transferases 1 (HAT1) that acetylates newly synthesize histone
H4 in the cytoplasm, an important step for incorporation of histone into chromatin
(Verreault, Kaufman, et al. 1998), while RbAp48 but not RbAp46 is a component of
CAF1, which assembles nucleosomes during the S-phase of the cell cycle (Verreault,
Kaufman , et al. 1996).
In addition, they interact with sequence specific transcription factors. They were
first identified as proteins associated with the retinoblastoma protein (RB), a tumor
suppressor protein mutated in many types of cancers. RB is known as a cell cycle
regulator for the G1 to S phase transition, and a regulator of cell differentiation (Qian
and Lee 1995). The RbAp46 and 48 also directly interacts with friend of GATA-1
(FOG1), a transcription regulator (Lejon, et al. 2011). FOG1 interacts with GATA-1
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transcription factor, which is important for gene expression in the erythrocyte lineage.
The interaction between FOG1 and RbAp48 mediate recruitment of NuRD complex to
certain loci in the chromatin ( Hong, et al. 2005). Also, the p55 directly interact with
suppressor of zeste 12 (Suz12) a subunit of PRC2 (Nowak , et al. 2011). These
interactions with histones and transcription factors suggest that RbAp46/48 can function
as a recruiter for NURF to chromatin.

1.3.4 NURF Remodeling Activity
Recruiting NURF to chromatin is thought to be through recognition of PTMs on
histones and/or protein-protein interaction with sequence specific TFs. Once recruited,
NURF slides the nucleosome to regulate the accessibility to DNA. As mentioned above
BPTF has functional domains that recognize H3K4me3 and H4K16ac and mediate
interaction with number of TFs and DBPs. Also, the RbAp46/48 can mediate
interactions with TFs as well as H3 tail. Although the ATPase subunit can interact with
the nucleosomal DNA and linker DNA, these interaction are sequence non-specific
(Alkhatib and Landry 2011).
Studying SNF2L and its homolog SNF2H dynamic in vivo using photo-bleaching
fluorescence microscopy approaches showed that they continuously sample
nucleosomes by ATP independent transient interaction with resident time less than 2
milliseconds (ms). In this transient interactions, ISWI complex screens the chromatin
until a localization signal at a specific locus increases its resident time (150 to 500 ms),
which allow the remodeling activity (Erdel, Schubert, et al. 2010) (Erdel and Rippe
2012).

	
  

43	
  

	
  
Biochemical investigations of Drosophila NURF revealed that the ATPase activity
of NURF is stimulated by nucleosome (not DNA or histone octamer), and it slides
nucleosome over DNA in either directions in 10bp moving step without eviction of
histone or altering the histone octamer composition (Tsukiyama and Carl 1995)
(Hamiche, Sandaltzopoulos, et al. 1999) (Schwanbeck, Xiao and Wu 2004). The
direction of nucleosome sliding by NURF can be determined by the presence of a
barrier at one direction such as a localized TF or a positioned nucleosome which
promoter sliding to the other direction (Kang, Hamiche and Wu 2002). NURF requires
nucleosomes as a substrate and the recognition of histone tails especially the histone 4
tail are important for the recognition as well as the remodeling activity (Hamiche, Kang,
et al. 2001) (Clapier, Längst, et al. 2001). The importance of H4 tail, specifcally the
basic amino acids between 16 to 19 the lysine, arginine, histidine and arginine (16KRHR-19) are likely due to their binding to the ATPase domain in the ISWI proteins,
which is required to stimulate the ATPase and remodeling activity (Clapier and Cairns
2012). Indeed, NURF binds a nucleosome at two separate locations: at the linker DNA
near the entry site and the nucleosomal DNA ~ 20 bp from the dyad axis at region
where the H4 tails protrude from the nucleosome (Schwanbeck, Xiao and Wu 2004).
The length of the linker DNA is important for the remodeling activity by ISWI containing
complexes (Zofall, Persinger and Bartholomew 2004) (Schwanbeck, Xiao and Wu
2004).

	
  

44	
  

	
  
1.3.5 Regulation of NURF Remodeling Activity
Although the ATPase subunit (ISWI) has intrinsic ATPase activity, this activity is
significantly more efficient in context of NURF complex, and it requires at least the ISWI
and NURF301 (BPTF homolog in Drosophila) subunits (Xiao, Sandaltzopoulos, et al.
2001). Regulation of the remolding activity of NURF can be through incorporation of
inactive ATPase subunit, PTMs or interfering with substrate recognition (Alkhatib and
Landry 2011).
NURF remodeling activity can be regulated by incorporation of ATPase inactive
isoform of the ATPase subunits. In human tissues, SNF2L+13 exist and is able to
assemble NURF complex (Barak, Lazzaro and Cooch, et al. 2004). This finding
suggests existence of a population of NURF in the cells that is unable to remodel
chromatin.
In Drosophila, it has been shown that the ISWI is a target of poly-ADP
ribosylation by the poly-ADP-ribose polymerase (PARP). Poly-ADP ribosylation of ISWI
by PARP reduces the ISWI remodeling activity and its association with chromatin (Sala,
et al. 2008). Also, ISWI can be subjected to acetylation by the histone acetyl
transferases GCN5 (Ferreira , et al. 2007). It has been shown that GCN5 acetylate
lysine 753, which is located in the HAND domain of ISWI. The modified ISWI is likely
associated with NURF complex, as KD of NURF301 reduces the abundance of the
acetylated ISWI (Ferreira , et al. 2007). Although, the role of this modification in ISWI
activity is not known, the modified residue is a conserved residue in Drosophila,
Xenopus and human which suggests that it might has an impact in its activity (Ferreira ,
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et al. 2007). In addition, acetylation of mammalian BRM, the ATPase subunit of
SWI/SNF complex, regulates its activity (Bourachot, Yaniv and Muchardt 2003).
Additionally, NURF activity can be affected by the composition of the histone
octamer and the nucleosome structure. It has been shown that H2A.Z histone variant
increases the ATPase hydrolysis and remodeling activity of ISWI containing complexes
(Goldman, Garlick and Kingston 2010). This activity has been shown to require the
acidic patch of H2A.Z that interacts with the H4 tail of adjacent nucleosome. Same work
showed that BPTF co-IPs with H2A.Z variant 9-fold greater than H2A (Goldman, Garlick
and Kingston 2010). Role of the linker histone (H1) on modulating the NURF activity
has been debated. It has been shown that H1 incorporation does not affect NURF
remodeling activity (Clausell, et al. 2009 ). However, early reports showed that
incorporation of linker histone has inhibitory effect on ISWI remodeling activity (Horn, et
al. 2002).
Moreover, the H4 N-terminal tail is required for ISWI recognition to nucleosome
(Clapier, Längst, et al. 2001). For NURF, the basic residues in H4 tail (16-KRHR-19) is
critical for NURF ATPase and remodeling activity, and mutation of these residues has a
negative effect on NURF activity (Hamiche, Kang, et al. 2001). In addition, acetylation at
H4K12 and H4K16 mask a critical epitope formed by H4 N-terminal tail and DNA that is
essential for ISWI to recognize the nucleosome (Clapier, Nightingale and Becker 2002).
The role of H2A C-terminal tail on modulating the ISWI activity has been studied. It has
been shown that nucleosome remodeling by human SNF2H and Drosophila ISWI
subunits is reduced with a truncated H2A C-terminal tail (H2A 1-122aa). However, in
the context of a full complex the ACF complex remodel the nucleosomes with the
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truncated H2A C-terminal tail with similar efficiency as full length H2A (Vogler, et al.
2010).

1.3.6 NURF’s Biological Function and Interacting Partners
Studying the role of the NURF complex is achieved in vivo by investigating its
essential and specific subunit BPTF (Xiao, et al. 2001) (Barak, Lazzaro, et al. 2003).
Many reports from Drosophila, mouse and human showed that NURF can interacts with
multiple TFs and DBPs and these interactions have impacts on gene expression.
These include GAGA, HSF, VP-16, Ken, ecdysone receptor (EcR), heterochromatin
protein 2 (HP2), NAP-1 (Drosophila), upstream transcription factor 1 (USF1) (chicken),
serum response factor (Srf), Smad2 (mouse), myc-associated zinc finger protein
(ZF87/MAZ), Kelch-like ECH-associated protein 1 (KEAP1), progesterone receptor
(PR), Smad2, CTCF, structural maintenance of chromosomes (SMC1), H2A.Z (human)
(Alkhatib and Landry 2011) (Qiu, et al. 2015). Some of these proteins interact at multiple
surfaces in BPTF as well as other NURF subunits such as GAGA (Xiao, et al. 2001). In
Drosophila, the interaction sites for GAGA were mapped at regions contain the HMG,
PHD and the glutamine rich, while the VP16 and HSF bind to glutamine rich region.
Also, ISWI interacts with GAGA, suggesting collaborate interaction (Xiao,
Sandaltzopoulos, et al. 2001).
The biological role of NURF is mostly studied in Drosophila. Truncated mutations
of NURF301 (BPTF homolog in Drosophila) showed that NURF is essential for
Drosophila development and is specifically required for the transition from the larva
stage to the adult stage (Badenhorst, Voas, et al. 2002). In addition, NURF301 is
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required for normal expression of the homeotic genes Ultrabithorax (Ubx) and engrailed
(EN) important for determination of body segments (Badenhorst, Voas, et al. 2002). The
requirement of BPTF on homeotic genes expression is also conserved in human
(Barak, Lazzaro and Cooch, et al. 2004). Additionally, truncated mutations on NURF301
induce melanotic tumors (over proliferation of immature blood cells). This likely because
NURF negatively regulates set of the JAK/STAT signaling pathway target genes, which
activation of this pathway associated with the melanotic tumor phenotype (Badenhorst,
Voas, et al. 2002). Subsequently, NURF has been identified as a co-repressor of the
JAK/STAT genes through direct interaction with the Zinc finger protein Ken (Ken), a
repressor for JAK/STAT target genes. The proposed model is that Ken mediates the
repressor effect through recruiting NURF to the promoter regions, which modulates the
nucleosome to repress transcription (Kwon, Xiaob, et al. 2008). The human B-cell
lymphoma 6 (BCL6) proto-oncogene is an ortholog of Ken and preliminary data in our
lab suggest an interaction between BCL6 and human NURF. Confirming this
observation will shed light on a role of NURF in lymphoblastic leukemia and other type
of cancers associated with BCL6 such as breast cancer.
Additional work further showed that the location of the truncated mutations in
NURF301 gave different phenotypes on Drosophila development. Mutations that
truncate NURF301 at the N-terminal region failed to undergo transition from the larva
stage to adult stage (pupation). However, truncated mutations at the C-terminal region
(before the PHD and the Bromodomain) can undergo this stage with developmental
abnormalities and sterile phenotype (Badenhorst, Xiao, et al. 2005). The effects of the
N-terminal truncated mutations are likely due to the role of this region in the complex
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integrity (binding to other subunit of NURF complex). This also, suggests that the Cterminal part of the protein is not essential for the function of NURF. This is supported
later by identifying different isoform of NURF301 in Drosophila, which show that the Cterminal region is not required for gene expression of the majority of NURF-dependent
genes (Kwon, Xiao, et al. 2009), in particular the repressive effect on the JAK/STAT
pathway.
Microarray for the N-terminal truncated mutations show deregulation of 477
genes with 274 a down regulated and 203 are up regulated. It has been shown that the
N-terminal but not the C-terminal region of NURF is required for expression of ecdysone
response genes. The ecdysone is a steroid that is equivalent to human sex steroids
(androgen, estrogen and progesterone), and it is a ligand for EcR of the ecdysteroidsignaling pathway, a nuclear signaling pathway important for larva development.
It has been shown that the EcR directly interacts with NURF in the presence of the
ligand, and ChIP using ISWI antibody, detect enrichment at EcR target genes that is
reduced in mutant NURF301. Together, this suggests that upon ligand activation the
EcR recruits NURF to its target genes to promote gene expression (Badenhorst, Xiao,
et al. 2005).
In addition, NURF function as a co-activator of Wingless (Wg) signaling
pathways, an important pathway for embryonic development, which is deregulated in
cancer (Song, Spichiger-Haeusermann and Basler 2009) (Howe and Brown 2004). It
has been shown that the β-Catenin/Armadillo transcription factor, a signal transducer for
the Wg pathway, directly interacts with NURF301 and mediates its recruitment to
promoter regions of some genes downstream of Wg pathway (Song, Spichiger-
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Haeusermann and Basler 2009). As β-Catenin/Armadillo transcription can recruit many
co-activators such as HATs, the RNA polymerase II associated factor 1 (PAF1) and the
SWI/SNF complex upon signal induction, recruiting NURF to their target promoters
further support the requirement of NURF as a co-activator of gene initiation (Song,
Spichiger-Haeusermann and Basler 2009).
As mentioned earlier, the full length NURF301 (with the PHD and bromodomain)
is not required for the developmental defects in Drosophila embryo and the animal is
viable. However, both male and female are sterile and defects in spermatogenesis and
oogenesis were observed (Kwon, Xiao, et al. 2009). NURF is required for germ line
stem cells self renewal. In testis, NURF is required for maintaining two stem cell
populations the germ line stem cells, which generate the germ cells, and somatic stem
cells (cyst cells), which help the differentiation of germ cells, and primary spermatocyte
differentiation (Kwon, Xiao, et al. 2009) (Cherry and Matunis 2010). Stem cell
populations are maintained within microenvironment (niche) that mediate extrinsic
signals required for maintain stem cells state. Mutant NURF301reducesstem cell
populations and results in premature differentiation. Further investigation showed that
NURF acts as a positive regulator of JAK/STAT pathway in these cells (Cherry and
Matunis 2010). Together with the role of NURF as a negative regulator of JAK/STAT
pathway in the immune system, these findings showed that NURF can has different
roles downstream of one pathway in cell type specific manner.
In the Drosophila ovary, ISWI mutants lose germ stem cell populations likely due
to defects in self-renewal. The observed effect could be due to defect in bone BMP
pathway, which is important for maintaining a stem cell state (Xie and Xi 2005). An
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equivalent phenotype observed in NURF301 mutant suggesting that this effect is due to
NURF complex. Defects in BMP signaling can result from defects in ecdysone signaling
(Ables and Drummond-Barbosa 2010). As mentioned earlier NURF physically interact
with the ecdysone receptor, it has been suggested that through these functions NURF
regulates germ line stem cell population in the ovary (Ables and Drummond-Barbosa
2010).
Additionally, in progesterone signaling pathway NURF is one of the first
complexes recruited to promoters upon progesterone exposure in breast cancer cell
lines (Vicent, et al. 2011). Progesterone Receptor (PR) directly interacts with BPTF, and
recruits NURF complex to promoter regions at set of downstream genes in human
breast cancer cell lines. At promoters, H3K4me3 maintains NURF and its remodeling
activity facilitate binding of a protein kinase that phosphorylates the linker H1, prior to its
displacement from the chromatin (Vicent, et al. 2011). These steps are required for
additional recruitment of co-activators such as SWI/SNF remodelers to promote gene
expression.
In human, FAC1 expression level and cellular localization is different in fetal brain
and adult brain. It is highly expressed in fetal brain and undifferentiated neuron and
localizes in nucleus and cytoplasm. In adult tissues and differentiated neurons is
decreased but still detected in nucleus. However, in brain tissues from patient with
Alzheimer’s disease and amyotropic lateral sclerosis the expression increased and
localize in the nucleus, cytoplasm and hallmark features of this disease such β-amyloid
plaque, pathological accumulation of protein degradation between neurons (Bowser,
Giambrone and Davies 1995). Investigating role of FAC1 shows that it acts as a
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transcription repressor and can recognize specific DNA motif through the N-terminal
region (K. L. Jordan-Sciutto, et al. 1999). Screening for factors that can interact with
FAC1 using yeast two-hybrid system revealed an interaction between FAC1 and the
sequence specific transcription factors ZF87/MAZ and KEAP1, a protein function as a
regulator for oxidative stress response. ZF87/MAZ is an activator of SV40 promoter in
NIH3T3. Using luciferase reporter assay derived by SV40 promoter, FAC1 significantly
reduces the ZF87/MAZ activity. However, mutant FAC1 that can’t bind the ZF87/MAZ
has no effect on the promoter activity (K. Jordan-Sciutto , et al. 2000). The interaction
with KEAP1 is likely regulate its cellular localization during neurodegenerative disease,
and its stability, as the interacting surface with KEAP1 require the PEST domain, a
domain required for protein degradation by proteasomes (Strachan, et al. 2004).
Moreover, NURF has a role in regulating higher ordered chromatin structure. In
Drosophila, mutant ISWI (the ATPase subunit in NURF) show de-condensation of Xchromosome (Badenhorst, Voas, et al. 2002) as well as metaphase chromosomes, with
more pronounce defect in euchromatin regions, not heterochromatin regions (Corona ,
et al. 2007). In Drosophila, regulation of chromatin structure in male X-chromosome is
important for dosage compensation of gene expression. There are two X-chromosomes
in female and one in male, so males up regulate gene expression to adjust for gene
expression in female. These defects in higher-ordered chromatin structure in male Xchromosome has been associated with defect in linker histone H1 incorporation.
Although, ISWI subunit can be in NURF and other complexes (ACF, CHRAC), only
mutation in NURF301, not Acf1, the subunit of ACF and CHRAC, shows defect in
condensation of male X-chromosome (Badenhorst, Voas, et al. 2002) (Corona , et al.
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2007). The defect in X-chromosome structure following NURF mutation has been
linked to the histone acetylation activity of ATAC, a histone acetyl transferase complex
specific for H4K5/K12 acetylation in Drosophila. It has been shown that mutant NURF
significantly reduces H4K12 acetylation, likely through reduction in ATAC association to
the X chromosome. Abolishing of ATAC activity show similar phenotype in Xchromosome structure as NURF mutilation (Carre ́, et al. 2008).
Furthermore, it has been shown that NURF directly binds with the HP2 in
Drosophila. HP2 interacts with HP1, which is required to maintain repressed
environment at heterochromatin regions. Another, ISWI complex ACF, is required for
maintaining the integrity of the heterochromatin structure, however, the role of NURF in
this regard need to be investigated. Also, NURF directly interacts with the H2A/H2B
histone chaperone NAP-1, which is involved in regulation of heterochromatin structure
and nucleosome assembly (Stephens , et al. 2006).
In addition, NURF can function to maintain chromatin boundaries between active
and repressed chromatin regions. In chicken erythroid cells, USF1 protein binds at 5’
HS4 element upstream of the β-globin locus. This element functions as a barrier
element to prevent the spread of heterochromatin into the active globin locus, and USF1
is required for this function. It has been shown that USF1 interacts and recruits NURF
along with SET1, a histone methyl transferase, to the 5’ 4HS element. Knockdown of
BPTF led to increase nucleosome occupancy and loss of the barrier activity of the 5’
4HS (Li, et al. 2011). The role of NURF in regulating chromatin structure further
suggested as NURF directly interaction with CTCF, which is a multi-functional protein
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that involves in regulating chromatin looping and create boundary elements (Qiu, et al.
2015).
In agreement with role of NURF in Drosophila development and regulating
signaling pathways important for animal development, BPTF is essential for mouse
embryonic development (Landry , et al. 2008). BPTF KO in mice is embryonic lethal by
day E8.5. Further investigation showed that BPTF KO embryos failed to develop distal
visceral endoderm (DVE). This phenotype can be in part due to role of BPTF as a coactivator for TGF/Smad pathway, which is essential for formation of DVE tissues. It has
been shown that Smad2 transcription factors physically interact with recombinant BPTF
and mediate NURF to promoter regions of target genes (Landry , Sharov , et al. 2008).
A similar finding has been observed recently in zebrafish where BPTF interacts with
Smad2, which mediate its recruitment and remodeling activity at wnt8a promoter region,
an important regulator of neuroectodermal posteriorization. In this work BPTF has been
found to be essential for normal development of early stage of central nerves system
(Ma, et al. 2015).
In addition, Landry et al. further characterized the role of BPTF in mouse mESC.
It has been shown that mESCs with Bptf KO do not spontaneously differentiate and they
are viable with no defects in cell viability, cell growth or self-renewal. They do show a
minor reduction in cell proliferation as indicated by 6 hours increase in doubling time.
However, measuring the ability of mESC to differentiate using embryoid bodies and
teratoma formation approaches showed that BPTF is required for ESC differentiation
(Landry , et al. 2008).
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Gene expression profiles of BPTF KO in mESC showed that BPTF regulate
genes important for cell differentiation to mesoderm, endoderm and ectoderm cell
lineage. In agreement with previous work in Drosophila (Badenhorst, Voas, et al. 2002)
and human (Barak, Lazzaro, et al. 2003), BPTF in mice is required for regulation of
HOX gene clusters. In addition, most BPTF dependent genes have bivalent histone
markers in their promoters (H3K4me3 and H3K27me3) indicating a role in regulating
developmentally regulated genes.
Role of NURF in differentiation further studied in thymocyte (T-cell) development
using conditional BPTF KO mouse model (Landry, et al. 2011). Similar to mESCs,
thymocytes lacking BPTF are viable with no defects in cell proliferation. During T-Cell
development, BPTF is required for maturation from DP thymocyte to lineage committed
CD4 or CD8 cells. The role of BPTF and by extension NURF complex is different than
other chromatin remodeling complexes such as SWI/SNF and NURD were they showed
defects in early stages and are required for cell viability and proliferation (Gebuhr, et al.
2003) (Williams, et al. 2004). Further investigation revealed physical interaction
between BPTF and the Srf and AP-1 transcription factors that are required for mediating
TCR receptor signaling pathway. Srf recruits the NURF complex to Egr1 to regulate its
expression (Landry, et al. 2011). Egr1 is a TF that involve in thymocyte maturation in
response to TCR signaling (Rothenberg and Taghon 2005). This work suggests that
NURF is required for gene expression profile for lineage committed T-cell (Landry, et al.
2011).
Recently, our lab documents that BPTF and by extension NURF can function as
a cell type specific regulator of gene expression (Qiu, et al. 2015). This is interesting as
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NURF known to interact with common histone modifications such as H3K4me3 and
H4K16ac and common TFs found in different cell types. By comparing the BPTF
dependent genes from three different primary cell types mESCs, mouse embryonic
fibroblasts (MEF) and DP thymocytes, we showed that BPTF regulate different set of
genes in each of these cell types. Interestingly, BPTF/NURF dependent changes in
chromatin structure measured by micrococcal nuclease (MNase) digestion for 3.3 Mega
base (Mb) of mouse genome showed that BPTF, and by extension NURF, regulates
chromatin structure at sites common between cell types as well as sites that are specific
for each cell types. The BPTF/NURF dependent changes in chromatin structure, which
identified by this technique, are mainly over nucleosome free regions (NFRs), a feature
that are associated with regulatory elements (Cockerill 2011). Although, these changes
can be indirect effect of BPTF KO, it suggests that BPTF/NURF is a regulator of
chromatin structure at regulatory elements. In addition, this work documents a direct
interaction between NURF and CTCF, and further characterization of this interaction
suggests that CTCF is a recruiter for NURF to chromatin (Qiu, et al. 2015). The CTCFNURF interaction can influence cell type specific gene expression through regulating
the binding of cell type specific TFs (Qiu, et al. 2015). In addition, the work also
documents a direct interaction between NURF and cohesin subunit SA2. Cohesin is a
ring like structure that mediate CTCF dependent chromatin looping, and CTCF
independent enhancer-promoter looping ( Nasmyth and Haering 2009).
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1.3.7 Role of NURF in Human Disease
Less in is known about the role of NURF complex in human diseases. However,
recent reports showed overexpression of NURF subunit BPTF in some type of cancers.
While it is not clear whether BPTF and NURF complex is advantageous for the
tumorigenesis, the role of NURF in signaling pathways important for development
suggest a positive role in cancer.
The chromosomal location of BPTF is 17q24.2, and the gain of the 17q arm is
highly occurring in neuroblastoma and associated with adverse effect (Bown, et al.
1999). It also found in breast cancer (Monni, et al. 2001), prostatic cancer (Levin, et al.
2008), liver cancer (Raidl, et al. 2004) and lung cancer (Choi, et al. 2006). This suggest
over expression of BPTF, along with other genes in these segment is advantageous for
tumor growth. Indeed, a naturally occurring non-reciprocal translocation at 17q24.3 has
been identified in human lung embryonic stem cells that lead to over expression of
BPTF (Buganim, et al. 2010). In screening for gain of BPTF locus in 143 tumor samples,
it has been shown that gain of BPTF locus is found in 55% of neuroblastoma, 27% in
lung, 20% leukemia and 14% of colon tumors (Buganim, et al. 2010). This further
suggests the requirement of BPTF to cancer.
Recently some studies show the adverse effects of BPTF in human cancer. In
colorectal cancer (CRC) and hepatocellular carcinoma (HCC), recent reports showed
that BPTF expression is significantly over expressed in CRC and HCC tissues
comparing to control tissues. The high expression of BPTF is associated with the
severity of the disease, and associated with the expression of the endothelial
mesenchymal transition proteins vimentin and E-cadherin (Xiao, Liu and Lu, et al. 2015)
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(Xiao, Liu and Fang, et al. 2015). Also, BPTF is overexpressed in melanomas. In a
cohort study, BPTF overexpression is associated with poor prognosis in melanoma
patients. KD of BPTF in melanoma cell line showed significant reduction in cell
proliferation in vitro, and reduction in tumor growth following subcutaneous injection
(Dar, et al. 2015). In bladder cancer, H2A.Z is over expressed in bladder cancer cell
lines as well as bladder cancer tissues. As mentioned above, H2A.Z interacts with
BPTF. This interactions recruit BPTF to genes deregulated in bladder cancer. Similar to
H2A.Z KD, BPTF KD shows significant reduction in cancer cell proliferation and cell
migration (Kim, et al. 2013).
Studying the effect of KD of SNF2L gene expression in cancer cells show
reduction in cell growth, increase DNA damage and induction of cell death (Ye, et al.
2012). Interestingly, the expression level of SNF2L in normal cells lines is equivalent to
high malignant cell lines. However, the observed reduction in the cell growth and
induction of cell death is only observed in the tumor cell lines (Ye, et al. 2012). This
suggests that the cancer cells are more sensitive to loss of SNF2L than the normal
cells.
Although more studies are required to establish a strong correlation between
BPTF and NURF complex with cancer development or progression, the above
mentioned studies suggest that BPTF and likely SNF2L subunits are advantageous for
the cancer cells. This is further supported by the fact that NURF function down stream
of important signaling pathways that has a role in tumorigenesis such as TGFβ/Smad,
PR and JAK/STAT pathways (Alkhatib and Landry 2011).
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1.4 Transcription
1.4.1 Transcription and Chromatin Structure
In eukaryotes RNA-pol 2 transcribes protein-coding genes. Transcription is
divided into three stages transcription initiation, elongation and termination. As the
transcription occurs through chromatin template, regulating the chromatin structure is
crucial for all these stages (Li, Carey and Workman 2007).
At active genes, the TSS is a nucleosome free region (NFR) flanked by wellpositioned nucleosomes -1 and +1 downstream and upstream, respectively.
Nucleosomes are positioned immediately downstream of +1 and phased at regular
intervals but this phasing gradually lost towards the 3’ end of genes (Rando and Chang
2009) (Campos and Reinberg 2009). At the +1 and -1 nucleosomes the ATP-dependent
chromatin-remodeling complex SCRAP (SWR1 in yeast) deposits the H2A.Z histone
variant. The H2A.Z containing nucleosomes are less stable compared to canonical H2A
(Venkatesh and Workman 2015), and in humans, the level of H2A.Z at these sites is
correlated with gene expression (Bargaje, et al. 2012) (Barski, et al. 2007). In addition,
histone H3.3 is also enriched at TSS, which further decreases nucleosomes stability
(Jin and Felsenfeld 2007) (Ha, Kraushaar and Zhao 2014). Studies in yeast showed
binding of multiple chromatin remodeling complexes with the +1 nucleosomes such as
Isw1a, Isw2, Ino80 and RSC complexes (Yen, et al. 2012), and some of these
complexes involve in regulating the NFRs (Hartley and Madhani 2009) (Whitehouse, et
al. 2007).
Transcription begins by TF binding to promoters, which facilitate recruitment of
histone modifying enzymes and chromatin remodeling complexes. These co-activators

	
  

59	
  

	
  
modulate the chromatin structure further to facilitate the binding of general transcription
factors and assembly of the pre-initiation complex (PIC), which includes RNA-pol 2 (Li,
Carey and Workman 2007). The kinase activity of TFIIH phosphorylates the C-terminal
domain (CTD) of the RNA-pol 2 largest subunits at serine 5 (p-Ser5) The CTD contain
highly conserved seven amino acids YSPTSPS that in human exist in 52 repeats. The
phosphorylation of ser5 allows release of RNA-pol 2 from the promoter and begins
elongation (Jonkers and Lis 2015).
The presence of nucleosomes acts as a barrier for the elongating RNA-pol 2
during transcription elongation. Thus, cooperation of histone modifying enzymes,
histone chaperones and ATP-dependent chromatin remodeling complexes facilitate the
elongation. Recruitment of such complexes can be mediated directly through the CTD
of RNA-pol 2. For example the histone acetyl transferases CBP/p300 and PCAF and
the SWI/SNF complex co-purify with the RNA pol2 (Cho, et al. 1998). Histone
acetylation is associated with active transcription as it mediates open chromatin
confirmation and recruits factors that facilitate transcription (Carey , Li and Workman
2006) (Mizuguchi , et al. 1997) (Campos and Reinberg 2009). In addition, histone
chaperones can further modulate the nucleosomes within the coding regions. The
histone chaperone FACT is associated with the CTD and it mediates displacement of
H2A/H2B dimer from nucleosomes (Orphanides, et al. 1998). Also, the H3.3 variant is
enriched in gene bodies of active genes. Incorporation of this variant makes the
nucleosome less stable, and high turn over of H3.3 has been association with gene
activity (Ha, Kraushaar and Zhao 2014). Additionally, the H3/H4 histone chaperone
Spt6 is directly associated with RNA-pol 2 and it maintains the nucleosome integrity
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within the open reading frame. Loss of Spt6 induces cryptic transcription within genes
and defects in mRNA processing (Kaplan, Laprade and Winston 2003)(Yoh, Cho, et al.
2007). Together, these histone chaperones can coordinate nucleosome assembly and
disassembly during transcription.
In addition, Setd2 is a histone methyl transferase that methylates H3K36, an
important elongation marks. H3K36me3 is enriched in gene bodies and 3’end of active
genes (Barski, et al. 2007) (Spies, et al. 2009). In yeast, H3K36me3 is recognized by
the histone deacetylase Rpd3S complex. Once recruited, Rpd3S deacetylates
nucleosomes and maintains closed chromatin confirmation to prevent cryptic transcripts
(Campos and Reinberg 2009). It also reduces histone exchange within active genes.
Although the human homolog of Rpd3S has been identified, it only regulates
deacetylation around the TSS (Jelinic , Pellegrino and David 2011). However, in
humans Set2 is also recruited to active genes by the histone chaperone Spt6 partner
the interacting with Spt6 1 (Iws1). Iws1 is associated with CTD and depletion of Iws1
leads to increase histone acetylation in coding regions suggesting a role in recruiting
HDACs to gene bodies (Yoh, Lucas and Jones 2008). In addition to histone chaperones
and histone modifying enzymes, ATP-dependent chromatin remodeling complexes are
involved in regulating RNA-pol 2 elongation.

CHD Functions in Transcription Elongation
In yeast, Chd1 is associated with RNA-pol2 associated factors PAF complex,
Spt5 and FACT, which suggest a role for Chd1 in RNA-pol 2 elongation (Simic, et al.
2003). Genome wide investigation of nucleosome occupancy in Chd1 mutants showed
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defects in chromatin structure within coding regions (Gkikopoulos, et al. 2011). This
effect is associated with increases histone exchange and initiates cryptic transcription
within genes (Smolle, et al. 2012). These results highlight a requirement of Chd1 to
maintain chromatin structure integrity following RNA-pol 2 passing. This function is likely
conserved in mammals, as the human CHD1 also interact with the FACT subunit,
SSRP1 (Kelley , Stokes and Perry 1999) (Orphanides, Wu, et al. 1999). In addition to its
role in gene bodies, Chd1is required for normal transcription termination at subset of
target genes (Alén, et al. 2002). Additionally, CHD1 is involved in mRNA processing. In
human, CHD1 directly interacts with and recruits components of the spliceosome to
active genes, and depletion of CHD1 shows reduces the efficiency of mRNA splicing
(Sims III, et al. 2007).

ISWI functions in transcription elongation
In yeast, there are three ISWI complexes Isw1a, Isw1b and Isw2. Genome wide
studies show that Isw1a and Isw2 are localized at TSS and 3’ end sites of genes, while
Isw1b is localized in gene bodies and 3’end of genes (Yen, et al. 2012). Role of Isw2 at
upstream and downstream of genes is to slide nucleosomes to decrease NFR size and
repress transcription (Whitehouse, et al. 2007). The Isw1b complex directly interacts
with H3K36me3 through the PWWP domain of Ioc4 subunits (Maltby, et al. 2012). This
interaction recruits the complex to gene bodies and downstream of genes (Smolle, et al.
2012). Similar to depletion of H3K36me3, depletion of Isw1b complex increases histone
exchange and H4 acetylation within genes and generates cryptic transcripts. This
phenotype requires the remodeling activity as an ATPase inactive mutant showed
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similar results (Smolle, et al. 2012). Additionally, together with Chd1, the Isw1 and Isw2
complexes are required for transcription termination at GAL10 (Alén, et al. 2002).

RSC and SWI/SNF functions in transcription elongation
RSC is a SWI/SNF containing complex in yeast that is required to maintain open
NFR regions upstream of the TSS (Hartley and Madhani 2009). Genome wide
investigation showed localization of RSC and SWI/SNF complexes at TSSs (Yen, et al.
2012). However, RSC directly interacts with RNA-pol 2 (Soutourina, et al. 2006), and it
enhances RNA-pol2 elongation through chromatin using an in vitro system (Carey , Li
and Workman 2006). These suggest a role of this complex in regulating RNA-pol2
elongation in vivo. In addition, BRG1, the human SWI/SNF protein is also associated
with RNA pol2 (Neish , et al. 1998). BRG1 has been reported to localize in gene body of
the hsp70 gene and plays a role in RNA-pol2 elongation (Corey, et al. 2003). Also,
BRM, the second SWI/SNF protein in human, localizes in coding regions in some of its
target genes and helps recruiting the splicing machinery through direct interaction with
snRNPs U1 and U6 to facilitate alternative splicing (Batsche, Yaniv and Muchardt
2006).

1.4.2 Transcription and Messenger RNA Processing
Messenger RNA processing involves 5’ capping, exon splicing and
cleavage/addition of poly polyadenylation signal to ensure maturation of mRNA. These
processes occur co-transcriptionally as many of factors required for this process are
associated with the CTD of RNA-pol 2 (Bentley 2014). In general, following
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phosphorylation of Serine 5 at CTD of RNA-pol 2 and the release from the TSS, the
RNA-pol 2 pauses at downstream of TSS. This pausing step is mediated by factors
such as the negative elongation factors (NELF) and DRB-sensitive inducing factor
(DSIF) (Jonkers and Lis 2015). As capping enzymes and cap-binding complex (CBP)
interacts with DSIF, this step can function as a checkpoint to ensure proper mRNA
capping (Bentley 2014). Recruitment of the positive elongation factor-b (P-TEFb), which
contains cyclin-T and cyclin-dependent kinase 9 (CDK9), phosphorylates the Serine 2
(p-Ser2) of the RNA-pol 2 CTD and release the effect of the negative elongation factors.
This step allows RNA-pol 2 to engage in active elongation.
Splicing is a process by which introns are removed from the pre-mRNA. Splicing
requires assembling of spliceosome, a large ribonucleoprotin complex, in the intron
boundaries. Spliceosomes are composed of 5 U-rich (snRNAs), U1, U2, U4, U5 and U6
that are associated with proteins to form the snRNPs. Splicing occurs cotranscriptionally, and components of spliceosome are recruited through the CTD of
RNA-pol 2 or histone modifications (Bentley 2014)(Gunderson , Merkhofer and Johnson
2011). It also, promotes RNA-pol 2 elongation (Fong and Zhou 2001). Defects in
spliceosome assembly leads to RNA-pol 2 pausing (Chathoth, et al. 2014), Which result
in defects in mRNA processing. These lead to generate immature mRNA that can be
targeted by the RNA degradation mechanisms such as nuclear exosomes in the
nucleus or non-sense mediated decay (NMD) in the cytoplasm. These mechanisms are
quality check step to insure a mature mRNA can be exported and translated (Houseley
and Tollervey 2009)
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Alternative splicing is a process that greatly increases unique gene products from
the genome by generating up to several different mRNA splice forms one gene.
Alternative splicing is influenced by elongation rate, and factors that induce inclusion of
alternatively spliced exons can reduces the RNA-pol 2 elongation rate in order to
provide more window time for splicing machinery to assemble at these sites (Bentley
2014). It has been shown that reduction of RNA-pol 2 elongation increases inclusion of
alternatively spliced exons in transcripts (Ip, et al. 2011). Furthermore, deletion of
factors that influence alternative splicing reduces pausing RNA-pol 2 at alternatively
spliced exons which lead to skip the inclusion of these sites in the transcript (Batsche,
Yaniv and Muchardt 2006). Moreover, binding of DNA binding proteins can pause RNApol 2 within genes and promote inclusion of alternatively spliced exons as shown for
CTCF (Shukla, et al. 2011).
Histone modifications also play a direct role in alternative splicing. For example,
H3K36me3 is recognized by the MORF-related gene on chromosome 15 (MRG15), a
protein associated with multiple complexes such as histone demethylases and
deacetylases. MRG15 recruits the polypyrimidine tract–binding protein (PTBP1), which
binds to silencing element in alternatively spliced exons (Luco, et al. 2010). Binding of
PTBP1 represses inclusion of exons inclusion in transcripts, and KD of Set2 (the
H3K36me3 methyl transferase), or KD MRG15 reduces PTBP1 binding to this element
to help inclusion of these exons (Luco, et al. 2010). In addition, H3K36me3 can aid in
recruiting processing factors, and regulate alternative splicing. The PC4 and SFRS1
interacting protein 1 (Psip1) protein directly recognizes H3K36me3 within active genes
and recruits spliceosome component U5 snRNPs and serine/threonine (SR) proteins to
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promote splicing (Pradeepa , et al. 2012). Together, these suggest that mRNA
processing greatly influenced by chromatin structure and the rate of RNA-pol 2
elongation.
One outcome of defective splicing is intron retention in which an intron is not
removed from the mRNA (Ge and Porse 2013). In this case the intron containing mature
mRNA is sensed as an unprocessed transcript and targeted by non-sense mediated
decay (Wong , et al. 2013) or nuclear retention and nuclear exosome degradation (Yap ,
et al. 2012). As such intron retention can functions as a mechanism to regulate gene
expression (Yap , et al. 2012) (Wong , et al. 2013). Intron retention is common in yeast,
fungi and plant, and recently discovered in mammals as well (Braunschweig, BarbosaMorais , et al. 2014). In mammals, it can account for the regulation of cell-type specific
gene expression. For example, expression of some of neuronal specific genes is down
regulated in non-neuronal cells through intone retention and RNA degradation (Yap , et
al. 2012). A genome wide investigation of intron retention in mESCs cells and neuronal
cells shows that a subset of genes important for ESC biology retained introns and were
down regulated upon differentiation to neuronal cells (Braunschweig, Barbosa-Morais ,
et al. 2014). In addition, intron retention involves in normal regulation of granulocyte
differentiation (Wong , et al. 2013). Using RNA-seq approach Wong, et al. identified 86
genes that retained introns and results in down regulation of the protein level during
differentiation from promyelocytes to granyolocyte. In this work, the authors suggested
that defects in exon intron recognition by the spliceosome components are the
mechanism of retained introns in granulocytes (Wong , et al. 2013).
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As the elongation rate can influence mRNA processing (Chathoth, et al. 2014)
(Alexander , et al. 2010) (Fong and Zhou 2001), it can also impact intron retention. It
has been found that retained introns are associated with increase occupancy of total
RNA-pol 2 and the elongating form RNA-pol 2 p-Ser2. Inhibition of RNA-pol 2
elongation increases intron retention in 13 out of 18 tested transcripts. In addition,
retained introns are associated with high levels of chromatin modifying marks such as
H3K27ac and the ATP-dependent chromatin factor CHD2 suggesting that it results in
changes in chromatin structure (Braunschweig, Barbosa-Morais , et al. 2014).
Additionally, histone modification can promote intron retention. The H3.3K36me3
interacting protein BS69 has been found to promote intron retention at a subset of its
target genes (Guo, et al. 2014). BS69 physically interacts with a subunit of U5 snRNPs
(EFTU2) and its role in inducing intron retention is likely through antagonizing the
function of core spliceosome at a subset of its target genes (Guo, et al. 2014).
Additionally, a resent report shows that PTBP1 binding to introns promotes intron
retention (Yap , et al. 2012). Interestingly, different work showed that recruitment of
PTBP1 to genes can be through direct interaction with MRG15 which physically
interacts with H3K36me3. (Luco, et al. 2010). This further suggests a role of H3K36m3
in recruiting factors that can regulate intron retention.

1.4.3 THO Complex 4 (THOC4)
THOC4 (also known as ALY/Ref) is a conserved and ubiquitously expressed
RNA binding protein in mammals. It was first identified as a co-activator that directly
interacts with lymphoid enhancer-binding factor 1 (LEF-1) and acute myeloid leukemia1
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(AML-1) transcription factor, and enhances their binding to T-cell receptor alpha (TCRα)
enhancer (Bruhn, Munnerlyn and Grosschedl 1997). As the activity of the TCRα was
increased upon THOC4 overexpression, it has been suggested that THOC4 might
mediate collaboration of trans-acting factors to augment TCRα enhancer activity (Bruhn,
Munnerlyn and Grosschedl 1997).
Additionally, THOC4 has been shown to acts as co-activator at cis regulatory
element (Suganuma, et al. 2005). In erythroleukemia cell line, a novel DNase I
hypersensitive site was identified upstream of RH gene that enhances promoter activity
using luciferase reporter assays. Serial deletions and EMSA analysis of this region
revealed a 34 bp C-rich DNA element (TCCCCCTCCCC) that is associated with the
enhancer activity. Mass spec analysis identified THOC4 as the factor associated with
this elements (Suganuma, et al. 2005).
THOC4 also functions as a mRNA export factor through transcription export
complex (TREX). TREX is composed of THOC4, UAP56, CIP29 and THO complex
(Dufu, et al. 2010). UAP56 directly interacts with THOC4 and mediates its association
with the THO complex (Dufu, et al. 2010). Following 5’ capping and intron splicing,
THOC4 interacts with CBP80, a cap binding protein, to mediates the TREX to mRNA
(Cheng, et al. 2006). Subsequently, TREX mediates the TAP/NXF1 recruitment to
spliced mRNA through the direct interaction between THOC4 and TAP. These
interactions in turn mediate the export of mRNA through the nuclear pore (Stutz, et al.
2000).
Recruitment of THOC4 to genes can be through binding to mRNA as it has RNAbinding domain, and through RNA-pol 2 as the THOC4 homolog in yeast (Yra1) directly
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interacts with phosphorylated CTD of RNA-pol 2 (MacKellar and Greenleaf 2011).
Another recruiter of THOC4 to active transcripts is mediated by the interaction with the
IWS1 (Yoh, Lucas and Jones 2008). Spt6 is a H3/H4 histone chaperone and an
elongation factor that interacts with RNA-pol 2 phosphorylated at p-Ser2. Knock down of
IWS1 leads to depletion of THOC4 at gene bodies and defects in mRNA splicing (Yoh,
Cho, et al. 2007). In addition to THOC4, IWS1 recruits the histone methyl transferase
Setd2 to methylate H3K36 over gene bodies indicating a role in modifying the chromatin
structure during elongation (Yoh, Lucas and Jones 2008). Genome wide localization of
THOC4 in HeLa cells using ChIP-chip technique showed localization over gene bodies,
mainly intron regions (Swinburne, et al. 2006). Investigation of enriched signal over
representative genes, indicate that THOC4 is more enriched in the 3’ end than 5’ at
subset of genes (Swinburne, et al. 2006). This pattern resembles the localization of its
homolog in yeast Yar1 which localizes to 3’end of genes. Recently, Stubbs S. H. and
Conrad N. K. showed that THOC4 has export independent roles in regulating gene
expression (Stubbs and Conrad 2015). This work supported a previous report that
shows defect in elongation following THOC4 D using a reporter vector (DomínguezSánchez, et al. 2011). These suggest a role of THOC4 in on going elongation by RNA
Pol II prior to exporting mRNA.
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Figure 1.5
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Figure 1.5: A diagram showing THOC4 localization within gene bodies
THOC4 (red oval) can binds to mRNA through its RNA binding domain. In addition, it interacts
(dashed black line) with IWS1 that binds to SPT6. SPT6 directly interact with phosphorylated
Ser2 at CTD of RNA-Pol 2 (Yoh, Lucas and Jones 2008). In yeast, it directly interacts with
phosphorylated CTD of RNA-pol 2 (MacKellar and Greenleaf 2011). Also, THOC4 directly
interact with CBP80, a cap binding proteins (Cheng, et al. 2006).
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CHAPTER TWO
Methods

2.1 Cell Culture
The BPTF knockout (KO) mouse embryonic stem cells (mESCs) are described
previously (Landry , Sharov , et al. 2008). Control (CJ7) and BPTF KO mESC were
grown on gelatinized plates and grown in Dulbecco’s Modified Eagle Medium (DMEM)
(Life technology) as a base medium supplemented with 15% ESC-grade fetal bovine
serum (FBS) (Life Technologies), 1X penicillin-streptomycin (Quality Biological), 2 mM
glutamine (Life technology), 1X nonessential amino acids (NEAA) (HyClone), 0.1 mM 2mercaptoethanol and 1,000 unit/ml (U/ml) leukemia inhibitory factor (LIF) (ESGRO;
Millipore).
P19 cells were grown in DMEM (Life technology) as a base medium
supplemented with 10% FBS (Life Technologies), 1X penicillin-streptomycin (Quality
Biological), 2 mM glutamine (Life technology) and 1X NEAA (HyClone).

2.2 Generation and Purification of the Custom BPTF Antibody
The amino acid sequences (NP_789820.2 amino acid between 2302-2372)
correspond to the BPTF-2 epitope was cloned as two different constructs as a MaltoseBinding Protein (MBP) tagged protein and a 6 X His tagged protein. The constructs was
expressed in BL21 bacteria at 37°C with 0.5 mM of Isopropyl β-D-1thiogalactopyranoside (IPTG) and 3% Ethanol for 3 hours. The soluble lysate of bacteria
with MBP-tagged epitope protein was purified using amylose resin (New England Bio
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Labs). MBP-bound proteins were washed two times with 10 volumes of PBS to remove
unbound proteins and eluted with 10 mM maltose in PBS. Purified epitope was sent to a
custom polyclonal antibody production facility (Cocalico Biologicals, Inc.™, Reamstown,
PA) to immunize two rabbits. The immunization protocol scheduled as follow at day 0
pre-immune serum was collected before initial inoculation of the antigen (the purified
GST-epitope for BPTF). Following inculcation, the rabbits were giving three boost doses
at 14 days, 21 days and 49 days post-inoculation. Serum was collected from the rabbits
at 35 days and 56 days post-inoculation.
Antibody purification from the serum was performed using the 6X His tagged
epitope. The construct expressed in BL21-CodonPlus(DE3)-RIPL bacteria at 37°C with
0.5 mM IPTG and 3% Ethanol for 3 hours. The soluble lysate of bacteria was purified
with nickel column Ni-NTA agarose (QIAGEN, Netherlands). ~ 2 ml of mixed Ni-NTA
agarose were added to a disposable column. Then, the column was washed with 10 ml
washing buffer (50 mM NaH2PO4, 300 mM NaCl and 20 mM imidazole) two times. The
soluble lysate fraction was added to the column and the flow through was collected and
added to the column one more time. Then, the column was washed two times with the
washing buffer, and the bound protein was eluted with elution buffer (50 mM NaH2PO4,
300 mM NaCl and 250 mM imidazole) in 1 ml aliquots. The protein concentration in the
elution aliquots was measured using Bio-Rad protein assay (BioRad, Hercules, CA). To
purify the BPTF antibody from the immunized serum, the purified 6X His tagged epitope
was coupled in Amino Link column using AminoLink® Plus immobilization kit (Thermo
Scientific, Waltham, MA). The coupling performed following at pH 10 accoring to the
manufacture protocol. After coupling the antigen to the column, the column was washed
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with washing buffer (100 mM Tris [pH 8.0], 500 mM NaCl). The immunized serum was
run through the column with flow throw rate 1 ml/min. Then, the column washed three
times with the wash buffer and eluted with elution buffer (3.4 M MgCl2, 10 mM PO4 [pH
8.0]). The eluted samples were dialyzed in dialysis membrane with 3,500 Dalton
molecular weight cut off against PBS overnight for three days. The protein was then
quantified using Bio-Rad protein assay and concentrated to 1mg/ml using Centricon
Micro Concentrators (Amicon).
2.3 Chromatin Immunoprecipitation (ChIP)
ESCs were fixed for 10 min with 1% neutral buffered formalin PBS pH 7.4, then
washed three times with PBS for 5 minutes each wash. 10X106 fixed cells were
suspended in lysis buffer (50 mM Tris [pH 8.0], 1% SDS, 10 mM EDTA and 1 X
protease inhibitor cocktail (Roche). The DNA was sonicated with Bioruptor sonicator
three times for 15 min of alternating 30 sec. on, 30 sec. off, on ice to yield DNA
fragments between 200-500bp. Sonicated samples were centrifuged at high speed for
10 minutes and 200 µl of soluble chromatin was diluted with 1:10 in dilution buffer 200
µl of soluble chromatin was diluted with 1:10 in dilution buffer (16.7 mM Tris- HCl [pH
8.1], 167 mM NaCl, 1.1% Triton X-100, 1.2 mM EDTA and 1 X protease inhibitor
cocktail (Roche)) and mixed over night at 4°C with protein G Dynal beads (Life
Technologies) pre-bound with antibodies (10 µl of beads with 5 µg antibody). For each
pull-down 20% input was saved for determination of pull-down efficiency using qPCR.
The antibodies used for ChIP in this study include BPTF-2 (custom), THOC4
(Immunoquest, IQ221), RNA-pol 2 (Pol2) (abcam, ab817-100), H3K36me3 (abcam,
ab9050), pan-Histone H3 (abcam, ab1791) and normal IgG Rabbit (Cell Signaling,
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2729S). Next, bound chromatin subjected to series of washes 5 min each on ice; lowsalt buffer (20 mM Tris [pH 8.0], 150 mM NaCl, 1% Triton X-100, and 2 mM EDTA),
high-salt buffer (20 mM Tris [pH 8.0], 500 mM NaCl, 1% Triton X-100, and 2 mM
EDTA), lithium chloride (LiCl) buffer (10 mM Tris [pH 8.0], 0.25 M LiCl, 1% NP-40, 1%
deoxycholic acid, and 1 mM EDTA) and two times with TE buffer (10 mM Tris [pH 8.0],
1 mM EDTA). The DNA was eluted from the beads using two elutions with 250 ul elution
buffer (0.1 M NaHCO3, and 1% SDS) at room temperature for 30 min each. Eluted DNA
and the 20% input DNA were reverse cross-linked with 200 mM NaCl and incubated
overnight at 65°C. Next, samples were neutralized to 50mM Tris-HCl pH 6.8, 1mM
EDTA then treated with 0.1 mg/ml proteinase k for 4 h at 45°C. The DNA was extracted
using phenol-chloroform extraction, precipitated with ethanol and dissolved in water
treated with RNase A. sequences for primers used for ChIP-qPCR are provided in
(Table 2.1).

	
  

74	
  

	
  

Table 2.1: Primers used for ChIP analysis
A) Primers used to validate the BPTF-2 ChIP grade antibody
5' > 3'
Site 1 For
GTAAGCCCCAATCCCTGTTT
Site 1 Rev
GCTCCGTCTAGCCTGATGAC
Site 2 For
TCCTGTGTGCACTTCTCCAG
Site 2 Rev
ACCAACATCATGGTCCCTGT
Site 3 For
ACCAAGTCCCAGATTCAGTACG
Site 3 Rev
CTGGGATACCCGAGTGTGAAT
B) Primers used to validate a representative ChIP-Seq peaks
5' > 3'
Test 1 for
ACGGACTGATGCTTTGGGAA
Test 1 rev
CCTGGGCAAAGAGCTGTACT
Test 2 for
TCACCTCCTGCAAAGTCCAC
Test 2 rev
GTCAGGAGAAGCGGGAACAA
Test 3 for
GCGGTACCCTGGGGAATCTA
Test 3 rev
TAGCGGTACTCCAACCTGGG
Test 4 for
TTCATCATCTCCCACCCAGC
Test 4 rev
TGCTGCCCCTTTCACATCAA
Control 1 For
GAACTTCGGGAAGGGGAAGG
Control 1 Rev
AGGATCACGTGGCCAGAAAG
Control 2 For
GCATGCCAGAACCTTGTCTTC
Control 2 Rev
GGTCTCAGGCTGTTCCTTTCT
C) Primers used for ChIP over Ccnd1 gene
5' > 3'
1 For
ATCTCCTTCTGCACGCACTT
1 Rev
GCGTACCCTGACACCAATCT
2 For
CTGGCATTTTGGAGAGGAAG
2 Rev
CGGGTTGACCCAACTCTTTA
3 For
TCAGCATCTTTCCATTCACG
3 Rev
TGGAATACAGGTGGGGGTAA
	
   4 For
GGCAAAAACCAGCATCTCTC
	
   4 Rev
CACAGCGGTAGGGATGAAAT
	
  
! Primers correspond to Figure 3.1
A)
B) Primers correspond to Figure 3.2 E
C) Primers correspond to Figure 3.9 E
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2.4 Formaldehyde-Assisted Isolation of Regulatory Elements (FAIRE)
FAIRE were performed as previously described (Simon, et al. 2012). 1X107 fixed
cells were suspended in 500 µl lysis buffer (50 mM Tris [pH 8.0], 1% SDS, 10 mM
EDTA) and 1 X protease inhibitor cocktail (Roche). The DNA was sonicated with
Bioruptor sonicator three times for 15 min of alternating 30 sec. on, 30 sec. off, on ice to
yield DNA fragments between 200-500bp. Sonicated samples were centrifuged at high
speed, and 50 µl of soluble chromatin were used as an input. Input chromatin was
subjected to RNase A treatment (10 µg) for 30 min at 37°C, and incubated with
proteinase K (20 µg) at 55°C for 1 h and then over night at 65°C. Then, DNA were
extracted with phenol-chloroform, precipitated with ethanol and dissolved in TE buffer
(10 mM Tris-HCl [pH 7.4], 0.5 mM EDTA). The remaining 450 µl soluble chromatin
(FAIRE DNA) were extracted with phenol-chloroform, precipitated with ethanol and
dissolved in TE buffer. Then, treated with RNase A and proteinase K as described
above. FAIRE and input DNA were then washed and purified using Zymo-I spin
columns (Zymo research). DNA was mixed with DNA binding buffer in 2:1 (DNA binding
buffer: Sample) and centrifuged at high speed for 1 min, then washed twice with 200 µl
wash buffer. DNA was eluted with TE buffer (10 mM Tris-HCl [pH 7.4]), and used for
qPCR or high throughput sequencing.

2.5 FAIRE-qPCR
FAIRE-qPCR was performed as described (Giresi and Lieb 2009). Primers were
designed to amplify a reference region (region with low and similar enrichment in the
control and BPTF-KO samples), test regions (regions differentially enriched at FAIRE
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sample between control cells and BPTF-KO cells) and control regions (regions with
similar enrichment in control and BPTF-KO cells). The enrichment level for the above
regions were determined by visualizing mapped reads from the FAIRE-Seq. Then,
signal from the test regions and control regions generated from the input and FAIRE
samples were normalized to signal from the reference region in each sample. Next,
relative enrichment from each region were calculated using comparative ΔΔCt method.
Statistical significance was calculated using student’s t-test. Sequences for primers
used for FAIRE-qPCR are provided in (Table 2.2).
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Table 2.2: Primers used for FAIRE-qPCR
A)#Primers#used#to#validate#a#representative#of#FAIRE8Seq#sites#
##
5'#>#3'#
Test#1_For#
TCTCACCTCCACCCTTCTCC#
Test#1_Rev#
TGGGGCTTTAGCATGCCTTT#
Test#2_For#
GGGTGAGACAGGTCAGGTTT#
Test#2_Rev#
AATTGCGGGACTGGAACTTG#
Test#3_For#
TTTCACACCCACCATTAGCCA#
Test#3_Rev#
CTTTACTGCCACCAGGGAGC#
Test#4_For#
TCTGGGGACTTGTAGGGACA#
Test#4_Rev#
GGTGGATGCTGTCTGACCTG#
Control#1_For#
AATAGAACGGCCCTGGGTTG#
Control#1_Rev#
GGCTCTGCAAAATCCATGCC#
Control#2_For#
GGCTGGGGATATAACAGTCAGA#
Control#2_Rev#
AGCCTGCCGTTATGTTCTCTC#
Control#3_For#
TCACGCTCCACAGTAAAAAGGA#
Control#3_Rev#
AGCCTGCTAGTTTCTTCCAAGG#
B)#Primers#used#for#FAIRE8qPCR#over#Ccmd1#gene#
##
5'#>#3'#
A#For#
ATCTCCTTCTGCACGCACTT#
A#Rev#
GCGTACCCTGACACCAATCT#
B#For#
CTGGCATTTTGGAGAGGAAG#
B#Rev#
CGGGTTGACCCAACTCTTTA#
C#For#
TCAGCATCTTTCCATTCACG#
C#Rev#
TGGAATACAGGTGGGGGTAA#
D#For#
CCCCAACAACTTCCTCTCCT#
D#Rev#
ACTCTGGGAAGAAGCTCGTG#
E#For#
GAGGGGGTCCTTGTTTAGCC#
E#Rev#
GTCTCTGGCAGCTCTCACTG#
F#For#
GGCAAAAACCAGCATCTCTC#
F#Rev#
CACAGCGGTAGGGATGAAAT#
G#For#
GACCCTCCAATAGCAGCGAA#
G#Rev#
CATGGCGCTGCTACCGAT#
H#For#
GAAAGGCCACCTTGGGTCTT#
H#Rev#
CGCAAATGGGTGTTTGCTCT#
Standard#For#
ATACAACCAAACAGACACACAACC#
Standard#Rev#
CTACTGGCTGCCATGGCTTA#
!

	
  

A) Primers correspond to Figure 3.5.F
B) Primers correspond to Figure 3.9 D
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2.6 Library Preparation
Library preparation for ChIP-Seq and FAIRE-Seq and high throughput
sequencing were performed at the nucleic acid research facility (NARF), Virginia
Commonwealth University (VCU). Qubit™ high sensitivity kit (Invitrogen) was used to
determine DNA concentration. NEBNext® Ultra™ DNA Library Prep Kit for illumine® was
used for library preparation for ChIP-Seq and TruSeq DNA sample preparation kit was
used for library preparation for FAIRE-Seq. BioAnalyzer high sensitivity chip was used
to check libraries sizes and KAPA library quantification kit was used to measure the
libraries concentrations. Samples were run on Miseq then HiSeq 2000 or 2500.

2.7 Data Analysis
After removing barcodes, quality of the 100 nucleotides (nt) reads was assessed
using FastQC version 0.10.1 (Babraham Bioinformatics). Reads were trimmed to keep
nt between position 15 and 50 using a custom logarithm provided by Vishal N Koparde,
Ph. (NARF, VCU) to keep nt with high quality score (Figure 2.1). Bowtie2 software
(Langmead and Salzberg 2012) was used to map the reads to National Center for
Biotechnology Information (NCBI) build 37 (mm9) mouse genome with masked
repetitive elements. Mouse genome was downloaded from University of California,
Santa Cruz genome browser (UCSC) as mm9.2bit from the following link
(http://hgdownload.soe.ucsc.edu/goldenPath/mm9/bigZips/). Next, twoBitToFa utility
from UCSC genome browser
(http://hgdownload.cse.ucsc.edu/admin/exe/macOSX.x86_64/) was used to convert
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mm9.2bit to mm9.fa that can be used in bowtie2. Masking repetitive element was
performed using bedtools v2.17.0 (Quinlan and Hall 2010) with maskFasta command.
Annotations for repetitive elements obtained from UCSC genome browser. The masked
genome was indexed using bowtie2 as described in bowtie2 manual. Reads were
mapped as unpaired reads with the following conditions: one alignment reported for
each read and one mismatch allowed per seed. The resulting sam files from bowtie2
were converted to bam files then sorted and indexed with samtools (Li, et al. 2009).
Reads with mapping score less than 10 were filter out. For ChIP-Seq, SICER software
(Zang , et al. 2009) was used to call peaks using the following conditions; window size
200pb, gap size 200bp, fragment size 200bp and false discovery rate (FDR) 0.001 after
normalizing the reads count between BPTF ChIP-Seq and Input. For FAIRE-Seq,
Diffreps software (Shen , Shao, et al. 2013) was used to determine differential regions
between the control FAIRE samples and the BPTF KO FAIRE samples using the
following conditions; the two control replicates as treatment and the two KO replicates
as control, window size 100bp, step size 10, gap size zero, p-value 0.001 and negative
binomial test for statistical testing after normalizing the read count between the control
and BPTF KO bam files. The following command was executed ($ diffReps.pl -treatment wt-Rep1.bed wt-Rep2.bed --control KO-Rep1.bed KO-Rep2.bed -re Results -window 100 --step 10 --gap 0 --pval 0.001 -me nb --gname mm9).
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Figure 2.1

Figure 2.1: Trimming reads to keep bases with high quality scores.
Top panels show two examples of quality score for the full read length. Bottom panel shows the
quality score for the reads after trimming the first 15 bases and the last 50 bases.
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2.8 Co-localization Analysis with Previously Published ChIP-Seq Data Sets
Previously published ChIP-Seq peaks for histone modifications and chromatinassociated proteins from mouse ESC used for co-localization analysis were obtained
from Gene Expression Omnibus (GEO) database (Table 2.4). Co-localization analyses
to determine the enrichment of BPTF-peaks from ChIP-Seq or BPTF-dependent FAIRE
sites from FAIRE-Seq over the previously published ChIP-Seq peaks were performed
using Genome Runner tool (Dozmorov, et al. 2011). For background estimation of
random co-localization, random data set with equal number of sites for BPTF peaks or
BPTF-dependent FAIRE sites were generated from the portion of the mouse genome
with annotated epigenomic data from the Encyclopedia of DNA elements (ENCODE)
project. The co-localization analysis was performed by reporting the number of overlap
between the BPTF peaks or BPTF-dependent FAIRE sites and ChIP-Seq peaks for
each factor from the previously published ChIP-Seq peaks (Table 2.3). Co-localizations
that can occur by chance only were assessed by selecting random data sets with equal
number of sites for BPTF ChIP-seq peaks or BPTF-dependent FAIRE sites from the
portion of the mouse genome annotated with epigenomic data from the Encyclopedia of
DNA elements (ENCODE) project. The numbers of observed and expected by chance
overlaps were used to calculate p-values using Chi-square test (Table 2.4). The
pValues were corrected for multiple testing using False Discovery Rate procedure.
Genome runner analyses were performed by Dr. Mikhail Dozmorov (Department of
Biostatistics, VCU).
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Table 2.3: List of ChIP-Seq data used in this study

Factor
c"Myc
E2f1
Esrrb
Klf4
n"Myc
Smad1
Stat3
Tcfcp2l1
Zfx
Med1
Med12
Nipbl
Smc1
Smc3
Ctr9
RNA"PolMIIMSer2p
RAN"PolMIIMSer5p
Spt5
NelfA
Dpy30
H4K16ac
CtcfMChIA"PETMLoopMEnds
Aff4
Atrx
CoRest
Ell2
Ell3
Hdac1
Hdac2
Kap1
Lsd1
Nanog
Nr5a2
MOct4
p300

	
  

Accession,#
GSE11431
GSE11431
GSE11431
GSE11431
GSE11431
GSE11431
GSE11431
GSE11431
GSE11431
GSE22557
GSE22557
GSE22557
GSE22557
GSE22557
GSE20485
GSE20485
GSE20485
GSE20485
GSE20485
GSE26136
GSE43103
PMID:21685913
GSE30267
GSE22162
GSE27841
GSE30267
GSE30267
GSE27841
GSE27841
GSE31183
GSE27841
GSE44286
GSE19019
GSE44286
GSE36027MM

Factor
Brdm4
Rbbp5
Rest
Setdb1
Sox2
Suz12
Tbp
Tet1
Utx
Wdr5
Ctcf
H3K4me1
H3K4me3
H3K9ac
H3K9me3
H3K27ac
H3K27me3
H3K36me3
RNA"PolMII
Cdk9
Ringb1
YY1
Capd3
Cbp
Mbd3
Caph2
Tbx3
CtcfMChIA"PETMMLoopMEnds
E"PMSmcMChIA"PETMMLoopMEnds
H2A.Z
H2A.Zac
H3.3MTurnMOverMSites
Smc1MChIA"PETMLoopMEnds
RNA"PolMIIMChIA"PETMLoopMEnds
Mrg15
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Accession,#
GSE36561
GSE22934
GSE27841
GSE18371
GSE44286
GSE44286
GSE22303
GSE26832
GSE37821
GSE22934
ENCODEMRenMLab
ENCODEMRenMLab
ENCODEMRenMLab
ENCODEMRenMLab
ENCODEMRenMLab
ENCODEMRenMLab
ENCODEMRenMLab
ENCODEMRenMLab
ENCODEMRenMLab
GSE44286
GSE26680
GSE31785
GSE33346
GSE51522
GSE51522
GSE30919
GSE19219
PMID:M21685913
PMID:M25303531
GSE34483
GSE34483
GSE63641
PMID:M25303531
GSE44067
EMBO,Mvol30,Mp1473

	
  
2.9 Preparation of Nuclear Extract
Extraction of nuclear fraction was performed as previously described (Wysocka
2006). 1X107 cells were collected from 10 cm plate, washed one time with 1X PBS and
re-suspended in 1 ml of Buffer A (10 mM HEPES [pH 7.5], 1.5 mM MgCl2, 10 mM
potassium chloride (KCl), 1 mM DTT and 1X protease inhibitor cocktail (Roche)). Cells
were incubated for 10 min on ice and lysed with 10 strokes using a 2 ml dounce
homogenizer with a type A PVTF pestle. Then, the lysate were centrifuged at 3300 g for
15 min at 4°C. The supernatant was removed and the pellet was re-suspended (the
nuclear fraction) in buffer C (20 mM HEPES [pH7.5], 1.5 mM MgCl2, 450 mM KCl, 25%
glycerol, 0.2 mM EDTA, 1 mM DTT and 1X protease inhibitor cocktail (Roche)). Next,
the nuclear fraction was incubated on ice for 30 min and centrifuged for 15 min at
21,000 g at 4°C to remove insoluble fractions. The supernatant was then adjusted to
150 mM KCl with buffer D (20 mM HEPES [pH 7.5], 20% glycerol, 0.2 mMEDTA, 0.2%
Triton X-100 and 1X protease inhibitor cocktail (Roche)). Then, the nuclear fraction was
incubated either with pre-bound Dynabeads® M-270 Streptavidin with biotinylated
peptides (as described in section 2.10	
  Peptides pull down) or with pre-bound
Dynalbeads® protein G (Life Technologies) with antibody for BPTF (custom), THOC4
(Immunoquest, IQ221), or Normal IgG Rabbit (Cell Signaling, 2729S) (as described in
section 2.11 In vivo co-immunoprecipitation).

2.10 Peptides Pull-down
Dynabeads® M-270 Streptavidin (Life Technology) were washed with PBS and
incubated with 200 pico mole (pmole) biotinylated peptides (N-terminal Histone H3.1
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amino acids 1-20, H3.1 amino acids 1-20 mono-methylated at lysine 4, H3.1 amino
acids 1-20 tri-methylated at lysine 4, H3 amino acids 27-45 and H3 amino acids 27-45
tri-methylated at lysine 36 (EpiCypher) for 3 h on shaker. Then, beads were washed
three times with PBS, and re-suspended in PBS. Beads pre-bound with 200 pmole
biotinylated peptides were incubated with P19 cells nuclear extract prepared as
described in section 2.9 for 1 h on ice with mixing every 5 min. Following the incubation,
beads were washed with washing buffer (20 mM HEPES [pH 7.5], 300 mM KCl, 0.2%
Triton X-100) three times with 5 min each and one time with PBS. Proteins were eluted
with 1% SDS at 65°C for 30 min. Eluted proteins were used for Western blotting.

2.11 In vivo Co-immunoprecipitation
BPTF antibody (Millipore), THOC4 antibody (D3R4R, Cell Signaling) and normal
rabbit IgG antibody (2729S, Cell Signaling) was bound to protein G Dynal beads (Life
Technologies). 40 µl Beads were washed three times with 1X PBS and in then resuspended in 100 µl 1X PBS and incubated with antibody for overnight at 4°C in rotator.
Then, beads were washed 3 times for 5 min on ice with 1X PBS or pull down buffer to
remove unbound antibody. Beads pre-bound with the antibody were incubated for 3 h 4
°C rotator with mESC nuclear extract prepared as described in section 2.9 which
additionally treated with MNase (Worthington) before incubation. Following incubation
with nuclear extract, beads were washed with for three times with (20mM HEPES, 0.2%
X-100, 150 mM KCl and 2mM MgCl2) and bound proteins were eluted with 1% SDS at
room temperature for 30 min. Eluted proteins were used for Western blotting.
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2.12 THOC4-NURF in vitro Pull-downs
Protein expression:
To generate MBP -tagged THOC4, sequence corresponds to mouse THOC4 was
amplified from full-length mouse THOC4 containing plasmid (Urigene) with the following
primers; forward 5’ GGGATATCATGGCCGACAAAATGGAC 3’ and reverse 5’
GGGGGATCCTTAGCTGGTGTCCATCCTTGCATTGTAAG 3’. The amplified sequence
was cloned into pMAL c2X MBP (New England Biolabs), and recombinant proteins were
expressed in BL21-CodonPlus(DE3)-RIPL (Agilent Technologies) using 0.5 mM IPTG at
37°C for 3 h. The bacterial pellets were re-suspended in 1/10 culture volume with PBS,
1% Triton X-100 and 1X protease inhibitor cocktail EDTA free (Roche) and expressed
proteins were extracted by sonication on ice. Soluble extracted proteins were incubated
with amylose resin (New England Bio Labs). MBP-bound proteins were washed two
times with 10 volumes of PBS to remove unbound proteins, and stored in ~50% glycerol
at -20°C as resin bound MBP-tagged proteins. To obtain purified THOC4, MBP-THOC4
bound to resin was eluted with 10 mM maltose. Eluted protein then, dialyzed against
PBS, quantified with BioRad DC Protein assay (BioRad) using bovine serum albumin
(BSA) standards and diluted to100 ng/μl, which was used for in vitro pull-down.
Purified recombinant NURF complex contains FLAG-tagged BPTF, SNF2L and
RbAp48 were obtained from Dr. Joseph Landry (Qiu, et al. 2015). The N-terminal PHD
domain of mouse BPTF was cloned as a GST-tagged pGEX4T-1 (GE Life Sciences) by
Marissa Mack in Dr. Joseph Landry’s laboratory.

In vitro pull down
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For in vitro pull-down of NURF complex with MBP-tagged THOC4, equal amount
of resin bound MBP-THOC4 or MBP only were washed one time with wash buffer
(25mM HEPES, 100mM NaCl, 0.01% NP-40, 0.5 mM MgCl2 and 10% glycerol) and resuspended in 100 µl the wash buffer and 2 µl of purified recombinant NURF (stock 2
µg/µl) were added. Following incubation of 1 h on ice with mixing every 5 min, the resin
was washed four times with the wash buffer with changing into new tube after the third
wash. Next, bound proteins were eluted with 1% SDS at 65 °C for 30 min. Eluted
proteins were used for Western blotting with BPTF antibody (Millipore).
For in vitro pull-down of recombinant THOC4 with GST-N-PHD, equal amount of
resin bound GST-N-PHD or GST only were washed one time with in vitro pull-down
buffer (25mM HEPES 300mM NaCl, 1mM MgCl2, 0.01% NP40 and 10% glycerol) and
1mM of ZnCl2. Then, extensive wash with the in vitro pull-down buffer were performed
to remove the ZnCl2. Following the wash, the resins were re-suspended in 100 µl in vitro
pull-down buffer and 1 µl of purified THOC4 (stock 100 ng/µl) was added and incubated
for 1 h on ice with mixing every 5 min. Next, the resin were washed 5 times with in vitro
pull down buffer with changing into new tubes after the 3rd wash. Next, the bound
proteins were eluted with 1% SDS at 65°C, and eluted proteins were used for Western
blotting with THOC4 antibody (D3R4R, Cell Signaling).

2.13 Western Blotting
Monolayer cells were washed with PBS for three times, and incubated with 1 ml
of TRI-Reagent for 5 min. The homogenates were transferred into 1.5 ml tubes, and
incubated with 200 µl chloroform for 15 min. Then, samples were centrifuged for 15
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minutes at 20,000 RCF(relative centrifugal force) at 4°C. Three layers were formed; an
aqueous phase contains the RNA, an interphase contains the DNA and an organic
phase contains the proteins (bottom layer). After removing the aqueous and interphase,
1 ml of isopropanol was added and the tubes were incubated at room temperature for
10 min. Then, the samples were centrifuged at 20,000 RCF for 15 min at 4°C. The
supernatants were discarded and 1 ml of 0.3 M guanidine in 95% ethanol was added for
overnight wash at 4°C on shaker. Then, the guanidine was removed by centrifugation at
high speed and protein pellets were washed overnight with 1 ml of 100 % ethanol at 4°C
on shaker. Next, proteins were dissolved in 250 µl of 8 M urea in 1% SDS at 65°C
overnight. Protein concentration was measured using Bio-Rad Dc Protein Assay
provided by Bio-Rad Laboratories (Hercules, CA) using BSA standards. The proteins
were dissolved in 2 mg/ml. 50 µg of protein was loaded into a 4% SDS-PAGE for BPTF
or a 12% SDS-PAGE for THOC4, and run for 1 hour at 200 V and 300 mA. Next,
proteins were transferred into polyvinylidene fluoride (PVDF) membrane provided by
Bio-Rad Laboratories (Hercules, CA) for 17 hours at 20 V and 30 mA. Transfer buffer
for Bptf was (10 mM CAPS-NaOH [ph10.5] and 2.5 mM DTT), and for all other proteins
in this study was (25 mM Tris, 190 mM glycine and 20% methanol). After transfer, the
PVDF membranes were blocked with 5% non-fat dry milk in PBST (PBS, 0.1% Tween20) for 1 h, and incubated with primary antibody for overnight at 4°C. Primary antibodies
used in this study include BPTF 1:5000 (custom), SNF2L 1:5000 (Abcam), RbAp48
1:5000 (Abcam) and THOC4 1:1000 (Cell Signaling). Next, membranes were washed
three times with PBST for 10 min each, and the membranes were incubated with ECL
peroxidase labeled secondary antibody at 1:10,000 dilution for 2 hour. The plots were
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then washed for 10 min with PBST for three times and developed using super signal
West Femto Substrate (Thermo Scientific).

2.14 RNA Extraction and Quantitative RT-PCR
Total RNA was extracted using TRI-Reagent (Sigma-Aldrich) from mESCs grown
in 10 cm plate. The cells were washed with PBS and 1 ml of TRI reagent was added
and incubated for 5 minutes. Then, the contents were transferred to 1.5 ml centrifuge
tubes and 200 µl chloroform was added. Samples were mixed by vortexing and
incubated for 10-15 minutes. Tubes were then centrifuged at high speed for 15 min at
4°C. The resulted aqueous phase, which contains the RNA, was transferred into a new
1.5 ml tubes. 100 µl of acidic phenol was added and samples were centrifuged. RNA
precipitation was achieved by adding 250 µl of isopropanol and 250 µl of RNA
precipitation solution (1.2 M NaCl and 0.3 M disodium citrate). After mixing the contents
and incubating the tubes for 10 minutes at room temperature, the tubes were
centrifuged at high speed for 15 minutes at 4°C. The resulted pellets were washed two
times with 70% ethanol and RNA was dissolved in 50 µl molecular grade water. RNA
integrity was tested by 1.5% agarose electrophoresis. The absorbance at 260 and 280
wavelengths was measured by NanoDrop® ND-1000 Spectrophotometer (Thermo
scientific)
RNA was treated with DNase I to digest any traces of genomic DNA. 25 ug of
total RNA was digested in a 100 ul volume with DNase I (Sigma) in a digestion buffer
(10mM Tris pH 8.0, 3 mM MgCl2 and 2mM CaCl2) with RNAse Inhibitor (Life
Technologies) for 30 min at 37°C. Next, the RNA was extracted with acid phenol
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followed by chlorophorm:isoamyl alcohol. RNA was converted to complementary DNA
(cDNA) using SuperScript II reverse transcriptase (RT) (Life Technologies). 5 µg of total
RNA was converted using random hexamer and oligo dT primers following the
manufactures protocol (Life Technologies).
Quantitative RT-PCR was performed using 2X SsoAdvanced™ Universal
SYBR® Green Supermix (Bio Rad). The reaction mixture was prepared as follow: 5 µl of
primers 280 nM (forward and reverse primers), 5 µl of diluted cDNA (1:100 to 1:500)
and 10 µl of 2X SYBR Green ROX Mix. Quantification of the cDNA was performed using
an Applied Biosystems 7900HT systems. The qRT-PCR condition was as follow: 95ºC
for 15min, then 50 cycles of 95ºC for 10 seconds, 60ºC for 30 seconds and 72ºC for 30
seconds. Disassociation curve cycle was added at the end to ensure one product was
amplified. Primers used for qRT-PCR are provided in (Table 2.3).
Data analysis for intron retention
Relative gene expression was calculated using ΔΔCt method. To measure intron
retention, primers were designed to amplify exon-exon products (processed transcripts)
and exon-intron products (unprocessed transcripts). Enrichment from each primer set
was normalized to primers amplify GAPDH as ΔCT. Each normalized value was then
normalized to primer product that amplify exon 1 to control for change in gene
expression between control and BPTF KO cells as ΔΔCT. The relative abundance for
each normalized product for processed and unprocessed transcripts was compared
between control and BPTF KO mESCs. Statistical significant for the difference in the
relative abundance between control and BPTF KO mESC was determined using the
Student’s t-test.
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Table 2.4: Primers used of qRT-PCR
A)#Primers#used#to#test#Ccnd1#processed#transcript#
##
5'#>#3'#
A#For#
ATCTCCTTCTGCACGCACTT#
A#Rev#
GCGTACCCTGACACCAATCT#
B#For#
GATTGTGCCATCCATGCGGA#
B#Rev#
GAAGACCTCCTCTTCGCACTT#
C#For#
CATGAACTACCTGGACCGCTT#
C#Rev#
TCGATGAAATCGTGGGGAGTC#
D#For#
AGAGGCGGATGAGAACAAGC#
D#Rev#
GCAGTCCGGGTCACACTTGA#
E#For#
CCCCAACAACTTCCTCTCCT#
E#Rev#
ACCAGCCTCTTCCTCCACTT#
F#For#
GGCAAAAACCAGCATCTCTC#
F#Rev#
CACAGCGGTAGGGATGAAAT#
B)#Primers#used#to#test#Ccnd1#unprocessed#transcript#
##
5'#>#3'#
A#For#
ATCTCCTTCTGCACGCACTT#
A#Rev#
GCGTACCCTGACACCAATCT#
B#For#
TCAGCATCTTTCCATTCACG#
B#Rev#
TGGAATACAGGTGGGGGTAA#
C#For#
CCCCAACAACTTCCTCTCCT#
C#Rev#
ACTCTGGGAAGAAGCTCGTG#
D#For#
GAGCTGAGAGGTGCCAAATC#
D#Rev#
CAGGAGCCCCAGACACTTAG#
E#For#
AGGGCTTCAATCTGTTCCTG#
E#Rev#
GAGTTTCCTCAAGCCTTGCTC#
F#For#
GGCAAAAACCAGCATCTCTC#
F#Rev#
CACAGCGGTAGGGATGAAAT#
C)#Primers#used#to#test#processed#and#unporcessed#transcripts#for#a#four#
BPTFAdependent#genes#
##
5'#>#3'#
GAPDH#For#
#TGGCAAAGTGGAGATTGTTGCC#
GAPDH#Rev#
#AAGATGGTGATGGGCTTCCCG#
Gldc#Exon2#For#
ATCCAGAATTCTCCAGTAAGTTCC#
Gldc#Exon2#Rev#
TCGAGACTCTGCATGCCATTG#
Gldc#E24#A#E25#For#
TCGATCCGGGCAATGGTTG#
Gldc#E24#A#E25#Rev#
AGAGGTAGCAGCATTTCCACT#
Gldc#E24#A#I#24#For#
GGAACCTCAGGGGCAACAGG#
Gldc#E24#A#I#24#Rev#
CGTATTCTAGAGAGGTAGCAGCATT#
Scd2#Exon2#For#
GCAGATGTTCGCCCTGAACTA#
Scd2#Exon2#Rev##
AGTGTGATCCCGTACAAGGC#
Scd2#E5#A#E6#For#
TTAGCTCTCGGGAGAACATCTTG#
Scd2#E5#AE6#Rev#
AACGTGGTGAAGTTGATGTGC#

A) Primers correspond to Figure 3.9 C processed transcripts
B) Primers correspond to Figure 3.9 unprocessed transcript
C) Primers correspond to Figure 3.10 A
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2.15 Integrating Reporter Assay
pNI-P-MCS vector containing Neomycin resistant gene (Neo) as a reporter gene
was obtained from (Qiu, et al. 2015). To test whether the Ccnd1 promoter is BPTF
dependent, the 3.2kb of promoter region of Ccnd1 was amplified from mouse genomic
DNA with Phusion polymerase (New England Biolabs) using the following primers; For
5’ GGGGTACCTGCCTGGCCACGGGTGGCTCACC 3’ and Rev 5’
GGGGCGGCCGCAGTCTGTAGCTCTCTGCTACTGC 3’. The amplified fragment was
cloned upstream of the Neo gene. Next, the plasmid was linearized with Sca I as it has
a single restriction enzyme site in the pNI-P-MSC plasmid and phenol:chloroform:
isoamyl alchol extracted. Four ug of the purified linearized plasmids (either pNI-P-MCSCcnd1 or pNI-MCS control) were then transfected into 1-2 X 106 control and BPTF KO
mESC using Lipofectamin 2000 (Life Technologies) following the manufactures protocol
in 6 well plates. 48- h post-transfection, selection for Neomycin resistant colonies
started with incubating the transfected cells with ESC media containing 300 µg/ml of
geneticin (Life technologies). Following 3 week of selection, plates were stained with
staining solution (0.1% methylene blue, 50% methanol) and destined with water. Then,
the number of colonies was counted from control and BPTF KO mESC. Expression is
shown as the ratio of pNI-P-MCS colonies / pNI-MCS.

2.16 THOC4 KD in mESC
In order to generate stable THOC4 KD mESC line, the Retro-X™ system
(Clonetech) and the retroviral expression vector murine stem cell virus (pMSCV) purovector (Clonetech) were used. Short hairpin RNA (shRNA) were designed to target the

	
  

92	
  

	
  
sequence at THOC4 (NM_011568) 256-274 (AGCAGACCGAAACAACTTC). Two
complementary oligonucleotides (top strand and bottom strand) were designed to create
shRNA using Sequence Selector tool from Clontech (Figure 2.2). The top strand
oligonucleotides and bottom strands oligonucleotides were diluted were mixed as 1:1
dilution to give double strand oligonucleotides. The ds oligos were cloned into pMSCV
vector at BglI and EcoRI sites, and transfected into E. Coli GC10 super competent cells
and plated into LB agar with 100 µg/ml ampicillin. Ampicillin resistant colonies were
selected and analyzed with diagnostic restriction digest and right clones were
sequenced to verify the sequence. Next, pMSCV constructs with shRNA targeting
THOC4 and Puromycin resistant gene were transfected into packaging cell lines PT67
(Cat. No. 631510) to create virus particles. 2-3 days following transfection, media that
contain the virus particles were collected and filtered and added to mESC plated in 10
cm plate. mESC were incubated with the virus for 3 days and then the media was
replaced with a new media contains Puromycin (1 µg/ml) for selection of cells that
integrated the viral genome. Stable clones were maintained in ESC media with 1 µg/ml
of Puromycin. The efficiency of THOC4 KD was test by protein extraction and Western
blotting as described in section (2.13). In parallel to shRNA specific to THOC4 target
sequence, a shRNA targeting a non-specific sequence was used as a control (5’GTGCGTTGCTAGTACCAACTT-TCAAGAG-3’).
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Figure 2.2

Figure 2.2: A cartoon showing the shRNA sequence specific to THOC4
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CHAPTER THREE
NURF Localizes and Regulates Chromatin Structure within Genes, Interacts with
THOC4 and Regulate Messenger RNA Processing

3.1 Introduction
The packaging of genomic DNA in chromatin reduces the accessibility to the
DNA template, and affects nuclear processes such as gene transcription. Transcription
initiation requires open chromatin confirmation at promoters and transcription start sites
to recruit activators and pre-initiation complexes. Active elongation of RNA-pol 2
through gene body requires nucleosomes disassembly and re-assembly to ensure
efficient elongation and normal mRNA processing (Studitsky, et al. 2004). Thus, factors
that regulate chromatin structure can have impacts on gene expression.
Major regulators of chromatin structure are ATP-dependent chromatin
remodeling complexes. These are multi-subunits complexes that are grouped into four
families based on the ATPase subunit, SWI/SNF, ISWI, CHD and INO80. They are
recruited to chromatin through histone modifications or DNA-binding proteins. Once
recruited these complexes utilize ATP energy to provide accessibility to DNA through
either slide, remove nucleosomes or change histone variants (Clapier and Cairns 2009).
Members from each of these families are known to localize and regulate RNA-pol 2
transcription initiation. In contrast to initiation, to date only members of CHD and
SWI/SNF are involved in regulating RNA-pol 2 elongation and mRNA splicing (Sims III,
et al. 2007) (Batsche, Yaniv and Muchardt 2006). However, studies in yeast showed
that a member of ISWI family directly recruited to gene bodies and regulate RNA-pol 2
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elongation (Smolle, et al. 2012). Whether this is a conserved function of ISWI family in
mammals is unknown yet.
One of the ISWI family members in mammal is NURF complex. NURF is
essential for embryonic development, and normal differentiation of mESC but not
viability (Landry , Sharov , et al. 2008). Work from Drosophila and mouse models and
human cell lines show that NURF function as a regulator of gene expression
(Badenhorst, Voas, et al. 2002) (Barak, Lazzaro and Lane, et al. 2003) (Landry, et al.
2011) (Qiu, et al. 2015).
The full extent to how NURF regulates gene expression is not known. It is known
that NURF is recruited to promoters through interactions between the C-terminal PHD
and Bromodomain of its specific subunit BPTF however whether this localization to
promoter regions is a general feature of mammalian NURF is unknown.
Genome wide investigation for protein localization using ChIP-Seq and changes
in chromatin structure using FAIRE-Seq or DNase I-Seq has been widely used to study
chromatin-associated proteins. Projects such as the Encyclopedia of DNA Elements
(ENCODE) has successfully used such approaches to map PTMs on histone proteins,
RNA-pol 2 and DNA binding proteins such as CTCF and identify regulatory elements in
the genome in many of human tissues and mouse tissues (Rosenbloom, et al. 2013). In
addition, ChIP-Seq has been used to map binding sites for ATP-dependent chromatin
remodeling complexes and revealed valuable information on how such complexes
function in the genome. For example, ChIP-Seq analysis for BRG1 and CHD7
chromatin remodeling factors showed their localization at distal regulatory elements in
mESC (Schnetz, et al. 2010) (L. Ho, J. L. Ronan, et al. 2009). In addition, mapping the
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ISWI homolog in yeast advance our understanding for their role in regulating gene
expression through upstream, downstream and within genes (Yen, et al. 2012) (Smolle,
et al. 2012).
In this work we wanted to explore how NURF, an ISWI containing complex, is
involved in regulating gene expression using genome wide approaches. Studying the
role of NURF in vivo is achieved by targeting its unique and specific subunit BPTF
(Xiao, Sandaltzopoulos, et al. 2001) (Barak, Lazzaro and Lane, et al. 2003). We
investigated the localization of NURF specific subunit BPTF using ChIP-Seq and BPTF
dependent changes in chromatin structure using FAIRE-Seq. We also aimed to identify
a novel mechanism for NURF recruitment to the genome. Our analyses show that BPTF
localization in the genome and changes in chromatin structure are broadly localized in
the genome with preferences to TSSs, gene bodies and downstream of genes.
Biochemical investigations show that the N-terminal PHD of BPTF physically interacts
with the RNA-pol 2 associated protein THOC4, which suggests a recruiting mechanism
to intragenic regions. Further, investigating the role of BPTF within the BPTF-dependent
gene Ccnd1 shows that BPTF is required for normal mRNA processing. BPTF KO
induces intron retention in the Ccnd1 transcript, which results in an unstable transcript.
Further analysis discovers that an additional subset of BPTF-dependent genes have
defects in intron retention suggesting that this mechanism occurs more broadly across
the genome.
Collectively, our data suggest a model in which BPTF is recruited to gene bodies
through THOC4 and once recruited, it is required for normal mRNA processing. This
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work proposes a novel function of NURF independent from transcription initiation in
vivo.

3.2 Generation and Characterization of BPTF ChIP-Grade Antibody
To map NURF localization in the mouse genome, we targeted its unique and
essential subunit BPTF (Xiao, Sandaltzopoulos, et al. 2001) (Barak, Lazzaro and Lane,
et al. 2003). Identifying BPTF localization using ChIP-seq was challenging due to
lacking a specific ChIP-grade antibody. To solve this problem, we tested two custom
rabbit polyclonal antisera, a previously published BPTF-1 antibody targeting an Nterminal epitope (Landry, Sharov, et al. 2008) and a novel BPTF-2 targeting a Cterminal epitope of mouse (Figure 3.1.A).
Western blot analysis shows that both purified antibodies recognize a protein
with a size equivalent of BPTF in total protein extract from control, but not Bptf KO
mESCs, which indicates a specificity to BPTF protein (Figure 3.1.B). To test whether
these antibodies can be used to pull-down BPTF bound chromatin, BPTF binding sites
from previous studies (Qiu, et al. 2015) (Landry, et al. 2011) were tested using ChIPqPCR. BPTF-2 shows better efficiency in ChIP comparing to BPTF-1 and IgG control
(Figure 3.1.C). To further confirm BPTF-2 performance, we did ChIP-Seq using BPTF-1,
BPTF-2 and IgG control. The total number of mapped DNA fragments were more using
BPTF-2 than using BPTF-1 or IgG (Figure 3.1.D). These suggest that BPTF-2 antibody
specifically recognizes BPTF and can be used for ChIP-Seq experiment.

	
  

98	
  

	
  

	
  

99	
  

	
  

	
  

100	
  

	
  

3.3 BPTF Broadly Localizes to the Genome, and Enriched at Sites of Proteins
Known to Interact with NURF
Using our custom BPTF-2 antibody, we mapped BPTF and by extension the
NURF complex localization to the mouse genome using ChIP-Seq. Two biological BPTF
ChIP-Seq replicates and total genomic DNA, as an input control, were sequenced in the
nucleic acid research facility (NARF) at Virginia Commonwealth University. High quality
reads (see method section 2.7) were mapped to the mouse genome with masked
repetitive element using Bowtie2 software (Langmead and Salzberg 2012) (Figure3.2.A).
To measure the reproducibility between the two replicates, the deeptools package
(Ramírez, et al. 2014) was used to calculate the Pearson Correlation Coefficient
between the mapped reads of the two replicates as well as the input. This analysis
shows good reproducibility between the two replicates (r=0.89) (Figure 3.2.B). Next,
examining the ChIP-Seq signal over the genome using the integrative genome viewer
(IGV) (Robinson, et al. 2011) indicates a broad BPTF localization through the genome
(Figure 3.2.C). This localization pattern is different than the other chromatin remodeling
complexes BRG1, CHD7, CHD4 and INO80 in mESCs (Figure 3.2.C). Moreover, to test
whether this is a genome wide observation, we used deeptools package with the default
parameters to calculate reads enrichments from each remodelers over 500,000 bins of
the mouse genome with 500bp bin size. In the signal extraction scaling (SES) plot (Diaz,
et al. 2012), the H3K4me3 and H3K27me3 were used as examples for narrow and broad
peaks, respectively. H3K4me3 localization is very narrow and highly enriched at its
binding sites, while H3K27me3 localization is very broad and less enriched at its binding

	
  

101	
  

	
  
sites (Figure 3.2.D). The SES plot shows that BPTF has broader localization pattern
compared to other remodelers, which have narrower enrichment (Figure 3.2.D). These
suggest that a broad localization pattern of BPTF is likely a feature of ISWI containing
complexes.
To determine regions of enrichment, we next used SICER (Zang , et al. 2009), a
peak calling software used to identify broad peaks, to call for significantly enriched
regions for BPTF compared to an input control. SICER identified 54,247 BPTF binding
sites with false discovery rate (FDR) 0.001. Representative sites were validated using
ChIP-qPCR (Figure 3.2.E). At these sites high enrichment of BPTF signal over the input
signal was detected (Figure 3.2.F). Also, high enrichment of BPTF signal was detected
over sties co-occupied by H3K4me3, H4K16ac, CTCF and cohesin, which are known to
physically interact with NURF complex (Figure 3.2.G). This enrichment of BPTF over the
sites of these factors indicates that they can recruit BPTF and the NURF complex to
chromatin. The results from the ChIP-qPCR and the overlap with known NURF
interacting factors suggest that the enrichment that we obtained from our ChIP-Seq
experiments is specific to BPTF.
Collectively, these data are consistent with a previously suggested model for ISWI
proteins where they continually sample the chromatin with short resident time, and more
resident time at sites that occupied by a recruiter like the histone modifications
H3K4me3, H4K16ac, CTCF or cohesin (Erdel and Rippe 2012).
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3.4 BPTF Localization Is Correlated with BPTF Dependent Genes
Previous work from our lab documents NURF complex as a regulator of gene
expression in mESC (Qiu, et al. 2015). In order to investigate the correlation between
NURF complex and gene expression, we examined BPTF localization from our ChIPSeq relative to BPTF-dependent genes from mESC, which were previously identified
(Landry , Sharov , et al. 2008). In this analysis we looked for genes that have a BPTF
peak within TSS and transcription terminator site (TTS) of Refseq genes, and then
asked how many of these genes are BPTF dependent in their expression in mESC. A
Venn diagram shows a significant correlation between BPTF peaks and BPTFdependent genes (pValue= 5.8X10E-9) (Figure 3.3.A). Similar analysis for other
chromatin remodeling complexes shows that the correlation obtained for BPTF is
equivalent to INO80 (pValue=1.5X10E-7), but not as significant as CHD7 and BRG1
(pValue=1.5X10E-59, pValue=9.1E-188, respectively) (Figure 3.3.A).
Next, previous genome wide studies identified set of enhancers in mESC (Hnisz,
et al. 2013). To test whether BPTF localizes with these enhancers we performed similar
co-localization analysis as performed to BPTF-dependent genes. This analysis shows
that BPTF peaks do not have preferences over enhancers (pValue=1), while the other
remodelers strongly overlap with these elements as previously reported (pValue< 9.2E320 for BRG1, CHD7 and INO80) (Figure 3.3.B) (L. Ho, J. L. Ronan, et al. 2009)
(Schnetz, et al. 2010). Together these data suggest that BPTF and by extension NURF
mainly localize within genes, and not significantly bind to distal regulatory elements at
least in mESC.
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3.5 BPTF Localization Enriched at TSSs, Gene Bodies and 3’End of Genes
To better understand how BPTF functions at genes, we investigated BPTF
localization over a 3kb of meta-gene. As expected, we observed high BPTF signal at
promoters, transcription start sites and 5’UTRs similar to other chromatin remodelers
(Figure 3.4.A). Interestingly, BPTF signal was high throughout gene bodies and higher
at the 3’end of genes. The observed pattern of BPTF signal over the 3kb of meta-gene
resembles a pattern of factors associated with active elongation such as H3K36me3
(Shen , et al. 2012), RNA-pol 2 p-Ser2 and CTR9 (Rahl, et al. 2010) (Figure 3.4.B). To
test whether BPTF signal is associated with active genes in mESC, we utilized a
previously published RNA-Seq data for mESC (Shen , et al. 2012). Similar meta-gene
analysis shows that BPTF signal is high at actively transcribed genes especially at
TSSs and 3’end of genes (Figure 3.4.C). Next, we wanted to look for the distribution of
BPTF peaks identified by SICER as a significant enrichment of BPTF over input control.
To this end, we mapped BPTF binding sites identified by SICER to genomic annotations
using the cis-regulatory element annotation system (CEAS) (Shin, et al. 2009). This
analysis shows significant localization of BPTF ChIP-Seq peaks over gene features.
(Figure 3.4.D). Comparing to other remodelers, BPTF peaks are more frequent at
coding regions, introns and 3’UTR regions than upstream regions (Figure 3.4.D).
Together, these results show that BPTF localizes at intragenic regions and is more
enriched at coding regions and 3’end of genes than at promoters. These results suggest
that NURF predominantly localizes to gene bodies with minimal localization to
promoters.
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3.6 BPTF Maintains Open Chromatin Structure at Upstream, Introns and
Downstream of Genes
NURF is an ATP-dependent chromatin-remodeling complex that promotes
accessibility to underling DNA sequence (Tsukiyama and Carl 1995) (Barak, Lazzaro
and Lane, et al. 2003). To investigate whether the observed pattern of BPTF localization
in genes is accompanied by remodeling activity of NURF, we decided to map NURF
dependent changes in chromatin structure in the genome. To this end, we investigated
open chromatin structure in control and BPTF KO mESCs (Landry , et al. 2008) using
the technique of formaldehyde assistance isolation of regulatory elements followed by
high throughput sequencing (FAIRE-Seq). In FAIRE-Seq, the chromatin is fixed by
formaldehyde, sheared with sonication and subjected to phenol-chloroform extraction.
DNA fragments that are not bound by nucleosomes are enriched in the aqueous phase,
which is subsequently purified and subjected to high throughput sequencing (Simon, et
al. 2012) (Figure 3.5.A).
Two biological replicates from control and BPTF KO mESCs were sequenced
along with total genomic DNA as an input control. Mapping the FAIRE-Seq profile to
mouse genome with masked repetitive elements revealed 24-33% of reads were
uniquely mapped (Figure 3.5.B). High Pearson Correlation Coefficient calculated using
deeptools package (Ramírez, et al. 2014) between the two control replicates and BPTF
KO replicates indicates good reproducibility (Figure 3.5.C). We also compared our
FAIRE-Seq profile from control cells to a recently published FAIRE-Seq profile from
mESCs (Murtha, et al. 2014) and found high correlation, which suggest that our data is
of high quality (Figure 3.5.C).
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Screening through the FAIRE-Seq profiles using IGV identified regions that are
enriched in control but not BPTF KO FAIRE-Seq indicating that NURF is required to
maintain open chromatin regions at these sites and our approach can be used to
identify those regions (Figure 3.5.D, red highlights). Next, we used Diffreps software
(Shen, et al. 2013) to identify those differently enriched regions between the control and
BPTF KO mESC replicates with pValue< 0.001. Differeps identified 56,800 differentially
enriched regions with 27,864 regions enriched in control cells that require NURF to
maintain open chromatin structure in control cells (we called those open regions) and
28,936 regions enriched in Bptf KO cells that require NURF to maintain closed
chromatin structure in control cells (we called those closed regions) (Figure 3.5.E).
Validation of a representative number of FAIRE sites was performed by FAIRE-qPCR
(Figure 3.5.F). Next, we did correlation analysis between BPTF dependent changes in
chromatin structure identified by FAIRE-Seq (here after BPTF-dependent FAIRE sites)
and BPTF-dependent genes in mESC, similar to figure 3.3.A. This analysis shows
significant co-localization of BPTF-dependent FAIRE sites within BPTF dependent
genes (pValue=4.43E-5) (Figure 3.5.G, right). Similar analysis was performed for BPTFdependent FAIRE over enhancer in mESC. This analysis shows a significant overlap
over enhancer (pValue=1.0E-28) suggesting that BPTF and by extension NURF is
required for regulating chromatin structure at distal regulatory elements (Figure 3.5.G,
left) in mESC.
To investigate whether BPTF-dependent FAIRE sites are enriched over genes,
we mapped the identified open and closed regions over genomic annotations using
CEAS software (Shin, et al. 2009). In contrast to closed FAIRE sites, open FAIRE sites
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showed significant enrichment in 1kb upstream, 5’UTR, introns, 3’UTR and 1kb
downstream of genes (Figure 3.5.H). This suggests that within genes, BPTF and NURF
complex maintain open chromatin structure. To investigate whether BPTF is localized
over BPTF-dependent FAIRE, we measured BPTF ChIP-Seq signal over TSSs, TTSs of
genes and enhancers that have BPTF-dependent FAIRE sites. These analyses show
BPTF enrichment at TTS of genes and enhancers that have BPTF-dependent FAIRE
sites (Figure 3.5.I, J). Together, these results show broad localization of BPTFdependent changes in chromatin structure, and within genes it mostly maintain open
chromatin regions at upstream, introns and downstream regions of genes.
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3.7 BPTF Localization and Remodeling Activity Overlap with Factors Localize in
Promoters, Gene Bodies and Downstream of Genes
Recruitment of BPTF at promoter regions can be explained by interaction with
H3K4me3 and H4K16ac. However, our finding from ChIP-Seq and FAIRE-Seq analyses
showed that BPTF localizes at gene bodies and 3’end of genes suggesting novel
recruiting mechanisms for BPTF at these regions. In attempt to identify such
mechanisms, we screened for overlap between BPTF ChIP-Seq peaks and BPTFdependent FAIRE sites (chromatin remodeling activity) over a panel of histone
modifications and DBPs using previously published ChIP-Seq data from mESCs (Table
2.3). Toward this end, we collaborated with Dr. Mikhail Dozmorove (Department of
Biostatistics, VCU) to use Genome Runner (GR), a previously published tool that can be
used to measures significant overlaps between ChIP-Seq data set (Dozmorov, et al.
2011). As expected, we observed significant overlap between BPTF peaks (All BPTF
peaks from ChIP-Seq) and H3K4me4, H4K16ac, CTCF and cohesin (Smc1) peaks
(Figure 3.6.A) (Table 3.1). We also detect overlap with factors known to localize at
promoter regions such as H3K9ac, H3K27ac, NelfA, a negative elongating factor,
Mediators (Med1 Med12), RNA-pol 2 p-Ser5 and DPY30, a H3K4me3 associated
protein (Figure 3.6.A). In addition we detected overlap with factors associated with gene
bodies such as H3K36me3, CDK9, a subunit of the positive elongation factor P-TEFb,
the H3K36me3 interacting protein MRG15 (Xie, et al. 2011), and the PAF1 subunit
CTR9. Also, we detected overlap with histone variants H2A.Z, H2A.Zac, H3.3 and the
H3K4me1 (Figure 3.6.A). The H3.3 and H2A.Z are histone variants, and nucleosomes
with these variants are less stable compered to canonical histone. H2A.Z is enriched in
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promoters, enhancer regions and CTCF binding sites (Hu, et al. 2013) (Fu, et al. 2008),
and maintain low nucleosome occupancy at these regions (Hu, et al. 2013). Also, its
level at promoters is correlated with gene expression (Barski, et al. 2007). H3.3 is also
found in TSS, gene bodies and distal regulatory elements, and its incorporation into
nucleosomes decreases nucleosome stability (Jin and Felsenfeld 2007) and prevents
incorporation of linker histone. Thus, the observed overlap of BPTF peaks with these
variants indicates that BPTF localizes over regions with less stable nucleosomes such
as regulatory element, TSSs and CTCF binding sites. The overlap with H2A.Z agrees
with a previous finding that H2A.Z interact with BPTF in vivo (Kim, et al. 2013).
We repeated the GR analysis for BPTF-dependent FAIRE sites. We found that
BPTF-dependent FAIRE sites overlapped with known BPTF recruiters (H3K4me3,
H4K16ac, CTCF and cohesin (Smc1 and Smc3), the promoter-associated factors
H3K9ac, H3K27ac and DPY30, and the elongation factors H3K36me3 and CDK9. Also,
overlap with H2A.Z, H2A.Zac, H3.3 turnover and H3K4me1 was detected (Figure 3.6.B)
(Table 3.2).
The observed overlap between BPTF peaks and BPTF-dependent FAIRE with
DPY30 was interesting because previous work suggest the DPY30 is a potential subunit
of NURF. However, we found that the majority (93%) of DPY30 peaks that overlap with
BPTF are overlap with H3K4me3. This suggests that DPY30 is associated with BPTF
through H3K4me3 (Figure 3.6.C).
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Table 3.1: Results from co-localization analysis for BPTF ChIP-Seq
peaks
BPTF9ChIP3Seq9all9peaks99
Factor
Observed Expected Diff
p3val
Obs/Tot
NelfA
1575
53
OVER 0.00E+00
0.03
H4K16ac
9824
584
OVER 0.00E+00
0.18
Lsd1
2044
143
OVER 0.00E+00
0.04
Tet1
2781
134
OVER 0.00E+00
0.05
H3K4me1
6288
538
OVER 0.00E+00
0.12
H3K4me3
2669
180
OVER 0.00E+00
0.05
H3K9ac
2798
171
OVER 0.00E+00
0.05
H3K27ac
2231
183
OVER 0.00E+00
0.04
H3K36me3
7841
172
OVER 0.00E+00
0.14
Cdk9
2745
274
OVER 0.00E+00
0.05
H2A.Z
4931
327
OVER 0.00E+00
0.09
H2A.Zac
2006
141
OVER 0.00E+00
0.04
H3.3CTurnCOverCSites
8863
389
OVER 0.00E+00
0.16
RNAJPolCIICChIAJPETCLoopCEnds
1894
64
OVER 0.00E+00
0.03
Smc1CChIAJPETCLoopCEnds
1883
191
OVER 5.56EJ308
0.03
Rbbp5
1511
56
OVER 4.64EJ300
0.03
Dpy30
1605
108
OVER 5.04EJ291
0.03
Ctcf
2051
327
OVER 7.28EJ280
0.04
p300
1410
61
OVER 1.06EJ274
0.03
RNAJPolCIICSer5p
1244
33
OVER 1.06EJ254
0.02
Med1
1336
75
OVER 2.72EJ250
0.02
Ctr9
1128
17
OVER 6.30EJ239
0.02
Tbp
1170
34
OVER 1.06EJ237
0.02
Ringb1
1345
104
OVER 2.91EJ236
0.02
Med12
1329
98
OVER 5.24EJ236
0.02
Smc1
1628
239
OVER 1.16EJ230
0.03
Merg15
1060
10
OVER 2.64EJ228
0.02
Yy1
1379
135
OVER 1.97EJ227
0.03
Spt5
944
18
OVER 1.38EJ197
0.02
RNAJPolCII
1042
76
OVER 2.02EJ185
0.02
E2f1
940
43
OVER 1.20EJ181
0.02
Wdr5
890
25
OVER 2.32EJ181
0.02
Capd3
837
29
OVER 2.75EJ167
0.02
Esrrb
851
53
OVER 1.68EJ156
0.02
Klf4
762
28
OVER 2.04EJ151
0.01
Nipbl
805
49
OVER 1.02EJ148
0.01
Zfx
715
19
OVER 1.60EJ146
0.01
Smc3
1197
241
OVER 4.29EJ142
0.02
Hdac1
765
47
OVER 3.94EJ141
0.01
Tcfcp2l1
929
123
OVER 1.25EJ137
0.02
RNAJPolCIICSer2p
629
13
OVER 2.54EJ131
0.01
Cbp
787
83
OVER 6.59EJ127
0.01
nJMyc
585
16
OVER 8.03EJ120
0.01
Rest
671
49
OVER 1.18EJ119
0.01
Hdac2
670
64
OVER 1.47EJ111
0.01
H3K27me3
786
171
OVER
1.04EJ88
0.01
EnhancerJPromoterCSmc1CChIAJPETCCLoopCEnds
430
15
OVER
1.66EJ86
0.01
MBD3
461
48
OVER
3.36EJ75
0.01
Setdb1
356
12
OVER
3.82EJ72
0.01
Ell2
328
18
OVER
1.49EJ62
0.01
CtcfCChIAJPETCCLoopCEnds
370
35
OVER
1.91EJ62
0.01
cJMyc
282
5
OVER
3.01EJ60
0.01
Aff4
322
20
OVER
3.94EJ60
0.01
Suz12
298
28
OVER
1.05EJ50
0.01
Caph2
206
20
OVER
3.13EJ35
0
COct4
417
144
OVER
6.89EJ31
0.01
H3K9me3
1275
837
OVER
6.28EJ22
0.02
Stat3
90
9
OVER
3.81EJ16
0
Ell3
134
34
OVER
1.15EJ14
0
Kap1
267
119
OVER
4.47EJ14
0
Utx
112
25
OVER
1.03EJ13
0
Atrx
68
5
OVER
1.63EJ13
0
Nanog
336
198
OVER
2.14EJ09
0.01
Brdm4
57
9
OVER
3.42EJ09
0
CoRest
88
26
OVER
6.25EJ09
0
Sox2
312
188
OVER
2.72EJ08
0.01
Tbx3
40
13
OVER
2.08EJ04
0
Nr5a2
103
66
OVER
4.39EJ03
0
Smad1
12
5
no
8.95EJ02
0
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Table 3.2: Results from co-localization analysis for BPTF
dependent FAIRE sites
BPTF9dependent9FAIRE3Seq9all9regions
Factor
Smc1
H4K16ac
Tet1
Ctcf
H3K4me1
H3K4me3
H3K9ac
H3K27ac
H3K36me3
Cdk9
H2A.Z
H2A.Zac
Smc1@ChIACPET@Loop@Ends
RNACPol@II@ChIACPET@Loop@Ends
Smc3
Dpy30
H3.3@Turn@Over@Sites
p300
Lsd1
Yy1
Med12
NelfA
Med1
EnhancerCPromoter@Smc1@ChIACPET@@Loop@Ends
Capd3
Aff4
Sox2
RNACPol@II@Ser5p
RNACPol@II
@Oct4
Cbp
Tbp
Nanog
Ell2
Ctcf@ChIACPET@@Loop@Ends
Rbbp5
Nipbl
Spt5
Ringb1
Caph2
Ell3
Utx
Hdac2
Ctr9
Merg15
Mbd3
Brdm4
Suz12
E2f1
Hdac1
RNACPol@II@Ser2p
Klf4
Tcfcp2l1
H3K27me3
CoRest
Wdr5
Setdb1
Rest
H3K9me3
Esrrb
nCMyc
Zfx
cCMyc
Kap1
Tbx3
Stat3
Nr5a2
Smad1
Atrx

	
  

Observed
1532
5712
1772
2047
5684
2546
2741
2626
3444
2682
3422
2152
2608
1890
1426
1271
1295
1049
921
1049
712
685
668
612
562
520
613
480
554
515
422
359
477
355
368
369
314
270
341
270
281
261
252
234
221
214
150
163
124
132
108
107
140
219
96
107
83
106
325
75
46
39
31
117
27
23
18
17
26

Expected
42.66667
377.3333
52.33333
195.3333
325.6667
95.66667
81
105
107.3333
80
215.6667
93
140.3333
50
43
38
118.6667
23.66667
29.33333
82
14.33333
14.66667
11.66667
9
9
9.666667
51.66667
7.333333
47.33333
34
20
6
53.66667
9.666667
22
25
8
4.666667
33
6
13.33333
13
11.66667
6.666667
5.333333
14
3
8.333333
4.666667
11
2
2
17.33333
64.33333
5.333333
12.66667
4.333333
13.66667
573.6667
6.666667
2.666667
1.333333
0.333333
46
3
2.333333
50.33333
1.333333
4.666667

Diff
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
UNDER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
UNDER
OVER
OVER
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p3val
Obs/Tot
0.00E+00
0.03
0.00E+00
0.1
0.00E+00
0.03
0.00E+00
0.04
0.00E+00
0.1
0.00E+00
0.04
0.00E+00
0.05
0.00E+00
0.05
0.00E+00
0.06
0.00E+00
0.05
0.00E+00
0.06
0.00E+00
0.04
0.00E+00
0.05
0.00E+00
0.03
8.02EC289
0.03
1.69EC257
0.02
2.21EC217
0.02
5.72EC217
0.02
1.08EC185
0.02
1.26EC183
0.02
6.70EC149
0.01
2.40EC142
0.01
1.78EC140
0.01
4.71EC130
0.01
4.48EC119
0.01
3.08EC109
0.01
1.55EC105
0.01
2.41EC102
0.01
1.64EC95
0.01
4.29EC94
0.01
8.22EC82
0.01
1.83EC76
0.01
1.32EC75
0.01
4.02EC73
0.01
5.89EC69
0.01
1.64EC67
0.01
2.20EC65
0.01
1.29EC57
0
2.73EC57
0.01
5.38EC57
0
3.30EC55
0
7.31EC51
0
1.75EC49
0
1.61EC48
0
6.67EC47
0
4.02EC40
0
1.30EC32
0
1.86EC32
0
1.03EC25
0
4.28EC24
0
4.91EC24
0
8.13EC24
0
8.94EC23
0
2.83EC20
0
1.32EC19
0
9.04EC18
0
2.39EC17
0
4.36EC17
0
7.58EC17
0.01
5.82EC14
0
8.04EC10
0
1.86EC09
0
2.57EC08
0
2.62EC08
0
1.17EC05
0
2.66EC05
0
1.04EC04
0
1.62EC04
0
1.62EC04
0

	
  
3.8 Novel Sites of BPTF Enrichment and Remodeling Activity Co-localizes with
H3K36me3 and H3K4me1 and Significantly Associated with BPTF-Dependent
Genes
Next, we set out to identify novel recruiting mechanisms of BPTF to the
chromatin. BPTF is known to physically interact with H3K4me3, H4K16ac, CTCF and
cohesin. To discover new NURF recruitment factors we filter out BPTF peaks that
overlap with these factors. To this end we divided BPTF peaks into two groups. Group
A, contains BPTF peaks that overlap with sites of H3K4me3, H4K16ac, CTCF or
cohesin. Group B, contains all other BPTF peaks (Figure 3.7.A). Similar strategy was
performed for BPTF-dependent FAIRE sites (Figure 3.7.B).
First, we investigated which group is more correlated with BPTF dependent
genes in mESCs. For BPTF ChIP-Seq peaks, localization analysis showed that Group B
is significantly correlated with BPTF dependent genes (pValue=1.54E-17) (Figure 3.7.A,
Group B), but Group A is not (pValue=0.5) (Figure 3.7.A, Group A). For BPTFdependent FAIRE sites, similar analysis showed that Group B is significantly overlapped
with BPTF dependent genes (pValue=5.6E-5) (Figure 3.7.B, Group B) but Group A is
not (pValue=0.9) (Figure 3.7.B, Group A). These analyses suggest that BPTF
recruitment by factors other than H3K4me3, H4K16ac, CTCF and cohesin are more
correlated with BPTF-dependent genes.
To identify factors that could function with NURF to regulate gene expression, we
repeated GR analysis using Group A and Group B for BPTF ChIP-Seq peaks and
BPTF-dependent FAIRE sites. While Group A for both BPTF peaks and BPTFdependent sites overlapped with many factors similar to the entire data set, the Group B
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peaks overlap with limited number of factors (Figure 3.7.C, D) (Table 3.3) (Table 3.5).
The Group B for BPTF ChIP-Seq peaks enriched with H3K36me3, H3K4me1, H2A.Z,
and H3.3 turnover (Figure 3.7.C) (Table 3.4). The group B for BPTF-dependent FAIRE
sites also enriched with H3K36me3 and H3K4me1 (Figure 3.7.D) (Table 3.6). These
results demonstrate that the sites more significantly correlated with BPTF-dependent
genes are occupied by H3K36me3 and H3K4me1. These results suggest that these
factors either directly or indirectly can recruit BPTF/NURF to the genome.
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Table 3.3: Results from co-localization analysis for BPTF ChIP-Seq
peaks Group A
BPTF9ChIP3Seq9peaks9group9A
Factor
Smc1
H4K16ac
Dpy30
Lsd1
NelfA
p300
Rbbp5
Tet1
Ctcf
H3K27ac
H3K36me3
H3K4me1
H3K4me3
H3K9ac
Cdk9
H2A.Z
H2A.Zac
H3.3HTurnHOverHSites
RNANPolHIIHChIANPETHLoopHEnds
Smc1HChIANPETHLoopHEnds
RNANPolHIIHSer5p
Med1
Med12
Tbp
Yy1
Smc3
Ringb1
RNANPolHII
E2f1
Ctr9
Spt5
Wdr5
Capd3
Nipbl
Klf4
Zfx
Hdac1
Merg15
nNMyc
Tcfcp2l1
Hdac2
Esrrb
Cbp
RNANPolHIIHSer2p
EnhancerNPromoterHSmc1HChIANPETHHLoopHEnds
Ell2
Aff4
Rest
cNMyc
Suz12
Mbd3
Setdb1
HOct4
CtcfHChIANPETHHLoopHEnds
H3K27me3
Caph2
Ell3
Sox2
Stat3
Utx
Nanog
Brdm4
CoRest
Kap1
H3K9me3
Atrx
Tbx3
Smad1
Nr5a2

	
  

Observed Expected Diff
1628
69 OVER
9824
134 OVER
1539
23 OVER
1823
34 OVER
1556
14 OVER
1390
12 OVER
1420
13 OVER
2536
29 OVER
1606
75 OVER
1809
44 OVER
4902
44 OVER
3528
125 OVER
2669
40 OVER
2633
35 OVER
2213
75 OVER
3253
73 OVER
1914
34 OVER
4326
100 OVER
1560
17 OVER
1359
49 OVER
1240
9 OVER
1265
20 OVER
1259
23 OVER
1164
11 OVER
1201
38 OVER
1193
59 OVER
1078
25 OVER
974
14 OVER
927
9 OVER
910
5 OVER
890
4 OVER
823
7 OVER
831
12 OVER
784
13 OVER
723
8 OVER
698
4 OVER
712
11 OVER
687
3 OVER
582
2 OVER
645
27 OVER
610
15 OVER
596
16 OVER
527
19 OVER
476
1 OVER
372
3 OVER
320
5 OVER
311
3 OVER
316
10 OVER
278
1 OVER
270
8 OVER
266
9 OVER
235
5 OVER
309
36 OVER
210
7 OVER
269
33 OVER
186
7 OVER
113
11 OVER
171
39 OVER
75
2 OVER
78
8 OVER
135
42 OVER
51
1 OVER
67
9 OVER
108
30 OVER
314
187 OVER
34
1 OVER
19
2 OVER
10
1 OVER
33
19 no
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p3val
Obs/Tot
0.00E+00
0.14
0.00E+00
0.82
0.00E+00
0.13
0.00E+00
0.15
0.00E+00
0.13
0.00E+00
0.12
0.00E+00
0.12
0.00E+00
0.21
0.00E+00
0.13
0.00E+00
0.15
0.00E+00
0.41
0.00E+00
0.3
0.00E+00
0.22
0.00E+00
0.22
0.00E+00
0.19
0.00E+00
0.27
0.00E+00
0.16
0.00E+00
0.36
0.00E+00
0.13
1.31EN283
0.11
2.33EN280
0.1
3.43EN279
0.11
8.39EN276
0.11
9.55EN261
0.1
2.30EN252
0.1
1.05EN237
0.1
3.46EN231
0.09
1.32EN213
0.08
8.72EN206
0.08
2.04EN204
0.08
2.20EN200
0.07
9.37EN183
0.07
2.22EN181
0.07
8.18EN170
0.07
6.60EN159
0.06
9.69EN156
0.06
1.94EN154
0.06
7.34EN154
0.06
2.00EN130
0.05
3.42EN129
0.05
1.64EN128
0.05
1.07EN124
0.05
3.36EN107
0.04
5.69EN107
0.04
3.28EN82
0.03
2.78EN69
0.03
1.52EN68
0.03
2.73EN65
0.03
1.80EN62
0.02
2.83EN56
0.02
8.84EN55
0.02
2.39EN50
0.02
1.36EN49
0.03
1.39EN43
0.02
1.60EN42
0.02
2.78EN38
0.02
4.16EN20
0.01
5.74EN20
0.01
7.91EN17
0.01
3.97EN14
0.01
2.28EN12
0.01
3.88EN12
0
2.67EN11
0.01
2.76EN11
0.01
9.79EN09
0.03
2.38EN08
0
2.06EN04
0
6.64EN03
0
5.19EN02
0

	
  
Table 3.4: Results from co-localization analysis for BPTF
ChIP-Seq peaks Group B
BPTF9ChIP3Seq9peaks9group9B
Factor
H3K36me3
H3K4me1
H3.33Turn3Over3Sites
H2A.Z
H4K16ac
Merg15
Rest
H3K27me3
RNAAPol3II3ChIAAPET3Loop3Ends
Smc1
Ctr9
Smc13ChIAAPET3Loop3Ends
Smc3
Esrrb
H3K27ac
Cdk9
Cbp
RNAAPol3II3Ser2p
H3K4me3
Mbd3
Tcfcp2l1
Ctcf3ChIAAPET33Loop3Ends
Setdb1
Ringb1
Tet1
H3K9me3
Ctcf
Lsd1
EnhancerAPromoter3Smc13ChIAAPET33Loop3Ends
Kap1
Atrx
Yy1
Spt5
RNAAPol3II3Ser5p
p300
Rbbp5
Wdr5
NelfA
Nanog
Tbp
H3K9ac
Capd3
E2f1
Nipbl
nAMyc
Tbx3
Hdac2
Hdac1
H2A.Zac
Med1
Suz12
Utx
Stat3
Klf4
Nr5a2
RNAAPol3II
Ell2
Dpy30
CoRest
Zfx
Brdm4
Caph2
3Oct4
Smad1
Ell3
cAMyc
Aff4
Med12
Sox2

	
  

Observed Expected Diff
2939
133 OVER
2760
407 OVER
4537
321 OVER
1678
270 OVER
0
456 UNDER
373
6 OVER
355
33 OVER
517
127 OVER
334
50 OVER
0
192 UNDER
218
13 OVER
524
180 OVER
4
178 UNDER
255
42 OVER
422
137 OVER
532
217 OVER
260
61 OVER
153
11 OVER
0
120 UNDER
195
32 OVER
284
87 OVER
160
22 OVER
121
10 OVER
267
86 OVER
245
87 OVER
961
638 OVER
445
258 OVER
221
114 OVER
58
12 OVER
159
82 OVER
34
4 OVER
178
99 OVER
54
15 OVER
4
29 UNDER
20
58 UNDER
91
42 OVER
67
31 OVER
19
46 UNDER
201
142 OVER
6
22 UNDER
165
117 OVER
6
19 UNDER
13
30 UNDER
21
41 no
3
13 no
21
8 no
60
38 no
53
33 no
92
120 no
71
51 no
28
16 no
34
21 no
15
7 no
39
26 no
70
54 no
68
53 no
8
14 no
66
79 no
21
25 no
17
14 no
6
8 no
20
17 no
108
115 no
2
3 no
21
24 no
4
5 no
11
12 no
70
72 no
141
143 no
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p3val
Obs/Tot
0.00E+00
0
0.00E+00
0.02
0.00E+00
0.11
1.57EA228
0.04
1.03EA101
0
1.28EA79
0.01
2.46EA60
0
1.08EA53
0
8.31EA48
0.01
9.34EA44
0
1.43EA41
0.01
9.51EA39
0.01
3.87EA38
0
3.30EA35
0.01
1.13EA33
0.07
6.48EA31
0
9.14EA29
0.01
1.27EA28
0
5.81EA28
0
2.40EA27
0
1.18EA24
0.01
1.31EA24
0
2.85EA22
0
4.74EA22
0
3.67EA18
0.01
3.49EA16
0.01
1.42EA12
0.07
4.69EA09
0.01
3.79EA08
0
6.80EA07
0
1.13EA06
0
1.99EA06
0
2.64EA06
0
1.34EA05
0
1.67EA05
0
2.12EA05
0
2.74EA04
0.03
8.07EA04
0
1.41EA03
0
2.49EA03
0
4.19EA03
0.01
9.31EA03
0
9.51EA03
0
1.11EA02
0
1.24EA02
0
1.58EA02
0
2.62EA02
0
3.09EA02
0
5.42EA02
0
7.00EA02
0
7.04EA02
0
7.95EA02
0.01
8.80EA02
0
1.07EA01
0
1.50EA01
0
1.72EA01
0
2.01EA01
0
2.80EA01
0
5.55EA01
0
5.90EA01
0
5.93EA01
0
6.22EA01
0
6.39EA01
0
6.55EA01
0
6.55EA01
0
7.39EA01
0
8.35EA01
0
8.67EA01
0
9.05EA01
0

	
  
Table 3.5: Results from co-localization analysis for BPTF
dependent FAIRE-Sites Group A
BPTF9dependent9FAIRE3Seq9all9group9A9regions9
Factor
Smc1
Smc3
H4K16ac
Tet1
Ctcf
H3K4me1
H3K4me3
H3K9ac
H3K27ac
H3K36me3
H2A.Z
H2A.Zac
Smc1>ChIAAPET>Loop>Ends
RNAAPol>II>ChIAAPET>Loop>Ends
Cdk9
Dpy30
p300
Yy1
Lsd1
NelfA
Med12
Med1
H3.3>Turn>Over>Sites
Capd3
EnhancerAPromoter>Smc1>ChIAAPET>>Loop>Ends
RNAAPol>II>Ser5p
RNAAPol>II
Aff4
Sox2
Tbp
Rbbp5
>Oct4
CBP
Ell2
Ringb1
Nipbl
Spt5
Nanog
Ctcf>ChIAAPET>>Loop>Ends
Caph2
Ell3
Hdac2
Ctr9
Utx
Mbd3
E2f1
Suz12
Brdm4
Merg15
Hdac1
Wdr5
Tcfcp2l1
Klf4
CoREST
RNAAPol>II>Ser2p
Setdb1
H3K27me3
Rest
nAMyc
Esrrb
Zfx
cAMyc
Kap1
STAT3
Tbx3
Atrx
Smad1
H3K9me3
Nr5a2

	
  

Observed
1532
1417
5707
1629
1617
2845
2544
2506
2108
1433
2355
1801
1998
1473
2343
1200
1011
904
761
666
618
602
628
541
514
474
489
477
405
352
354
354
340
321
300
277
245
263
240
230
217
193
188
184
168
120
116
112
108
104
100
97
84
84
76
65
90
56
45
43
37
31
46
20
16
15
14
57
4
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Expected
7.666667
5.333333
52.66667
6
32.33333
48.66667
8.666667
13.66667
12
16
26.33333
16
18
8.333333
14.33333
6.333333
2.666667
9.666667
3.333333
1.333333
1
0.666667
18.33333
0.666667
2.666667
1.333333
7
3
9
0.333333
3
6
3.666667
1.333333
5
1
0.666667
9.666667
1.666667
0
0.666667
2
1.333333
1
1.333333
0.666667
1
0.666667
1.333333
1.333333
0.333333
1
0
0.666667
0.333333
0.333333
10
1.666667
0.333333
1.333333
0.333333
0
6.333333
0
0.333333
0.333333
0.333333
87.66667
7

Diff
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
UNDER
no

p3val
Obs/Tot
0.00E+00
0.19
0.00E+00
0.17
0.00E+00
0.7
0.00E+00
0.2
0.00E+00
0.2
0.00E+00
0.35
0.00E+00
0.31
0.00E+00
0.31
0.00E+00
0.26
0.00E+00
0.18
0.00E+00
0.29
0.00E+00
0.22
0.00E+00
0.25
0.00E+00
0.18
0.00E+00
0.29
1.04EA279
0.15
1.88EA234
0.12
1.54EA203
0.11
1.17EA173
0.09
2.15EA152
0.08
4.45EA141
0.08
2.54EA137
0.07
1.74EA132
0.08
4.56EA123
0.07
1.79EA115
0.06
1.55EA107
0.06
4.34EA107
0.06
6.54EA107
0.06
1.58EA86
0.05
3.09EA80
0.04
1.00EA78
0.04
8.40EA77
0.04
6.73EA75
0.04
1.55EA72
0.04
3.33EA65
0.04
1.37EA62
0.03
2.20EA55
0.03
8.43EA54
0.03
1.30EA53
0.03
1.13EA52
0.03
4.21EA49
0.03
4.38EA43
0.02
1.30EA42
0.02
1.01EA41
0.02
3.77EA38
0.02
1.81EA27
0.01
1.40EA26
0.01
1.08EA25
0.01
8.37EA25
0.01
6.47EA24
0.01
1.11EA23
0.01
2.31EA22
0.01
3.97EA20
0.01
1.78EA19
0.01
2.37EA18
0.01
6.56EA16
0.01
1.02EA15
0.01
1.22EA12
0.01
1.85EA11
0.01
2.29EA10
0.01
1.13EA09
0
2.50EA08
0
2.76EA08
0.01
7.64EA06
0
6.28EA05
0
1.07EA04
0
1.82EA04
0
9.71EA03
0.01
3.66EA01
0

	
  
Table 3.6: Results from co-localization analysis for BPTF
dependent FAIRE-Sites Group B
BPTF9dependent9FAIRE3Seq9all9froup9B9regions9
Factor
H3K4me1
H3K36me3
H2A.Z
H3.37Turn7Over7Sites
H4K16ac
Smc17ChIA6PET7Loop7Ends
H3K27ac
RNA6Pol7II7ChIA6PET7Loop7Ends
H2A.Zac
Cdk9
Sox2
Nanog
Ctcf
Lsd1
H3K9ac
Merg15
7Oct4
Ctcf7ChIA6PET77Loop7Ends
Enhancer6Promoter7Smc17ChIA6PET77Loop7Ends
H3K4me3
H3K9me3
Med12
Tet1
Utx
Smc1
Ell3
Med1
Hdac2
Cbp
Ctr9
Yy1
H3K27me3
Suz12
Aff4
Brdm4
Caph2
Pol7II7Ser2p
Mbd3
Smc3
Ell2
Klf4
Nipbl
Esrrb
Rest
Tcfcp2l1
Spt5
Setdb1
Dpy30
Hdac1
Atrx
Nr5a2
Kap1
p300
Ringb1
RNA6Pol7II
Capd3
Tbx3
CoRest
NelfA
Smad1
Stat3
Zfx
Tbp
RNA6Pol7II7Ser5p
Wdr5
Rbbp5
c6Myc
E2f1
n6Myc

	
  

Observed
2839
2011
1067
667
5
610
518
417
351
339
208
214
430
160
235
113
161
128
98
2
268
94
143
77
0
64
66
59
82
46
145
129
47
43
38
40
32
46
9
34
23
37
32
50
43
25
18
71
28
11
14
71
38
41
65
21
11
12
19
3
3
2
7
6
7
15
0
4
1

Expected
276
100.6667
180.6667
98
339
126.6667
87.33333
45.66667
68.66667
66.33333
34.33333
40.66667
172.6667
20
65.33333
5.666667
30
20.66667
8.333333
80.66667
497
12.33333
39.66667
10
39.66667
9.666667
12.33333
8.666667
21
4.666667
63.33333
53.33333
7
6.333333
4
5.333333
2.666667
9.666667
43.33333
4.666667
1.333333
7.666667
6.333333
16.66667
14.33333
5
2
38.33333
10.33333
1.333333
33.33333
42.66667
19
22.66667
44.33333
10
4
5.333333
10.33333
0.666667
1
1
5.333333
8
9
15.66667
0.333333
3.666667
0.666667
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Diff
OVER
OVER
OVER
OVER
UNDER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
UNDER
UNDER
OVER
OVER
OVER
UNDER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
UNDER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
OVER
UNDER
OVER
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no

p3val
Obs/Tot
0.00E+00
0.06
0.00E+00
0.04
1.38E6140
0.02
9.08E695
0.01
9.46E673
0
2.45E671
0.01
3.68E669
0.01
6.32E667
0.01
2.93E643
0.01
4.36E642
0.01
4.12E629
0
2.04E627
0
8.79E626
0.01
1.55E625
0
8.35E623
0
9.74E623
0
2.35E621
0
1.75E618
0
2.20E618
0
4.13E618
0
9.39E617
0.01
1.60E615
0
2.51E614
0
6.65E613
0
2.52E610
0
3.39E610
0
9.55E610
0
1.32E609
0
1.81E609
0
9.32E609
0
1.26E608
0
1.71E608
0
5.19E608
0
1.24E607
0
1.54E607
0
1.80E607
0
9.45E607
0
1.49E606
0
2.40E606
0
3.41E606
0
7.08E606
0
1.53E605
0
2.46E605
0
5.51E605
0
1.22E604
0
2.60E604
0
3.46E604
0
1.56E603
0
3.49E603
0
3.89E603
0
5.57E603
0
8.69E603
0
1.18E602
0
2.44E602
0
4.42E602
0
4.82E602
0
7.07E602
0
8.95E602
0
9.46E602
0
3.17E601
0
3.17E601
0
5.64E601
0
5.64E601
0
5.93E601
0
6.17E601
0
8.57E601
0
1.00E+00
0
1.00E+00
0
1.00E+00
0

	
  
3.9 BPTF Directly Interacts with the RNA-pol 2 Associated Protein THOC4
Our findings from the genome wide studies showed that overlap with H3K36me3
and H3K4me1, which suggest that these modifications could potential recruit BPTF to
chromatin. BPTF has multiple functional domains that could interact with H3K4me1 and
H3K36me3 (Alkhatib and Landry 2011). One of these domains is the PHD domain,
which is known to interact with histones, modified histones and non-histone proteins
(Musselman and Kutateladze 2011). BPTF has two conserved PHD domains (Figure
3.8.A). Although the C-PHD domain specifically interacts with the H3K4me3 (Wysocka,
Swigut, et al. 2006), it is possible that interaction with H3K4me1 or H3K36me3 can be
mediated through an uncharacterized N-PHD domain.
In order to discover possible interactions between BPTF and these histone
modifications, we performed in vitro co-immunoprecipitation using synthetic peptides for
H3K36me3 and H3K4me1 to pull-down endogenous BPTF from P19 cells, an
embryonic cancer cell line (McBurney 1993). As a positive control we used synthetic
peptides for H3K4me3, and synthetic peptides for H3 N-terminal tail and H3 amino acid
27-45 to guard for binding to unmodified H3. As expected we detected strong interaction
with the positive control H3K4me3, but did not detect an interaction between BPTF and
the K3K36me3 and K3K4me1 histone modifications (Figure 3.8.B). We concluded that
under these conditions, BPTF dose not interacts with H3K36me3 or H3K4me1. As the
N-PHD domain of BPTF has not been characterized, we speculate that it might interact
with novel recruiter for BPTF.
A project conducted by Marissa Mack in Dr. Landry’s lab showed that the N-PHD
does not interact with histone, DNA or RNA. However, unbiased screening using mass-
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spectrometry to identify novel factors associated with the N-PHD from total nuclear
extract discovered an interaction with the THOC4 (also known as REF/Aly). THOC4 is a
highly conserved protein that interacts with phosphorylated CTD of RNA-pol 2
(MacKellar and Greenleaf 2011), interacts with mRNA through RNA-binding domain and
localizes at gene bodies (Yoh, Lucas and Jones 2008) (Swinburne, et al. 2006). THOC4
can play multiple roles in transcription (Stubbs and Conrad 2015) including mRNA
processing (Yoh, Lucas and Jones 2008) mRNA export (Dufu, et al. 2010) (Stutz, et al.
2000) (Cheng, et al. 2006) and transcription activation (Bruhn, Munnerlyn and
Grosschedl 1997) (Suganuma, et al. 2005).
In order to confirm this interaction, we did co-immunoprecipitation (Co-IP)
analysis using mESCs nuclear extract. Co-IP using BPTF antibody detects
immunoprecipitation of THOC4, and reciprocal Co-IP with THOC4 antibody detects
immunoprecipitation of BPTF further supporting the in vivo interaction (Figure 3.8.C). To
investigate whether the THOC4 directly interacts with BPTF we performed in vitro pulldown using recombinant MBP-tagged THOC4 and recombinant NURF complex. This
analysis showed pull-down of BPTF with the MBP-THOC4 (Figure 3.8.D). To further
confirm that the interaction is mediated through the N-PHD domain, we performed in
vitro pull-down using GST-N-PHD and MBP-THOC4 (Figure 3.8.E). This analysis
showed that the N-PHD domain is sufficient in interacting with THOC4. Together these
results suggest a direct interaction between NURF complex and THOC4, likely through
the N-PHD domain of BPTF.
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3.10 BPTF Localizes to Gene Body and Regulates the Chromatin Structure and
mRNA Processing of Ccnd1 Gene
Our results show localization of BPTF in gene bodies and downstream regions of
genes, and interaction with THOC4, a mRNA processing factor. Next, we wants to
investigate whether recruiting BPTF to these regions could impact gene expression. To
this end, we selected the Cyclin D1 (Ccnd1) gene. We focused on Ccnd1 because (i) It
is a BPTF-dependent gene in mESCs (Landry, Sharov, et al. 2008), (ii) our ChIP-Seq
data show localization of BPTF at the gene body and 3’UTR, but not at the promoter
region (Figure 3.9.A), (iii) our FAIRE-Seq show a NURF-dependent change in chromatin
structure at 3’UTR (Figure 3.9.A).
In a separate project in our lab, we first confirmed that Ccnd1 is a BPTF
dependent genes using Northern blot, and its expression is down regulated in BPTF KO
mESCs. From this analysis no truncated transcripts were observed following BPTF KO.
In addition, we investigated whether BPTF regulate the promoter of Ccnd1 gene using
integrating reporter assay. In this assay, the Ccnd1 promoter is cloned upstream of
Neomycin resistant gene (Neo), and a linearized vector then stably transfected into
control and BPTF KO mESC. The active promoter will drive the expression of the Neo
gene which allows the cells to grow in Neomycin containing media. Thus, testing
whether the promoter is a BPTF dependent or independent is determined by monitoring
the ability of the control cells and BPTF KO mESCs to grow in media with Neomycin.
This analysis shows that the Ccnd1 promoter is BPTF independent in mESC, as no
difference was observed in the promoter activity in BPTF KO cells (Figure 3.9.B). These
results suggest that Ccnd1 is not regulated by NURF functions at the promoter.
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Further, our ChIP-seq data show no localization of BPTF at Ccnd1 promoter (Figure
3.9.A). Together, these finding suggest that BPTF regulate Ccnd1 gene expression
independent from transcription initiation.
Following transcription initiation, RNA-pol 2 engages in active elongation stage to
generate a pre-mRNA. Processing of the pre-mRNA including 5’ capping and splicing
occur co-transcriptionally as elongation proceeds through the DNA template. Successful
completion of this process results a mature mRNA that can be exported from the
nucleus and translated in the cytoplasm (Bentley 2014). However, defects in this
process result in unprocessed pre-mRNAs that are degraded by RNA degradation
pathways (Houseley and Tollervey 2009).
Our preliminary data suggest that BPTF does not regulate Ccnd1 transcription
initiation. As our genome wide data show that BPTF localizes in gene bodies and
results from our co-IP shows interaction with the mRNA processing factors THOC4, we
hypothesized that BPTF might regulate the pre-mRNA processing of Ccnd1. To test this
hypothesis, we used qRT-PCR to measure the presence of processed (spliced) and
unprocessed (unspliced) Ccnd1 transcripts. To adjust for the amount of the Ccnd1
transcript between the control and BPTF KO mESC we normalized to exon 1. While no
difference is observed in the processed transcripts, we observe an increase in the
unprocessed transcripts near the 3’end of the gene with BPTF KO (Figure 3.9.C). The
increase in the unprocessed transcripts is not due to amplification of genomic DNA, as
minus RT controls failed to show amplification for all the tested primers (Figure 3.9.C).
These analyses show that BPTF KO promotes intron retention in the Ccnd1 transcripts.
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The observed defects in intron retention correlate with our FAIRE-Seq data which
shows a defect at the 3’UTR of Ccnd1. To confirm this correlation we performed FAIREqPCR across the gene and confirmed the observed alteration in the chromatin structure.
The results show changes in the chromatin structure at the last coding exons and
3’UTR (Figure 3.9.D). Together these results suggest that BPTF regulates Ccnd1
mRNA processing, and open chromatin structure at the 3’end of the gene.
Next, we investigated whether the observed defects in mRNA processing are
associated with defects in THOC4 recruitment following BPTF KO. To this end we
perform ChIP assays. From these analyses we confirmed BPTF enrichment at the
Ccnd1 gene body and 3’UTR (Figure 3.9.E). Because the recruitment of many factors is
co-dependent we next performed ChIP for THOC4. This analysis found a reduction in
THOC4 localization at Ccnd1 promoter and gene body following BPTF KO (Figure
3.9.E), and this reduction in part overlaps with BPTF localization (Figure 3.9.E amplicon
# 3). To show that the observed reduction in THOC4 recruitment the Ccnd1 is not due
to a reduction in the protein level following BPTF KO in mESC, we measured THOC4
protein levels in BPTF KO ESC by Western blotting. This analysis showed no difference
in THOC4 level demonstrating that BPTF does not regulate THOC4 protein expression
(Figure 3.9.F). Together, these results suggest a correlation between THOC4
recruitment and BPTF recruitment.
The above results show defects in mRNA splicing at Ccnd1 and intron retention.
Pre-mRNA processing occurs co-transcriptionally and it can be influenced by RNA-pol 2
elongation rate and chromatin structure (Braunschweig , Gueroussov , et al. 2013).
Genome wide investigation showed an association between RNA-pol 2 pausing and
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intron retention in the transcript (Braunschweig, Barbosa-Morais , et al. 2014). RNA-pol
2 pausing can be in part due to defects in recruiting splicing factors (Fong and Zhou
2001) (Alexander , et al. 2010). In addition, H3K36me3 occupancy in genes increases
following inhibition of intron exclusion from transcripts (Kim, et al. 2011). Our ChIP
results show increase in RNA-pol 2 occupancy at the gene body and the 3’UTR as well
as an increase in H3K36me3 level throughout the gene in BPTF KO mESC (Figure
3.9.E). This suggests defects in normal elongation rate of RNA-pol 2 and occupancy of
the elongation mark H3K36me3 following BPTF KO. Thus, in agreement with previous
reports, our analyses show that the defects in intron retention within Ccnd1 transcripts
are accompanied with increase RNA-pol 2 and H3K36me3 occupancy within Ccnd1
gene.
Next, we wanted to test whether THOC4 has a role in BPTF recruitment at
Ccnd1 gene. To this end, we created THOC4 stable KD mESC line using retrovirus
system (Figure 3.9.G). To test whether THOC4 KD affects BPTF expression, we
examined BPTF protein level using Western blotting. This analysis shows an increase in
BPTF expression following THOC4 KD (Figure 3.9.G). To test if BPTF localization at
Ccnd1 gene body and 3’UTR is dependent on THOC4, we investigated BPTF
localization at Ccnd1 gene in THOC4 KD and control cells. This analysis shows
reduction in BPTF localization following THOC4 KD, after normalizing for differences in
BPTF expression with THOC4 KD (Figure 3.9.H). These results suggest that BPTF
recruitment to Ccnd1 is dependent on THOC4 localization. Along with the results from
THOC4 recruitment in BPTF KO cells, it is likely that BPTF recruitment and THOC4
recruitment are interdependent on each other.
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Our findings at Ccnd1 gene show that BPTF is localized at the gene and is
required for regulating the chromatin structure at 3’UTR. Loss of BPTF results in
alteration of chromatin structure, defects in elongation rate and promote intron retention.
Together, our results suggest that BPTF is required for normal Ccnd1 mRNA
processing.
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3.11 BPTF Regulates mRNA Processing at Multiple BPTF-Dependent Genes
The observed defects in mRNA processing at Ccnd1 gene suggest a role for the
NURF complex in regulating mRNA processing. In order to test whether this occurs
broadly, we used qRT-PCR to measure processed and unprocessed transcripts for four
different BPTF-dependent genes Gldc, Cnot1, Scd2, Soat1 genes. Our genome wide
data sets indicate that these genes have BPTF peaks, BPTF-dependent FAIRE sites
and are down regulated in expression following BPTF KO (Landry , Sharov , et al.
2008). Similar to the analysis for Ccnd1 Figure 3.9.C we used qRT-PCR to measure the
presence of processed (splices) and unprocessed (unspliced) transcripts of these
genes, after normalizing for the transcript level in the control and BPTF KO mESC.
Similar to the defects in Ccnd1 mRNA processing, we detect significant increases in the
unprocessed transcripts (unspliced) with no difference in the processed transcripts
(spliced) following BPTF KO (Figure 3.10.A). We did not detect amplification using
these primers in the minus RT control (Figure 3.10.B). This suggests that BPTF, and by
extension NURF, regulates mRNA processing at multiple genes.
Collectively, our results suggest a novel model for NURF complex in regulating
gene expression additional to its classical role in transcription initiation. In this model,
NURF is recruited to gene bodies and 3’ end of genes through physical interactions
between its BPTF subunit and THOC4. NURF localization to gene bodies recruits
mRNA processing factors to mediate normal pre-mRNA processing to generate mature
mRNAs. We propose that defects in chromatin structure with NURF depletion result in
RNA-pol 2 pausing and an increase in H3K36me3 levels. These defects in chromatin

	
  

150	
  

	
  
structure resulting in RNA-pol 2 pausing result in intron retention that promotes the
transcription degradation (Figure 3.11).
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Figure 3.11

With NURF
5
AAAA

5’ Cap

1

Stable
NURF

5’ Cap

NURF

N-PHD

H3K4me3

Thoc
4

4

2

N-PHD
S5
S2

Thoc
4

RNA pol2

3
Wild type cells,
1- Thoc4 localization mediates Bptf/NURF binding
2- Promotes open chromatin confirmation
3- Normal RNA pol II elongation rate
4- normal mRNA processing

Without NURF
5
AAAA

5’ Cap

1

unstable
NURF

5’ Cap

NURF

Thoc
4

H3K4me3

4

2
S5
S2
RNA pol2

3

Figure 3.11: Proposed
KO BPTF cells , model for the role of NURF in regulating mRNA processing
1- Reduces THOC4 localization
2- Promotes closed chromatin confirmation
3- Decreases RNA pol II elongation rate
4- Defects mRNA processing and induce intron retension

In control cells, THOC4 recruits NURF to gene bodies (1). Once recruited NURF
regulates the chromatin structure (2). This allows normal elongation of RNA-pol 2
(3), and leads to normal mRNA processing (4). Eventually, this generates mature
processed mRNA (5). In BPTF KO, hence no NURF complex, lacking BPTF
reduces THOC4 localization (1) and lead to defects in chromatin structure (2).
This alters RNA-pol2 rate and induce pausing within the gene (3). This causes
defects in the mRNA processing and intron retention within the transcripts (4).
Eventually, this generates immature mRNA (5).
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CHAPTER FOUR
Discussion and Future Directions

4.1 Discussion
One level of controlling gene expression is through regulation of chromatin
structure, which acts as a barrier, to provide accessibility for DBPs. Major regulator of
chromatin structure are ATP-dependent chromatin remodeling complexes (Clapier and
Cairns 2009). In common, these complexes utilize ATP to mediate their remodeling
activity. However, they have different function in vivo, which in part is due to their
subunits compositions and their interacting partners. Thus, studying how these
complexes are targeted to certain region in the genome and where they regulate the
chromatin structure will help to understand their roles in vivo.
One ATP-dependent chromatin-remodeling complex is NURF. In mESC, NURF
complex is not essential for the pluripotency state or cell viability, but it is required for
normal ESC differentiation. This is likely due to the observed defects in genes required
for differentiation. Works from animal models and human cell lines show that the major
role of NURF is to act as a regulator of RNA-pol 2 transcriptions (Alkhatib and Landry
2011). It is known that NURF is localized at promoters to regulate accessibility of TFs at
promoter regions (Badenhorst, Voas, et al. 2002) (Alkhatib and Landry 2011). This
recruitment achieved through interaction with H3K4me3 and/or sequence specific TFs.
However, how prevalent this role of NURF in regulating gene expression is unknown. It
is known that the role of chromatin remodeling complexes in transcription is not limited
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to transcription initiation. Genome wide studies uncovered roles of chromatin
remodeling complexes within genes and at distal regulatory elements (Schnetz, et al.
2010) (Smolle, et al. 2012). Thus, it is likely that NURF has as of yet uncharacterized
roles in regulating gene expression. The goal of this project is to discover novel ways
NURF regulates transcription of the genome by completing three specific aims…

Aim1: Identifying NURF Localization Genome Wide in Mouse Genome
In this aim we mapped NURF’s specific subunit BPTF in the mouse
genome using ChIP-Seq approach. In order to use this technique we generated
and characterized a BPTF ChIP grade antibody.

Aim2: Identifying NURF Dependent Changes in Chromatin Structure Using
FAIRE-Seq
In this aim we mapped NURF dependent changes in chromatin structure
using FAIRE-Seq approach. FAIRE-Seq profile from control and BPTF KO
mESCs were compared to identify NURF dependent changes in chromatin
structure.

Aim3: Characterize a Mechanism of NURF Recruitment to Chromatin and
Role in Regulation of Gene Expression
In this aim we characterized the role of a previously uncharacterized
domain in BPTF using in vivo and in vitro pull-downs.
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Also, we used qRT-PCR and ChIP analyses to characterize role of NURF
function within five BPTF-dependent genes.

As a result of completing these aims we show that BPTF localizes to and
remodels chromatin within gene bodies and 3’UTR of genes. This is an important
finding as it suggests new roles for NURF complex within gene bodies and 3’UTR. In
addition we discovered a new role for a previously uncharacterized domain the Nterminal PHD domain of BPTF. We show using in vivo and in vitro pull downs that this
domain mediate direct interaction with the RNA-pol 2 associated protein THOC4. This
interaction recruits BPTF and likely NURF to gene bodies as BPTF recruitment at
Ccnd1 gene is abolished following THOC4 KD. Moreover, we show using Ccnd1 as an
example that recruiting NURF to gene bodies has functional consequences as it is
required for normal mRNA processing, and BPTF KO is associated with defects in premRNA intron retention in the transcripts of BPTF dependent genes. We further show
that the defects in pre-mRNA intron retention found in four BPTF dependent genes.

4.1.1 Mapping NURF Localization in the Genome Using ChIP-Seq
NURF is a chromatin associated complex, the lack of ChIP-grade specific
antibody to study its localization limited investigating its role in vivo. In this work we
generated and characterized a ChIP-grade specific antibody for NURF specific subunit
BPTF. This antibody is specific as evident by the Western blotting (Figure 3.1 B), and
efficient in immunoprecipitation of BPTF bound chromatin as shown by ChIP-qPCR
(Figure 3.1.C). Moreover, our preliminary high seq experiments that compared amount
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of mapped reads from BPTF-1, BPTF-2 and IgG further confirmed the efficiency of
BPTF-2 antibody and that it can be used in genome wide experiments. Thus, the
availability of this tool will help in studying BPTF localization and by extension NURF
complex in vivo.
In this work we used BPTF-2 antibody to map BPTF localization in the mouse
genome. The results from our ChIP-Seq analysis uncovered new insights for BPTF and
by extension NURF complex localization. We found that BPTF is broadly localized to
the genome as opposed to pointed enrichment at certain sites. This localization pattern
of NURF, an ISWI complex, is in agreement with a previously suggested model for
localization of ISWI containing complexes to chromatin (Erdel, Schubert, et al. 2010). In
this model ISWI complexes continuously sample the chromatin with low residence time
in an ATP-independent manner. These low residence sampling functions are
interspersed with times of high residence presumably because they anchored at regions
where there is a localization signal. The signal can be histone modifications, histone
variants or DNA binding proteins. In case of NURF, the signals can be H3K4m3,
H4K16ac, CTCF or cohesin, as they physically interact with NURF subunits (Alkhatib
and Landry 2011) (Qiu, et al. 2015). Indeed, the identified BPTF peaks significantly
overlap with the sites of these factors (Figure 3.6.A) and BPTF signal are enriched over
these sites (Figure 3.2.G). In order to test this model, measuring residence time for
NURF with mutants that abolish interaction to these signals would be useful. Previously
reported mutations in the C-PHD domain (Wysocka, Swigut, et al. 2006) and the
bromodomain (Ruthenburg, et al. 2011) can be used in this regard as they specifically
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abrogate BPTF interaction to H3K4me3 and H4K16ac respectively, without affecting the
complex integrity.

Our results show BPTF localization at promoters, 5’UTR, within genes and 3’end
of genes (Figure 3.4.A, C). The enrichment at promoter regions is in agreement with the
known interaction between the C-PHD domain of BPTF and H3K4m3, a marker at
promoters (Shen , et al. 2012), and it also agrees with the many works that show the
role of NURF in regulating accessibility at promoter regions (Barak, Lazzaro and Cooch,
et al. 2004) (Vicent, et al. 2011). In addition, the obtained signal from our BPTF ChIPSeq at promoter regions (Figure 3.4.A) is similar to a signal from a previous ChIP-Seq
experiment performed using tagged construct for the C-terminal region of BPTF that has
the C-PHD and the bromodomain (Ruthenburg, et al. 2011). This further supports the
validity of our data.
In contrast to these known functions for NURF at promoter regions, we
uncovered new localization of BPTF at gene bodies, 3’UTR and downstream of genes.
This localization pattern for BPTF is novel to mammalian NURF, and resembles the
ISWI complexes in yeast in which there are three ISWI containing complexes Isw1a,
Isw1b and Isw2. Genome wide localization studies show that Isw1a and Isw2 localize at
TSSs and TTSs, while the Isw1b is physically recruited at gene bodies and 3’end of
genes (Smolle, et al. 2012) (Yen, et al. 2012). Isw1b is recruited to these gene features
through direct interactions between H3K36me3 and the PWWP domain of its IOC4
subunit (Smolle, et al. 2012). Although we see strong correlation between BPTF-ChIPSeq peaks and H3K36me3, our pull down analysis did not detect interactions with this
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modification in mESC. This might be due to lack of a subunit in NURF that has PWWP
domain, which interacts with H3K36me. This suggests that although the recruiting
mechanism is not conserved in mammals, the need for the ISWI complexes in gene
bodies and the 3’UTR is conserved.
A previous study performed BPTF ChIP-Seq in T47D human cell lines (Vicent, et
al. 2011). However, this study has low sequence depth and used a low quality antibody
that shows unspecific binding. The finding from this study showed that 41% of identified
BPTF peaks were localized to intragenic regions (Vicent, et al. 2011). This is in general
agrees with our finding that BPTF enriched within gene features.
Our genome wide data show that a significant portion of BPTF peaks localize at
gene bodies and 3’end of genes regions which do not localize known NURF recruiters.
How NURF is recruited to these regions? We envision that additional recruiters can
interact with NURF subunits and mediate the localization to these regions. Recruiting
factors to gene bodies can be through direct association with the elongating RNA-pol 2.
An example for this mechanism is recruiting the histone chaperone Spt6 to gene bodies,
which is mediated through direct interaction with phosphorylated p-Ser 2 at the CTD
domain of RNA pol-2 (Yoh, Cho, et al. 2007). In addition, interaction with factors
associated with RNA-pol 2 can recruit additional factors to gene bodies. Example of
such recruitment is the Chd1 chromatin remodeling factor that interacts with Paf1
complex and FACT complex, which are associated with RNA-pol 2 (Simic, et al. 2003).
Furthermore, histone modifications within genes bodies such as H3K36me3 can serve
as a recognition signal to recruit factors to gene bodies through direct interactions as
the case with the chromatin remodeling complex Isw1b (Smolle, et al. 2012) and factors
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involved in recruiting splicing regulators such as MRG15 (Zhang, et al. 2006). It is
possible that NURF can be recruited to gene bodies thorough one on these
mechanisms. The specific subunit of NURF, BPTF has functional domains such as Nterminal PHD, DDT, C-terminal PHD and bromodomain (Alkhatib and Landry 2011).
While the DDT, C-PHD and bromodomain mediate the interaction with ISWI, H3K4me3
and H4K16ac, respectively, the N-terminal PHD has not been characterized. Due to the
potential role of PHD domain in mediating protein-protein interaction with histone and
non-histone proteins (Musselman and Kutateladze 2011) we focused on characterizing
the role of BPTF N-terminal PHD domain.

4.1.2 Mapping BPTF/NURF Dependent Changes in the Genome Using FAIRE-Seq
Our results from the FAIRE-Seq analysis shows that BPTF-dependent changes
in chromatin structure reside within intragenic and intergenic regions, and within genes
more sites are at promoter regions (Figure 3.5.H). We also observed that NURF
maintain open chromatin structure and closed chromatin structure at almost equal
number of sites (27,864 open sites and 28,936 closed sites) suggesting that NURF
functions to reduce and promote accessibility to chromatin equivalently with no baized
toward one outcome. Although, we don’t see direct overlap between BPTF-ChIP Seq
peaks and BPTF-dependent FAIRE sites, we see more BPTF occupancy at TTS of
genes that have FAIRE-dependent sites and enhancer regions that overlap with BPTFdependent FAIRE sites versus the one that don’t, which suggests direct activity of
NURF at some of these sites.
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The distribution of open and closed NURF dependent changes in chromatin
structure in the genome is distinct. Within genes NURF mainly maintain open chromatin
structure at 1kb upstream, 5’UTR, 3’UTR and 1kb downstream, while it maintains
closed chromatin structure at intergenic (Figure 3.5.H). This pattern is also observed for
the yeast ISWI complexes Isw1a, Isw1b and Isw2 complexes (Whitehouse, et al. 2007)
(Yen, et al. 2012). Changes in chromatin structure following deletion of Isw2 were
localized 5’ end and 3’end of genes as well as intergenic regions (Whitehouse, et al.
2007), and similar pattern was observed for Isw1a (Yen, et al. 2012). However, Isw1b
mostly function within genes and 3’end of genes (Gkikopoulos, et al. 2011) (Yen, et al.
2012). This further suggests a conserved role of ISWI complexes in gene expression at
upstream within and downstream of genes.

4.1.3 Correlation Between BPTF Localization and BPTF-Dependent FAIRE Sites
and BPTF Dependent Genes in mESC
In mESCs there are 1,679 BPTF-dependent genes (Landry , Sharov , et al.
2008). Our ChIP-Seq and FAIRE-Seq data show that 871 out of 1,679 have BPTF
ChIP-Seq peaks (Figure 3.4.A) and 732 out of 1,679 have BPTF-dependent FAIRE
sites (changes in chromatin structure) (Figure 3.6.G) within the TSS and TTS. Although
we detect a correlation between BPTF dependent genes and BPTF localization and this
correlation equivalent to the INO80 complex, the correlation is not as strong as the
BRG1 and CHD7 chromatin remodeling factors we tested (Figure 3.4.A). The observed
correlation between NURF binding and function and gene expression agrees with the
observed correlation of ISWI proteins. Weak correlations were detected between ISWI
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proteins binding and gene expression in yeast and Drosophila (Gelbart, et al. 2005)
(Gkikopoulos, et al. 2011) (Sanchez and Zhou 2011). However, it seems that this
observation is not limited to ISWI complexes, but also extended to other chromatin
associated proteins. In a comprehensive analysis in yeast for correlation between
localization of 70 chromatin associated proteins and their dependent genes, it has been
shown that only 24% genes occupied by a factor are sensitive to its deletion (Lenstra
and Holstege 2012). Thus, it has been suggested that in general there is a weak
correlations between localization of chromatin-associated proteins and gene expression
(Lenstra and Holstege 2012). This likely indicates that while a chromatin-associated
factor can bind many genes, only genes with specific properties are sensitive to its lost.
It is also possible that other factors can compensate for its lost on some genes, which
indicates functional overlap and redundancy. In agreement with this, studies showed KD
of one chromatin remodeler have slight defect in chromatin structure, which is
significantly synergized by double mutant as for example the case for Chd1 and Isw1
double mutant in yeast (Gkikopoulos, et al. 2011).

4.1.4 BPTF Localization and BPTF Dependent Changes Over H3K36me3 and
H3K4me1 are More Correlated with BPTF Dependent Genes
Our overlapping analysis using genome runner with a panel of histone
modifications and DBPs show significant overlap between BPTF peaks as well as
BPTF-dependent changes in chromatin structures and factors localized at promoter
regions and within genes such as RNA-pol 2, H3K36me3, H3K4me1 and Cdk9
(Figure3.6.A, B). These agree with the pattern of BPTF signal from the ChIP-Seq over a
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meta-gene that resamples a signal of elongation factors (Figure 3.5.B). Along with the
observed distribution of BPTF peaks and BPTF dependent FAIRE sites over genes,
these indicate that NURF localization over genes is correlated with factors associated
with these regions.
As only 22% of BPTF peaks and 14% of BPTF-dependent FAIRE sites can be
explained by H3K4me3, H4K16ac, CTCF and cohesin, the majority of the remaining
sites are likely recruited to chromatin with novel recruiters. We found that BPTF ChIPSeq peaks and BPTF dependent FAIRE-sites that don’t overlap with H3K4me3,
H4K16ac, CTCF or cohesin (Group B sites) are more associated with BPTF dependent
genes (Figure 3.7.A, B). A work in Drosophila shows that the BPTF isoform that lacks
the C-terminal region (can’t recognize H3K4me3 and H4K16ac) is not required for the
majority of NURF dependent genes and the developmental defects associated with
losing NURF (Kwon, Xiao, et al. 2009). This suggests that recognition of H3K4me3 is
not required for the majority of BPTF genes. In agreement with BPTF signal from ChIPSeq, the overlap between group B peaks with the H3K36me3 and H3K4me1 suggest a
novel recruiting mechanism of BPTF to intragenic regions. This is further supported by
the overlap of group B FAIRE-sites with the elongation mark H3K36me3, which mainly
localizes at active genes.

4.1.5 BPTF Directly Interacts with THOC4
The results from our genome wide data suggest a novel recruiting mechanism of
BPTF in gene bodies. Although significant overlap was detected for H3K36me3, our
pull-down did not detect interaction with this modification (Figure 3.8.B). Thus, we
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thought that unknown factor is recruiting NURF through protein-protein interaction with
one of NURF subunit (BPTF, SNF2L or RbAp46/48 proteins). As BPTF is specific to
NURF and it has uncharacterized PHD domain, domain that is known to mediate
interactions with histone and non-histone proteins (Musselman and Kutateladze 2011),
it was subjected to investigation by a different project in our lab using unbiased
screening by mass-spectrometry. These analyses revealed an interesting interaction
with THOC4. THOC4 is a highly conserved mRNA binding protein that directly interacts
with the phosphorylated RNA-pol 2 in yeast (MacKellar and Greenleaf 2011). In
mammals, it also interacts with Iws1 a protein associated with RNA-pol 2 (Yoh, Cho, et
al. 2007). THOC4 also binds to mRNA and involves in mRNA processing and exporting
(Stubbs and Conrad 2015). These roles of THOC4 and our BPTF localization pattern
form the genome wide data suggest that THOC4 can recruit NURF to gene bodies. Our
in vivo pull down confirmed the interaction with THOC4 (Figure 3.8.C). However, a
previous work showed that THOC4 is identified as a protein associated with H3K4me4
using mass spectrometry (Vermeulen, et al. 2010). This study also showed enrichment
of all NURF subunits with H3K4me3 along with THOC4. Although this might support our
finding that THOC4 interacts with NURF complex, it does not rule out that this
interaction is indirect. As BPTF directly interact with H3K4me3, similarly THOC4 could
interact with H3K4me3 or any factors that interact with H3K4me3. In this case observing
NURF subunits and THOC4 in H3K4me3 pull down is due to indirect interaction through
H3K4me3. However, our in vitro pull-down using recombinant THOC4 protein and
recombinant NURF and the in vitro pull-down using the N-PHD domain arguing against
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this and indicate that the interaction between THOC4 and BPTF is direct (Figure 3.8.E,
D).

4.1.6 BPTF Regulates Messenger RNA Processing
The role of BPTF in regulating mRNA processing is suggested by BPTF
localization, BPTF dependent changes in chromatin structure and the interaction with
the mRNA processing factor THOC4. Our data at Ccnd1 support this hypothesis. The
observed defect in splicing at Ccnd1 transcripts at the last intron following BPTF KO is
associated with BPTF localization as well as BPTF-dependent changes in chromatin
structure. Also, a reduction in THOC4 localization was observed in the middle of Ccnd1.
In agreement with our results, a previous work showed that defects in THOC4
recruitment at c-myc gene is associated with increase in unspliced transcript (Yoh, Cho,
et al. 2007). In addition, depletion of THOC4, also affect recruitment of BPTF to Ccnd1
gene. Thus, our ChIP experiments suggest that THOC4 recruits BPTF, and once
recruited BPTF stabilizes THOC4 localization. Our results also show that BPTF KO is
associated with increase in H3K36me3 accumulation throughout the gene body and
increase RNA-pol 2 occupancy at the middle and the end of Ccnd1. These two features
are associated with intron retention in transcripts (Braunschweig, Barbosa-Morais , et al.
2014) (Kim, et al. 2011). Intron retention regulates the abundance of mRNA transcript
through generating immature transcripts that is subjected to degradation. Our results
from four genes support that the observed defects in Ccnd1 is likely occur at many
BPTF-dependent genes and not specific to one gene.
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How does NURF depletion result in intron retention? One possible mechanism is
that BPTF KO directly or indirectly enhances recruitment of factors that inhibit premRNA intron exclusion from the transcript by the splicing machinery. NURF remodeling
activity could remodel chromatin in front of RNA-pol 2 promoting its elongation. When
NURF is depleted, alterations in chromatin structure could occur which form barriers in
front of elongating RNA-pol 2, which in turn could result in a pausing of RNA-pol 2. This
pausing indicates a delay of RNA-pol 2 elongation, which provides more time for
splicing inhibitor to be recruited such as the splicing regulator PTBP1 (Yap , et al. 2012).
It has been shown that binding of PTBP1 protein at introns induces intron retention and
down regulation of genes (Yap , et al. 2012). PTBP1 directly interacts with MRG15 a
protein that localizes within genes through direct interaction with H3K36me3 (Zhang, et
al. 2006). Recruiting PTBP1 by H3K36me3/MRG15 has been shown to effect
alternative splicing (Luco, et al. 2010). As BPTF KO abnormally increases H3K36me3
within genes, it is possible that this facilitates recruitment of PTBP1, which in turn
inhibits exclusion of intron sequences from the transcript. In addition, H3.3K36me3 is
recognized by BS69 proteins, which is known to induce intron retention through
interfering with component of U5 snRNP spliceosome assembly (Gao, et al. 2009).
Thus, an increase in H3K36me3 occupancy might involve in recruiting factors known to
induce intron retention.

Our model from this work is that NURF is recruited to gene bodies through direct
interaction between BPTF and the mRNA processing factor THOC4 (Figure 3.11). Once
recruited, NURF stabilizes the mRNA processing factors and help in regulating the
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chromatin structure to facilitate elongation (Figure 3.11). BPTF KO alters the chromatin
structure, destabilizes the binding of mRNA processing factor, induces pausing of the
RNA-pol 2 within genes and increases H3K36me3. This lead to defects in pre-mRNA
splicing resulting in inclusion of an intron that affects the transcript stability (Figure3.11).

4.2 Future directions
This work investigates the role of NURF complex in regulating gene expression
in mESCs. However, recent work from our lab established that NURF functions as a cell
type specific regulator of gene expression (Qiu, et al. 2015). It would be of a great
interest to investigate if the roles for NURF discovered here as a regulator of intron
retention explain its functions as a cell type specific regulator of gene expression. To
facilitate these studies in addition to mESC, our lab has successfully generated BPTF
KO moues embryonic fibroblast (MEF) and DP thymocyte (Landry, et al. 2011) (Qiu, et
al. 2015). In addition, BPTF-dependent genes at these cell types have been identified
(Landry , Sharov , et al. 2008) (Landry, et al. 2011) (Qiu, et al. 2015). As the current
work generated and characterized a ChIP-grade antibody for BPTF, this will allow
mapping BPTF localization at these cell types. Employing BPTF-dependent genes
along with BPTF localization at these cell types and comparing BPTF localization
between these cells will be of great values to understand how NURF can function as a
regulator of gene expression in different cell types. In addition, investigating the
changes in chromatin structure by comparing FAIRE-Seq profile from control and BPTF
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KO cells will further help in determining what sites are common and specific between
different cell types.
The results from the current work show defects in mRNA processing as a
consequence of BPTF KO. In order to investigate whether this is a general effect
following BPTF KO, RNA-Seq approach would be required. In this experiment, RNASeq profile will be generated from control cells and BPTF KO cells, and mapped reads
to introns will be evaluated in these two conditions. In addition, RNA-Seq profile from
THOC4 KD cells would be useful to include in the comparison to assess to what extent
NURF and THOC4 work in regulating intron retention.
Although our work uncovered a new mechanism for BPTF recruitment to
chromatin through THOC4 localization within genes, recruiting mechanisms for large
number of BPTF sites at regions distal from genes still need to be uncovered. First, it
would be interesting to investigate how much of BPTF peaks could be explained by
interaction with THOC4. To this end, ChIP-Seq analysis would be required to identify
THOC4 localization in the mESC. The availability of ChIP-grade antibody for THOC4
suggests that genome wide profiling of THOC4 is possible. Alternatively, genome wide
mapping of BPTF using our ChIP-grade antibody in THOC4 KD background can be
used. Such analysis will be informative, as it will determine what fraction of BPTF peaks
requires THOC4.
Additionally, it would be interesting to investigate using unbiased screening what
proteins can interact with BPTF. To this end, generating a BPTF tagged construct that
would be stably transfected into the cell is needed. Following affinity purification of
BPTF bound partners; eluted fraction will be used for mass-spectrometry analysis. This
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approach will likely uncovered new partners of BPTF that can have an impact on its
function, and might explain part of its localization in the genome.
Finally, our work expands our understanding of how the mammalian NURF can
function as a regulator of gene expression. In oppose to its known role as a regulator at
promoter regions, we propose that NURF can also function within gene bodies to
regulate normal mRNA processing.
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